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SUMMARY 
Myogenesis is a key biological process in all vertebrates, comprising a 
series of tightly regulated steps mediated by myogenic regulatory factors. 
During the initial phase of myogenic differentiation, the actin cytoskeleton 
undergoes re-modeling with a reduction in actin stress fiber formation as 
myoblasts become elongated and aligned. This is followed by myogenic 
fusion of the mononucleated myoblasts to give rise to multinucleated 
myotubes. Disruptions in the myogenic signaling pathways block myogenic 
progression leading to an impaired muscular development. Adaptor protein 
p130Cas plays a critical role in many intracellular signaling cascades through 
undergoing phosphorylation and dephosphorylation as well as functioning as a 
scaffold for formation of multi-molecular complexes. Mice lacking p130Cas 
suffer from embryonic lethality with heart abnormality, systemic congestion 
and disrupted actin stress fiber formation, which support the crucial role of 
p130Cas in normal cardiovascular development. However, the physiological 
significance of p130Cas in other developmental processes, including skeletal 
myogenesis, remains to be determined. Skeletal muscle is critically involved 
in several biological functions, including force production and heat generation. 
Disruption to the muscle development or repair processes can lead to a 
detrimental state of the body.  
In this study, the importance of p130Cas in skeletal myogenic 
differentiation was addressed by the use of murine myoblastic C2C12 cells to 
investigate the regulatory mechanism involved in the facilitation of myotube 
formation. The silencing of p130Cas by shRNA resulted in the inhibition of 
myotube formation. Crucially, tyrosine phosphorylation of the p130Cas 
substrate domain was also found critically important for myogenic 
differentiation since myogenicity in p130Cas knockdown (CasKD) myoblasts 
was not rescued by the re-introduction of phosphorylation-defective p130Cas 
mutant (Cas15YF). In addition, integrin-3-dependent phosphorylation of 
p130Cas was shown to play a pivotal role in driving myotube formation via 
modulation of the actin cytoskeleton and muscle-specific gene expression. 
Depletion of integrin-3, a key regulator of myogenesis and actin dynamics, in 
C2C12 myoblasts attenuated both p130Cas phosphorylation and nuclear 
x 
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localization of SRF co-activator MAL during myogenic differentiation. 
Moreover, attenuation of p130Cas expression resulted in the activation of 
cofilin, an F-actin-severing protein. The increase in active (non-
phosphorylated) cofilin caused a shift of the intracellular G/F-actin 
equilibrium towards an increase in intracellular G-actin, which bound to MAL 
and subsequently, a reduction of MAL/SRF activity. Moreover, the 
introduction of a dominant-negative cofilin mutant restored myogenicity in 
CasKD myoblasts. Therefore, these results provided evidence that the 
integrin-3/p130Cas axis act to restrict the amount of G-actin in the cytoplasm 
and concomitantly facilitated the nuclear localization of MAL through the 
suppression of cofilin activity. 
In summary, this present study demonstrated the essential role of 
p130Cas for skeletal myogenic progression in C2C12 myoblasts and that the 
phosphorylation of p130Cas, mediated by integrin-3, facilitated inactivation 
of cofilin to promote myogenic differentiation through modulation of actin 
cytoskeleton remodeling and enhancing MAL/SRF transcriptional activity. 
These new findings provide novel insights into the regulatory mechanisms 
behind myogenesis with p130Cas as an important mediator of pro-myogenic 
signaling.  
xi 
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1 INTRODUCTION 
 
1.1 Vertebrate skeletal muscle 
Muscle tissue, one of the four basic types of tissue found in vertebrates, 
is a specialized tissue that can conduct electrical impulses as well as contract 
to produce a force. The development and regeneration of muscle tissue is 
highly crucial as muscle serves a multitude of functions in a living organism. 
In vertebrates, muscle tissue is further subcategorized into three main types 
based on their functionality and structural appearance, namely cardiac muscle, 
smooth muscle and skeletal muscle. Cardiac muscle and smooth muscle are 
involuntary muscles that are under the control of the central nervous system 
and their basic functions are essential for survival. Unlike smooth muscle, 
cardiac muscle has a striated appearance due to the presence of orderly 
arranged sarcomeres. Skeletal muscle also possess a striated appearance but 
the key difference separates skeletal muscle from the other two types of 
muscle is that it can be consciously controlled. Therefore, skeletal muscle is 
also known as voluntary muscle. 
Among the three major types of muscle, skeletal muscle is the most 
widely researched in many disciplines and early studies conducted using tissue 
culture models greatly contribute to the rapid progress in the field of skeletal 
muscle development (Yaffe, 1968; Devlin and Emerson, 1978; Konieczny and 
Emerson, 1984). Despite having over 600 skeletal muscle groups anatomically 
classified, all of these muscle groups are made up by similar fundamental 
structural units called muscle fibers or myofibers. The myofiber forms a 
multinucleated syncytium, a unique structure, which results from multiple cell 
fusions of individual mononucleated muscle cells or myoblasts. The 
mechanism behind cell fusion is of great interest as it is central to the 
development and regeneration/repair of muscle tissue. Fusion of muscle cells 
must be tightly controlled with precision to produce muscles of the correct 
orientation and size to perform the necessary biological functions. Along with 
in vitro experiments pertaining to muscle cell fusion, fruit fly Drosophila 
melanogaster (D. melanogaster) is used as a developmental model to study 
cell fusion of muscle in vivo. Recent in vivo studies identified two actin 
nucleation-promoting factors of the Arp2/3 complex, WASP and Scar, played 
3 
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key roles in facilitating cell fusion through the formation of fusion-associated 
F-actin foci (Sens et al., 2010; Mukherjee et al., 2011). The possibility of 
manipulating muscle cell fusion offers potential therapeutic significances in 
treating muscle injuries and muscle-related diseases. Cell therapy by 
transplantation and fusion of exogenous muscle cells with pre-existing muscle 
fibers may aid in the treatment of hereditary muscle diseases (Partridge and 
Davies, 1995; Wernig et al., 2000; Muir and Chamberlain, 2009). A clearer 
understanding of the mechanism pertaining to cell fusion will therefore be 
valuable in order to exploit this process for therapeutic purposes. 
In the vertebrate body, skeletal muscle accounts for nearly 40% of the 
body’s total mass, making it the most abundant tissue. Apart from its essential 
roles in force production for movement and support of the body, skeletal 
muscle is also one of the main generators of heat as well as a principal storage 
of carbohydrate and protein for the body (Schiaffino and Partridge, 2008). A 
severe loss or absence of skeletal muscle tissue or its function can be 
detrimental to the overall health of the organism as reported in patients 
suffering from muscular dystrophy (Emery, 2002). Therefore, the formation of 
muscular tissue is an important process during both embryonic and postnatal 
development and this process is known as myogenesis. In vertebrates, skeletal 
muscle formation is dependent on myogenic progenitor cells originating from 
the somite to give rise to nearly all skeletal muscle cells (Chevallier et al., 
1977; Tajbakhsh and Buckingham, 2000; Gros et al., 2005).  
 
1.1.1 Myogenesis – The development of muscle 
Myogenesis is a hierarchical multi-step process that is essential for the 
development, maintenance and regeneration of muscle tissues. It is an 
important process orchestrated by the concerted roles of master regulatory 
genes called myogenic regulatory factors (MRFs), controlling cell fate and 
committing cells to skeletal muscle lineage in response to extrinsic and 
intrinsic cues (Figure 1.1) (Pownall et al., 2002). The identification of the 
MRFs has greatly contributed to the understanding of the myogenic 
differentiation process. MRFs play important roles in regulating myogenic 
progression and function as terminal effectors of myogenic signaling cascades  
 
4 




Figure 1.1 – Schematic diagram of myogenic differentiation progression. Muscle 
precursor cells (myoblasts) continue to proliferate under mitogenic condition. In the 
presence of differentiation cues, the cells exit cell cycle and undergo a series of 
events that include cell alignment and formation of multinucleated myotubes resulted 
from cell fusion. These events are regulated by the expression of muscle regulatory 
factors and muscle-specific genes.    
5 
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by producing stage-specific transcripts. Together with MRFs, various signal 
transduction molecules such as mitogen-activated protein kinases (MAPKs), 
AKT/protein kinase B, cell cycle regulators and transcription factors, facilitate 
the expression of muscle-specific genes during myogenesis (Knight and 
Kothary, 2011; Bentzinger et al., 2012). 
In embryonic myogenesis, under the influence of morphogenetic and 
intrinsic signals, this multi-step process commences with specification of 
muscle lineage from embryonic progenitor cells, followed by proliferation of 
myogenic precursor cells (MPCs) called myoblasts. At this stage, these cells 
are capable of proliferation and self-renewal. In the absence of mitogenic 
stimuli, myogenic differentiation proceeds through a cascade of events that 
include irreversible cell cycle withdrawal of myoblasts, expression of muscle-
related genes, alignment and elongation of the cells, and fusion of 
mononucleated myoblasts into terminally differentiated multinucleated 
myotubes (Andres and Walsh, 1996; Pownall et al., 2002). The multinucleated 
myotubes further develop into mature muscle fibers or myofibers, which form 
the basic units for all skeletal muscles. As the muscle tissues mature, 
progenitor cells will enter a state termed quiescence and reside within the 
muscle tissue as satellite cells (Mauro, 1961; Buckingham, 2006). The process 
of myogenic differentiation has been recapitulated in vitro, in which myoblasts 
differentiate into myotubes with high efficiency in response to cues promoting 
differentiation, such as serum withdrawal or cell-cell contact, that ultimately 
lead to cell cycle withdrawal (Yaffe and Saxel, 1977; Lawson and Purslow, 
2000). In serum-deprived myoblasts, the depletion of specific mitogens, such 
as fibroblast growth factor 2 (FGF2), hepatocyte growth factor/scatter factor 
(HGF/SF), and transforming growth factor (TGF)- promotes myogenic 
differentiation (Ewton et al., 1988; Brunetti and Goldfine, 1990; Anastasi et 
al., 1997). 
Postnatal myogenesis occurs in a similar manner as embryonic 
myogenesis except that cell fusion in postnatal myogenesis occurs between 
myoblasts and pre-existing myotubes, and these myoblasts are derived from 
the activation of quiescent satellite cells, instead of embryonic progenitor cells. 
These quiescent satellite cells are defined as bona fide adult stem cells and 
6 
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share a common origin as embryonic muscle progenitors that can be traced 
back to the dermomyotome, a transient structure developed from the most 
dorsal portion of the somite (Gros et al., 2005; Relaix et al., 2005; Lepper and 
Fan, 2010; Bentzinger et al., 2012). In addition, common transcription factors 
and regulatory signaling molecules have been identified between embryonic 
myogenesis and postnatal myogenesis (Tajbakhsh, 2009). However, notable 
differences between the two events exist and distinct molecules have been 
reported to govern embryonic and postnatal myogenesis. Classically, Pax3 and 
Pax7 transcription factors are regarded as the major regulators of muscle cell 
specification and muscle tissue development during embryonic and postnatal 
stages of development in vertebrate (Oustanina et al., 2004; Relaix et al., 2005; 
Zammit et al., 2006). However, a recent in vivo study of Pax3 and Pax7 in 
adult satellite cells demonstrates that these two genes are dispensable for 
muscle tissue development and inactivation of these two myogenic 
determinants did not affect de novo myogenesis in adult, proposing the 
presence of distinct signaling molecules in play during postnatal myogenesis 
(Lepper et al., 2009). Instead, the myogenic activation of these adult satellite 
cells predominantly responds to environmental signals, such as mechanical 
stress or muscle injuries, which are transmitted through the p38 MAPK and 
AKT signaling cascades to initiate muscle differentiation and repair (Serra et 
al., 2007; Guasconi and Puri, 2009). 
Therefore, myogenesis is tightly regulated by an elaborate interplay of 
extrinsic and intrinsic regulatory mechanisms, neither of which is likely to be 
exclusive during both embryonic and postnatal development. The extent of 
contribution by each regulatory mechanism may vary depending on the 
developmental stage and cellular commitment. Morphogenetic signals play an 
important role in cellular commitment and the identity of these cells is further 
defined by intrinsic signals that stimulates or repress cell proliferation and 
differentiation during development (Pownall et al., 2002; He et al., 2009). 
 
1.1.2 The myogenic regulatory factors 
The current notion that a group of genes is responsible for the 
myogenic lineage is based upon the experiments in which myoblasts could be 
converted from mesodermal stem cell line, C3H10T1/2, and murine 
7 
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embryonic fibroblast (MEF) cell line, Swiss 3T3, after a brief treatment with 
demethylating agent 5-azacytidine (Taylor and Jones, 1979). It was then 
proposed that activation of a single locus or a few closely linked loci due to 
hypomethylation by 5-azacytidine was responsible for establishing the 
myogenic lineage (Konieczny and Emerson, 1984). This concept has been 
further supported by genomic transfection experiments in which introduction 
of DNA from 5-azacytidine-treated myoblasts successfully converted 10T1/2 
cells to myoblasts (Lassar et al., 1986). These previous studies of muscle 
differentiation eventually led to the discovery of the myogenic regulatory 
factors (MRFs) that acts downstream in the genetic network controlling 
myogenesis.  
The MRFs belong to a subfamily under the superfamily of basic helix-
loop-helix (bHLH) transcription factors with over 400 members that are 
involved in a wide array of developmental processes, including myogenesis 
and neurogenesis. In vertebrate, the MRF subfamily consists of myogenic 
factor 5 (Myf5), myoblast determination protein (MyoD), myogenin (Myog) 
and myogenic regulatory factor 4 (MRF4). MRF proteins are characterized by 
the presence of a highly conserved basic DNA domain, which binds to a 
consensus DNA motif (CANNTG) called an E-box, and a helix-loop-helix 
(HLH) domain that is required for heterodimerization with ubiquitous HLH-
containing proteins, known as E proteins. The E-box motif is present in the 
promoter region of many muscle-specific genes and deletion of this motif 
abolishes muscle-specific transcription in transient assays (Massari and Murre, 
2000). In addition, a conserved 3-amino acid motif, ATK, within the basic 
domain that confers the ability to induce the expression of muscle-specific 
genes makes MRFs distinct from all other bHLH proteins (Berkes and 
Tapscott, 2005). Members of MRF subfamily share about 80% amino acid (aa) 
homology in their bHLH domains. In vertebrates, although the individual 
MRF bHLH domains function similarly, specific activity of each MRF is 
determined by the presence of other regions/domains in the protein. 
Interestingly, myogenic defects resulted from a CeMyoD loss-of-function 
mutation in Caenorhabditis elegans (C. elegans) can be rescued using the 
Drosophila MRF or the chicken MyoD, indicating the remarkable functional 
conservation between vertebrate and invertebrate myogenic factors despite 
8 
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little sequence homology outside the bHLH domain (Zhang et al., 1999a). 
Expression of the MRF genes is exclusively in skeletal muscle and forced 
expression of these genes is able to convert many nonmuscle cells into muscle 
cells (Davis et al., 1987; Braun et al., 1990; Miner and Wold, 1990). In mouse 
model, gene knockout experiments established that the MRF proteins play a 
pivotal role in myogenesis (Rudnicki et al., 1993). Thus, it is well recognized 
that these MRF transcription factors are key regulators in the development of 
skeletal muscle. 
During skeletal muscle development, the MRF genes are activated 
sequentially and have specific activities on downstream muscle-specific genes 
modulating myogenic lineage establishment and differentiation (Tapscott, 
2005). During embryonic myogenesis, low expression of Myf5, together with 
Pax3 and Pax7, can be detected in cells of the dermomyotome. As 
development progresses, high expression of Myf5 and MyoD are detected in a 
pool of cells committed to skeletal muscle lineage, forming the primitive 
muscle structure called myotome. Subsequently, other MRF (myogenin and 
MRF4) and other muscle-specific genes are expressed at the differentiation 
stage of myogenesis (Perdiguero et al., 2009). Thus, Myf5 and MyoD has 
been conventionally  regarded as early MRFs involved in the commitment and 
proliferation of myoblasts, while the terminal differentiation of myoblasts 
involves late MRFs, namely myogenin and MRF4 (Patapoutian et al., 1995; 
Rawls et al., 1995; Pownall et al., 2002). In cultured myoblastic cell lines, 
stable autoregulation of Myf5 and MyoD expressions maintained the cells in 
their proliferative stage prior to myogenic differentiation (Thayer et al., 1989). 
However, expression of MyoD observed in differentiating myotubes 
contradicts this traditional notion. Together with myogenin, MyoD regulates 
the expression of genes necessary for terminal differentiation (Lassar et al., 
1991; Blais et al., 2005) and hence, making it also a late MRF. Similarly, 
MRF4 expression has been shown to promote myogenic commitment in 
Myf5/MyoD double-knockout mice, debating it as an early MRF (Kassar-
Duchossoy et al., 2004). Therefore, while it is clear that Myf5 and myogenin 
act primarily in lineage commitment and terminal differentiation of cells 
respectively, MyoD and MRF4 appears to partake in both processes. Although 
the function and regulation of these MRF genes may not necessarily be agreed 
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MyoD, also known as myogenic factor 3 (Myf3), is the first MRF gene 
identified and cloned in 1987 by subtraction-hybridization using cDNAs 
extracted from azacytidine-treated myoblasts (Davis et al., 1987). The 
identification of MyoD as a MRF is reputably a critical milestone in 
understanding the regulation of muscle development, which quickly led to the 
discovery of three more myogenic genes, namely Myf5, myogenin, and MRF4. 
The MyoD gene,  which is expressed only in myoblasts and skeletal muscle 
tissue but not in smooth or cardiac muscle or nonmuscle tissue, encodes a 
myogenic bHLH transcription factor that is made up of 318 aa in mouse (320 
aa in human) and has an observed molecular weight (MW) of 45 kilodaltons 
(kDa) under reducing condition. As a member of the MRF subfamily, the 
MyoD protein possesses the characteristic bHLH domain that is crucial for its 
myogenic transcriptional activity. 
The bHLH domain of MyoD is composed of approximately 70 aa and 
is responsible for the regulatory function of MyoD. Besides the bHLH domain, 
three other conserved domains have been identified in the structural analysis 
of MyoD, namely the N-terminal acidic domain, the histidine and cysteine-
rich (H/C) domain, and the helix III, and they function as transactivation 
domains (TADs) that binds to E-box motifs (Berkes and Tapscott, 2005). The 
N-terminal domain is a classical transactivation domain (TAD) that 
cooperatively binds MyoD to E-box motifs and disruption of this domain 
inhibits transactivation activity in a reporter gene assay (Weintraub et al., 
1991). The H/C and the helix III domains, located at the N- and C-terminal of 
the bHLH domain respectively, are important for the initiation of chromatin 
remodeling for gene expression as they facilitate stable binding of MyoD to 
the promoter region through an interaction with Pbx/Meis complex at the 
myogenin locus, independently of other TADs (Gerber et al., 1997; Berkes et 
al., 2004). Pbx/Meis complexes are constitutively bound to the E-box motifs 
found in the promoter regions of many muscle-specific genes, including 
myogenin. MyoD mutants, lacking a functional H/C domain or helix III 
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domain, are unable to interact with Pbx/Meis complex, thereby disrupting the 
expression of myogenin and other myogenic genes (Gerber et al., 1997; 
Bergstrom and Tapscott, 2001). In addition, the H/C-rich and helix III 
domains are functionally conserved between MyoD and Myf5, but not in 
myogenin, (Berkes and Tapscott, 2005), suggesting their key roles in 
determination of the functions of early and late MRFs. 
Expression of MyoD or the bHLH domain of MyoD is sufficient to 
activate the myogenic program and convert various nonmuscle cell types 
(melanoma, neuroblastoma, liver, and adipocyte) to myoblasts (Tapscott et al., 
1988; Weintraub et al., 1989).  This strongly supports the notion that MyoD is 
a master regulatory gene of skeletal myogenesis. Interestingly, in knockout 
experiments, mice devoid of MyoD are viable, fertile and exhibit normal 
skeletal muscle development by increasing and prolonging Myf5 expression 
(Rudnicki et al., 1992). Myogenin and MRF4 expression in MyoD knockout 
mice during myogenesis remains unaffected too. However, in the absence of 
MyoD, satellite cells do not progress through the differentiation stage but 
remain only in the proliferative stage, resulting in a severe defective 
regenerative capability of the muscle in adult MyoD knockout mice (Megeney 
et al., 1996). This illustrates a crucial role of MyoD in regenerative 
myogenesis, i.e. repair of muscle tissue. 
 
1.1.2.2 Myf5 
In the mouse embryo, Myf5 is the first MRF expressed during 
embryogenesis and it can be detected 8 days post coitum (dpc) in the 
dermomyotome (Ott et al., 1991). The protein is primarily localized in the 
nucleus and has a molecular weight of 28 kDa under reducing condition. Myf5 
is an upstream regulator of MyoD and is required for activation of MyoD in the 
myotome. Disruption of Myf5 resulted in a significant delay of MyoD 
activation at certain embryonic sites of myogenesis (Tajbakhsh et al., 1997). 
Unlike MyoD, expression of Myf5 is unlikely to be auto-regulated since 
ectopic expression of Myf5 in mice is unable to activate the endogenous Myf5 
(Delfini and Duprez, 2004). Myf5 is also expressed exclusively in the skeletal 
muscle and contains the characteristic bHLH domain which facilitates the 
protein binding to E-box motif as well as heterodimerization with HLH-
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containing proteins, such as E2A products. In addition, two other highly 
conserved domains that are important for the biological activity of Myf5 have 
also been reported each at the N- and C-terminal of Myf5 and the domains 
function as crucial TADs involved in gene expression. Deletion of either of 
these TADs completely inactivates Myf5 even if the bHLH domain remains 
intact (Winter et al., 1992). Forced expression of Myf5 can also initiate the 
myogenic program in various cell lines (Braun et al., 1989; Edmondson and 
Olson, 1989).  
Myf5 knockout mice were initially reported to suffer from perinatal 
death due to abnormal rib development but with no abnormality in the skeletal 
muscle except for a slight delay in the formation of myotomal cells during 
embryonic myogenesis (Braun et al., 1992; Tajbakhsh et al., 1996). 
Expression of other MRFs remains unaffected in Myf5 knockout mice. 
However, subsequent targeted disruption of the Myf5 alleles in which the 
PGK-neo-TK selection cassette was excised by Cre-recombinase gave rise to 
viable Myf5 knockout mice, exhibiting otherwise similar observed traits, and 
attributed the abnormal rib development observed in previous experiments 
was caused by long-distance effects on an unknown gene (Kaul et al., 2000). 
Together with MyoD knockout experiments, it is then postulated that Myf5 and 
MyoD play overlapping functional roles in myogenesis, particularly myogenic 
lineage commitment, since deletion of either gene alone does not affect 
skeletal muscle development. This hypothesis is further supported by the 
results from Myf5/MyoD double-knockout mice in which skeletal myogenesis 
is completely abolished with myogenin and MRF4 undetectable (Rudnicki et 
al., 1993). The absence of myoblasts in the Myf5/MyoD double-knockout mice 
suggests that these two genes are required for muscle lineage commitment and 
thus, considered as the early MRFs in myogenesis. Two independent groups of 
MPCs expressing exclusively either Myf5 or MyoD have been reported in 
mice and when cells expressing Myf5 is ablated, skeletal myogenesis proceeds 
normally in the presence of a MyoD-expressing lineage alone (Braun and 
Arnold, 1996; Haldar et al., 2008). These findings emphasize the presence of 
two independent myogenic lineages controlled by different upstream 
regulators, contributing to the plasticity of the muscular system during skeletal 
myogenesis. 
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1.1.2.3 Myogenin 
Myogenin (Myog), a member of the MRF subfamily, is also known as 
myogenic factor 4 (Myf4). The gene encodes a 224 amino acid-long bHLH 
transcription factor, migrating at a molecular weight of 34 kDa in SDS-PAGE. 
Myogenin is the third MRF isolated and identified by subtraction-
hybridization using cDNAs extracted from 5-bromo-2'deoxyuridine (BrdU) -
resistant myoblasts (Wright et al., 1989). Sequence analysis shows that 
myogenin shares high homology with other MRFs within the bHLH domain as 
well as within two other domains, the H/C-rich and helix III domains, which 
as mentioned earlier are not functionally conserved. In particularly, the helix 
III domain, which function as a domain critical for initiation of chromatin 
remodeling leading to myogenic gene expression, functions as a classical TAD 
in myogenin (Gerber et al., 1997; Bergstrom and Tapscott, 2001). Thus, the 
different function performed by a similar motif within the MRFs provides an 
explanation for the difference between specification and differentiation 
functions of MRFs, which share high sequence homology. 
Myogenin, a direct downstream target of Myf5 and MyoD in the 
myogenic network, is regarded as one of the two late MRF that is critically 
involved in the terminal differentiation stage during myogenesis in vertebrate 
and other MRFs are unable to compensate for the defect (Nabeshima et al., 
1993). In contrast, early myogenesis can be rescued in Myf5
myg-ki
/MyoD 
double-knockout mice, though the mutant mice die perinatally due to reduced 
muscle formation (Wang and Jaenisch, 1997). In addition, rib defects observed 
in Myf5 knockout mice (Braun et al., 1992) are rescued by expression of 
myogenin from the Myf5 locus (Myf5
myg-ki
), suggesting a functional 
redundancy of Myf5 and myogenin in rib formation (Wang et al., 1996). Even 
as a late MRF, transfection of myogenin into 10T1/2 cells or Swiss 3T3 
initiates the myogenic program as well as the activation of endogenous 
myogenin gene and tranactivation of MyoD (Wright et al., 1989). However, 
the efficiency at initiating the endogeneous myogenic genes is reportedly 
lower than that by Myf5 or MyoD transfection due to different evolved 
functions performed by the conversed H/C-rich and helix II domains in the 
MRFs (Gerber et al., 1997).  
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Mice lacking myogenin die perinatally and display a severe skeletal 
muscle deficiency, with only a few muscle fibers formed (Hasty et al., 1993; 
Nabeshima et al., 1993). Expression of MyoD is not affected while that of 
MRF4 is reduced. Interestingly, MRF4 can only be detected in the 
differentiated muscle fibers, suggesting that MRF4 operates downstream of 
myogenin but can potentially compensate myogenin deficiency and promotes 
differentiation in myogenin knockout mice (Rawls et al., 1995). While the 
myogenin knockout myoblasts failed to fuse into myotubes in vivo, the number 
of myoblasts expressing Myf5 or MyoD is not significantly affected suggests 
that myogenin does not play a role in specification of cells to myoblasts. 
However, it is noteworthy that myoblasts isolated from myogenin knockout 
mice are able to differentiate and form multinucleated myotubes under in vitro 
differentiation condition (Nabeshima et al., 1993). This suggests that other 
MRFs can compensate for myogenin deficiency in vitro and the differentiation 
potential of the myogenin knockout myoblasts under the two different 
conditions may be due to differences in the post-translational regulation since 
culture medium is not an exact replica of in vivo condition. Therefore, the 
biological function of myogenin does not lie with muscle lineage commitment 
but rather terminal differentiation. This is consistent with the upregulation of 
myogenin observed during myoblast differentiation in culture (Wright et al., 
1989) as well as results from double-knockout experiments of Myf5/myogenin 
and MyoD/myogenin in which the mutants also exhibited defective myoblast 
fusion (Rawls et al., 1995). 
 
1.1.2.4 MRF4 
Myogenic regulatory factor 4 (MRF4) is the last identified member of 
the MRF subfamily in vertebrates. Also known as myogenic factor 6 (Myf6) 
and herculin, the MRF4 gene encodes a 27 kDa bHLH transcription factor 
comprising of 242 aa and is located on the mouse chromosome 10 as Myf5 
gene, with approximately 8.5 kilobases (kb) separating the two loci (Miner 
and Wold, 1990). Similar to the other members of the MRF subfamily, MRF4 
contains a conserved bHLH domain and was identified and cloned by 
homology screenings for sequences similar to MyoD sequence (Rhodes and 
Konieczny, 1989; Miner and Wold, 1990). Likewise, MRF4 is solely 
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expressed in skeletal muscle tissue and transfection of this gene readily 
converts National Institute of Health (NIH) 3T3 and C3H10T1/2 cells into 
stable myogenic cell lines with similar, if not higher, frequency (Rhodes and 
Konieczny, 1989; Miner and Wold, 1990). Interestingly, subsequent 
expression of MRF genes in these stably MRF4-transfected cell lines differs. 
In MRF4-transfected NIH 3T3 cells, MyoD, myogenin and endogenous MRF4 
are expressed (Miner and Wold, 1990) while only MyoD and myogenin are 
expressed in MRF4-transfected C3H10T1/2 cells (Rhodes and Konieczny, 
1989).  
Functional studies of MRF4 using gene knockout and transgenic mice 
were performed by three different laboratories. The MRF4 knockout mice 
exhibited phenotypes ranging from ‘viable with no muscle defects’ to ‘lethal 
with some muscle defects and an increase in myogenin expression’ (Braun and 
Arnold, 1995; Patapoutian et al., 1995; Zhang et al., 1995). Viability of these 
mice appears to be directly correlated with the severity of rib abnormalities 
observed. The phenotypic variations observed in MRF4 knockout mice is 
likely due to the orientation of the targeting cassette and the deleted MRF4 
sequence which is unique in each generation of MRF4 knockout mice (Olson 
et al., 1996). In addition, the analysis of MRF4 gene was further complicated 
due to its close proximity to the Myf5 gene (Olson et al., 1996). Targeted 
disruption of MRF4 results in a cis effect on Myf5 in which the latter’s 
expression is affected (Floss et al., 1996; Yoon et al., 1997) since Myf5 
enhancer elements lie in a 14 kb region spanning the MRF4/Myf5 locus 
(Summerbell et al., 2000). Likewise, disruption of Myf5 also impaired the 
function of the neighboring MRF4 gene (Kassar-Duchossoy et al., 2004) and 
phenotypic similarities, like rib abnormalities, can be observed between Myf5 
knockout mice and MRF4 knockout mice.  
While the relatively normal skeletal muscle development in the MRF4 
knockout mice has suggested that MyoD and myogenin alone were sufficient 
to support skeletal muscle formation (Zhang et al., 1995; Yoon et al., 1997), 
the introduction of a myogenin promoter-MRF4 transgene into myogenin 
knockout embryos partially rescued myogenesis by restoring the endogenous 
MRF4 expression through positive autoregulation (Zhu and Miller, 1997). 
Collectively, these results suggested a functional redundancy between MRF4 
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and myogenin in myoblast fusion and myogenic terminal differentiation. On 
the other hand, recent studies have indicated a role in muscle lineage 
commitment for MRF4 whereby in MyoD/Myf5 double-knockout mice with 
MRF4 expression unaffected, skeletal muscle formation occurs normally 
(Kassar-Duchossoy et al., 2004). The MyoD/Myf5 double-knockout mice that 
were generated earlier exhibited severe muscle deficiency with both myogenin 
and MRF4 not detected (Rudnicki et al., 1993), a likely cis effect from Myf5 
mutations. Similar phenotype exhibiting a severe muscle deficiency was also 
observed in MyoD/MRF4 double-knockout mice and myogenin knockout mice, 
further prompting that MRF4 and MyoD participate in both muscle lineage 
commitment and terminal differentiation in a semi-redundancy manner (Rawls 
et al., 1998; Valdez et al., 2000). 
 
1.1.3 Factors regulating MRF expressions and their activities 
Aside from autoregulation or a direct downstream target of another 
MRF, the regulation of MRFs is also under the control of other molecules in 
the biological system. Several families of transcription factors play important 
roles in facilitating the differentiation and specification processes in skeletal 
muscle cells. The paired box (Pax) gene family, which encodes transcription 
factors characterized by the presence of a common paired-box domain, serves 
important and highly conserved roles in early development for the 
specification of tissues. Among the nine members, Pax transcription factors, 
Pax3 and Pax7, played important roles in myogenesis and are critical 
upstream regulatory genes the early MRF genes, Myf5 and MyoD 
(Buckingham and Relaix, 2007). In Pax3/Pax7 double-knockout mice, muscle 
formation is greatly disrupted and expressions of Myf5 and MyoD, as well as 
all other downstream myogenic factors, are abolished (Relaix et al., 2005; 
Bajard et al., 2006). Although earlier studies have suggested that Pax7 may be 
dispensable for embryonic muscle development and instead, plays a crucial 
role in postnatal development (Seale et al., 2000; Keller et al., 2004), muscle 
development can be partially recovered or less defective when Pax7 is 
expressed into Pax3 knockout mutant (Relaix et al., 2004, 2005). On the other 
hand, while in vitro expression of Pax3 or Pax7 dominant-negative constructs 
inhibits MRFs expressions and myogenic differentiation (Collins et al., 2009), 
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expression of Pax3 is unable to substitute the anti-apoptotic function of Pax7 
in murine satellite cells (Relaix et al., 2006). In addition, while removal of 
Pax3-expressing cells in mice is embryonically lethal, ablation of Pax7-
expressing cells does not inhibit commitment of myoblasts or embryonic 
myogenesis but only muscular defects in postnatal events (Hutcheson et al., 
2009). Together, these results illustrate the distinct and overlapping roles of 
Pax3 and Pax7 in the regulatory network of MRFs during embryonic and 
postnatal myogenesis. 
In addition, the serum response factor (SRF), which belongs to the 
MADS box transcription factors family, regulates differentiation and 
specification of skeletal muscle cells by controlling the expressions of MRFs, 
MyoD and myogenin, as well as many other muscle-specific genes such as 
skeletal alpha-actin (-actin), myosin heavy chain (MHC) and muscle creatine 
kinase (MCK) (Miano, 2003). SRF activates target genes by binding to the 
CArG box [CC(A/T)6GG] located within the serum response element (SRE) 
that is commonly present in the cis-regulatory regions of many muscle-
specific target genes. Inactivation of SRF in C2C12 murine myoblasts 
abolishes MyoD and myogenin expressions and prevents myotube formation, 
suggesting that SRF is necessary for myogenesis (Soulez et al., 1996). 
Transcriptional activity of SRF is regulated by its two families of SRF 
cofactors, the ternary complex factors (TCFs) and the myocardin-related 
transcription factors (MRTFs) that are controlled by unique signaling 
pathways – the Ras-extracellular regulated kinase (ERK) signaling and the 
Rho-actin polymerization pathways, respectively (Posern and Treisman, 2006). 
Phosphorylation of TCFs through the Ras-ERK signaling cascade promotes 
ternary complex formation of TCF with SRF and DNA which drives the 
expression of SRF target genes. On the other hand, while the founding 
member of MRTF family, myocardin, activates SRF constitutively, the 
activity of MRTF members, megakaryocytic acute leukemia (MAL) and 
MRTF-B, is regulated by Rho-actin polymerization pathway. Actin 
polymerization releases MAL from monomeric/globular actin (G-actin), 
leading to nuclear translocation of MAL which complexes with SRF and 
promotes SRF transcriptional activities. Early studies of the roles of SRF 
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during in vivo myogenesis were hindered by early embryonic lethality of SRF 
knockout mice (Arsenian et al., 1998). Subsequent studies revealed defective 
muscle growth, limited muscle regeneration capability following injury and 
down-regulation of interleukin-4 (IL-4) and insulin-like growth factor 1 (IGF-
1) activities in conditionally SRF-depleted muscles in mice, suggesting a key 
role of SRF in postnatal skeletal muscle development (Li et al., 2005; Charvet 
et al., 2006). 
The activity of MRFs is also influenced by the participation of other 
transcriptional activators, such as the Mef2, Six and Runx family members 
(Berkes and Tapscott, 2005). While, these transcriptional activators alone do 
not have myogenic activity but depends on transcriptional cooperation with 
MRFs to initiate the myogenic program, disruption of these genes can leads to 
an impaired myogenic process. For example, Mef2 and MyoD interacts 
directly in vitro and synergistically activate the myogenic program by binding 
to E boxes and Mef2 binding sites, which are often located in close proximity 
(Molkentin et al., 1995). Mutation of Mef2 leads to inhibition of myogenic 
differentiation in Drosophila (Lilly et al., 1995). The Six family is another 
example of transcriptional activators that is critically involved in myogenesis. 
Mice lacking Six1 and Six4 exhibit a severe muscular deficiency with 
expression of MyoD, myogenin, MRF4 and Pax3 affected (Grifone et al., 
2005). 
Similar to many other transcription factors, the modulated 
transcriptional activity of MRFs is also largely dependent on their interactions 
with co-activator or co-repressor proteins as well as post-translational 
modifications, such as phosphorylation. MRFs can interact with a variety of 
HLH-containing proteins to form different heterodimers. However, it is 
uncertain whether the heterodimers formed between a particular MRF and 
different HLH-containing proteins possess distinct biological functions. For 
example, ubiquitously expressed E proteins, E12 and E47, have been reported 
to form heterodimers with MyoD, and confers equally high DNA recognition 
affinity and enhanced transactivation potential (Lassar et al., 1991; Ma et al., 
1994; Rudnicki and Jaenisch, 1995). On the other hand, heterodimerization 
between MyoD and Inhibitor of DNA-binding (Id) proteins, which contain a 
HLH domain but lacks a basic DNA binding domain, negatively regulates the 
18 
Tan Wee Wee (HT080929L) 
activity of MyoD due to the formation of transcriptionally incompetent 
complexes (Benezra et al., 1990). Interactions with other transcriptional co-
factors can also influence the activity of MRFs. For example, the activity of 
MyoD is dependent on the recruitment of p300/CBP and PCAF, which allows 
maximal transcriptional activation (Dilworth et al., 2004). In contrast, the 
presence of MyoD and HDAC1 at the promoter of Myogenin gene abrogates 
transcription of downstream myogenic genes (Mal and Harter, 2003). 
Expression and activity of MRFs are also subject to regulation by 
protein kinases, directly or indirectly. Phosphorylation of specific residues can 
regulate the activity of MRFs and influence myogenic progression. For 
example, it has been reported that phosphorylation at threonine 87 of 
myogenin by protein kinase C (PKC) results in a significant decrease in its 
DNA binding activity (Li et al., 1992). Similarly, cyclin-dependent kinase 2 
(CDK2) and cyclin-dependent kinase 4 (CDK4) can both block the 
transcriptional activity of MyoD. Phosphorylation at serine 200 by CDK2 
promotes ubiquitination and degradation of MyoD (Tintignac et al., 2000) 
while CDK4 blocks DNA-binding activity of MyoD through an unknown 
mechanism that probably involves direct protein-protein binding (Zhang et al., 
1999b). Recent studies have also showed a dual layer control exhibited by p38 
MAPK, in particularly  and  isoforms, on the progression of myogenesis. 
Phosphorylation of E47, at serine 140, and MRF4, at serine 31 and 42, by p38 
MAPK promotes MyoD/E47 heterodimerization (Lluis et al., 2005) and 
represses transcriptional activity of MRF4 during early stages of myogenesis 
(Suelves et al., 2004). On the other hand, the inhibition of p38 MAPK 
signaling will promote late stages of myogenesis (Weston et al., 2003). The 
expression of Myf5 has been shown to be regulated by protein kinase A (PKA) 
via cAMP response-element binding protein (CREB)-mediated transcription 
(Chen et al., 2005). Interestingly, although PKA triggers the expression of 
several myogenic transcription factors, it has also been shown that PKA can 
inhibit the activity of MRFs (Knight and Kothary, 2011), suggesting a dual 
role of PKA in promoting and inhibiting myogenic events.  
In addition to upstream transcription factors, post-translational events, 
such as protein-protein interactions and phosphorylation, tightly controls the 
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activity of MRFs for the proper development of muscle. Heterodimerization 
between MRFs with different HLH-containing proteins or complex formation 
with other proteins can potentially produce unique biological functions in the 
regulatory cascade controlling myogenesis. Transition through the stages of 
myogenesis is also controlled by the intricate signaling mediated by protein 
kinases, coordinating the myogenic process. Furthermore, other post-
translational modifications, such as acetylation of MyoD by histone 
acetyltransferases (Polesskaya et al., 2000; Di Padova et al., 2007), 
autoregulation by MRFs (Thayer et al., 1989), and factors influencing nuclear 
translocation of MRFs (Rupp et al., 1994), have also been shown to regulate 
their myogenic activity. 
 
1.1.4 Relationship between myogenic differentiation, integrins and 
extracellular matrix 
The fate of a cell can be influenced by the physical properties, such as 
geometry (Bajaj et al., 2011), topography (Flemming et al., 1999) and 
stiffness (Flanagan et al., 2002; Engler et al., 2006), of the extracellular matrix 
(ECM) substrate that is composed of an interlocking network of fibrous 
proteins and polysaccharides, such as collagens, fibronectins, elastins, 
laminins and proteoglycans. ECM functions as a supporting scaffold for cells 
and also initiates biochemical and biomechanical cues which are transduced 
by cell surface receptors, such as integrins. Distinct cell lineage specification 
in mesenchymal stem cells (MSCs) can be programmed by culturing the cells 
on matrices with different levels of elasticity (Engler et al., 2006). For 
instance, culturing on soft matrix (~0.1 to 1.0 kPa) directs MSCs to 
neurogenic lineage while on stiffer matrix (8 to 17 kPa), the cells are 
committed to myogenic lineage. Pluripotency of mouse embryonic stem cells 
(mESCs) can be maintained in the absence of exogenous LIF by culturing the 
cells on soft substrate (~1 kPa) (Chowdhury et al., 2010). Similarly, culturing 
myoblasts on substrate with a stiffness of ~12 kPa (passive Young’s modulus) 
promotes optimal myogenic differentiation (Engler et al., 2004). Myosin/actin 
striations are not observed when the cells are differentiated on softer (~1 kPa) 
or stiffer (~17 kPa) substrates, suggesting that substrate’s rigidity can regulate 
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myofibrillogenesis. These results suggest that the cell fate can be regulated by 
varying ECM stiffness in a cell-type-dependent manner.  
Several studies have demonstrated that the interaction between cell and 
ECM plays an essential role for complete skeletal myogenic differentiation to 
occur (Buck and Horwitz, 1987; Osses and Brandan, 2002). Inhibition of 
collagen synthesis in cultured myoblasts abolishes myogenesis and blocks the 
expression of MyoD and myogenin (Saitoh et al., 1992). In addition, although 
the expression and nuclear localization of MRF myogenin remain unaffected, 
myotube formation is completely suppressed in myoblasts treated with 
inhibitors of proteoglycan synthesis or integrin antagonist RGDS peptides 
(Osses and Brandan, 2002). Proteoglycan is the main constituent in animal 
ECM and inhibition of proteoglycan synthesis affects the deposition and 
assembly of other ECM molecules, such as fibronectin and laminin (Carey, 
1991), potentially affecting the stiffness and integrity of the ECM. Addition of 
exogenous ECM is able to reverse the inhibitory effects and promotes 
myotube formation, suggesting that an intact ECM, coupled with the 
expression of myogenic genes, is required to complete the skeletal myogenic 
differentiation process. 
Cell-ECM interactions are mediated by integrins, a family of 
transmembrane receptors which forms a communication tool linking to the 
external environment of a given cell. Functional integrins are heterodimeric 
receptors composed by the combination of a  and a  subunit which define 
the ligand specificity. Therefore, the repertoire of ECM ligands that the cell 
can interact is defined by the integrins expressed by the cell. Integrins govern 
cell fate through both inside-out and outside-in signaling, facilitating cellular 
events such as cell adhesion, cell differentiation, cell proliferation and 
adhesion-initiated signal transduction (Geiger et al., 2001; Harburger and 
Calderwood, 2009). Altering ECM rigidity demolishes the precise spatial 
organization of ECM ligands, leading to a dysfunctional integrin-mediated 
signal transduction. Among the different  subunits of integrins, 1 and 3 
subunits are expressed in the vertebrate skeletal muscle and mediate 
myogenesis. However, integrin-1 is reportedly dispensable for myogenesis 
since myoblasts isolated from 1-null mice fused to form multinucleated 
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myotubes (Hirsch et al., 1998). In contrast, integrin-3 is essential in 
regenerative myogenesis as attenuation of integrin-3 expression impairs 
myogenic differentiation, particularly during muscle repair (Liu et al., 2011).  
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1.2 Adaptor protein p130 Crk-associated substrate 
The p130 Crk-associated substrate (p130Cas) is the founding member 
of the Crk-associated substrates (CAS) family in vertebrate, consisting of three 
other members, namely NEDD9/HEF1/Cas-L, EFS/Sin and CASS4/HEPL 
(Tikhmyanova et al., 2010a). It is also the most abundantly expressed among 
the four CAS family members in vivo or in cultured cells. Localization of the 
protein is influenced by its phosphorylation status. Unphosphorylated p130Cas 
is predominantly found in the cytoplasm while phosphorylated p130Cas is 
detected in membranous, nuclear and insoluble cytoskeletal fractions, as well 
as focal adhesion (FA) sites (O'Neill et al., 2000). p130Cas is ubiquitously 
expressed and its protein level remains consistent throughout cell cycle (Law 
et al., 1998). In lower vertebrates, chordates and insects including D. 
melanogaster, only one CAS family member has been reported while no 
homolog has yet been identified in C. elegans, Saccharomyces cerevisiae (S. 
cerevisiae) and lower eukaryotes (Tikhmyanova et al., 2010a). Members of 
the CAS family have been recognized as important multifunctional 
adaptor/scaffold/docking proteins modulating cellular signaling networks and 
influencing biological processes, such as cell cycle, cell migration, cell 
adhesion, wound healing, differentiation and survival, in both normal and 
pathological conditions (Defilippi et al., 2006; Singh et al., 2007; 
Tikhmyanova et al., 2010a).  
Alternative designations for p130Cas include BCAR1 (official gene 
name), CAS1, CASS1 and CRKAS. Originally identified as a 130 kDa protein 
that associates with Crk in a phosphorylation-dependent manner, p130Cas is 
found to be hyperphosphorylated at tyrosine residues in mammalian cells 
transformed by viral oncogenes, v-Crk and v-Src (Reynolds et al., 1989; 
Matsuda et al., 1990). The protein was first identified by immunoaffinity 
purification from rat 3Y1 fibroblastic cells transformed with v-Crk and its 
corresponding cDNA was then isolated and cloned (Sakai et al., 1994). The 
family name, CAS, was designated based on its association with Crk. Owing 
to its molecular structure, multiple binding consensuses on p130Cas are 
available for post translational modifications (PTMs), such as phosphorylation, 
as well as association with effector proteins including kinases and 
phosphatases, leading to the assembly of specific multi-protein complexes to 
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integrate and coordinate a variety of signaling events (Figure 1.2) (Defilippi et 
al., 2006; Tikhmyanova et al., 2010a). 
 
1.2.1 Functional and structural analysis of p130Cas domains 
Although p130Cas itself does not have any enzymatic or 
transcriptional activity known to date, functional analysis of the protein 
identified several conserved domains with sites for post-translational 
modifications, mainly consisting of serine and tyrosine phosphorylation, and 
protein-protein interactions. The domain structure of p130Cas protein, like 
other CAS family members, is characterized by four main elements (Figure 
1.3), namely an amino (N)-terminal Src homology 3 (SH3) domain, a large 
central substrate domain (SD), a serine-rich region (SRR) and a carboxyl (C)-
terminal domain (Sakai et al., 1994; Tikhmyanova et al., 2010a). Functional 
studies of these domains provide insights to the regulation and roles of 
p130Cas in signal convergence and determination of cellular responses. 
 
1.2.1.1 Src homology 3 domain of p130Cas 
The N-terminal SH3 domain of p130Cas shares high sequence 
homology (75%) with other CAS family members and interacts with proteins 
containing polyproline-rich motifs, such as focal adhesion kinase (FAK), 
PYK2/RAFTK, protein phosphatases such as PTP-PEST, PTP1B, and 
effectors such as C3G and CIZ (Defilippi et al., 2006; Tikhmyanova et al., 
2010a). The interaction between p130Cas SH3 domain and FAK contributes 
to tyrosine phosphorylation of p130Cas substrate domain by Src that is bound 
to FAK autophosphorylation site, Tyr-397 (Ruest et al., 2001), as well as FA 
targeting of p130Cas (Donato et al., 2010). Deletion of p130Cas SH3 domain 
impairs tyrosine phosphorylation and dephosphorylation events of p130Cas 
substrate domain since its SH3 domain is crucial for p130Cas to be localized 
to FAs where p130Cas is phosphorylated (Fonseca et al., 2004). In addition, a 
novel phosphorylation site tyrosine-12 (Y12) that lies within the p130Cas SH3 
domain regulates focal adhesion assembly, cell migration, and invasiveness of 
Src-transformed cells (Janostiak et al., 2011). Cell migration is retarded when 
this tyrosine residue is mutated to phenylalanine. While the full crystal 
structure of p130Cas has not been resolved, a 1.1 angstrom (Å) crystal   
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Figure 1.2 – p130Cas interacting partners and gene ontology. Top panel shows 
the various proteins that are reported to interact with adaptor protein p130Cas. 





Figure 1.3 – Schematic diagram of p130Cas domain architecture. Murine adaptor 
protein p130Cas is 874 amino acids long and contains a N-terminal Src homology 
(SH3) domain, a central substrate domain (SD), a serine-rich region (SRR) and a C-
terminal domain. In addition, the N-terminal region contains a proline-rich region 
(PRR) while 15 YxxP motifs are located within the central SD. Red arrowheads 
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structure of p130Cas SH3 domain is available, which enables better 
understanding of the protein-protein interaction involving SH3 domain and 
facilitates structure-based studies of SH3 domain inhibitors (Wisniewska et al., 
2005). 
 
1.2.1.2 Substrate domain of p130Cas 
The central substrate domain (SD) of p130Cas is characterized by the 
presence of fifteen YxxP motifs with at least ten of these motifs that can be 
phosphorylated by non-receptor tyrosine kinase Src to create binding sites for 
effector proteins with Src homology 2 (SH2) or phosphotyrosine-binding 
(PTB) domains, which in turns activate downstream signaling cascades (Shin 
et al., 2004). It is, therefore, not surprising that the majority of p130Cas 
phosphorylation occurs in the SD. Biophysical studies indicate that p130Cas 
acts as a mechanosensor that facilitates transformation of external physical 
information into intracellular biochemical signals (Sawada et al., 2006). 
In addition, p130Cas SD has been implicated in promoting cell 
motility (Shin et al., 2004) and metastasis (Brabek et al., 2005) via a manner 
dependent on Src phosphorylation of the YxxP motifs. Although FA targeting 
of p130Cas is independent of its SD tyrosine phosphorylation (Cunningham-
Edmondson and Hanks, 2009), tyrosine phosphorylation of p130Cas SD is 
required for the activation of p130Cas signaling which subsequently promotes 
the recruitment of downstream SH2-containing effectors, such as Crk and Nck 
to facilitate protrusion of the plasma membrane (Chodniewicz and Klemke, 
2004; Rivera et al., 2006). The Src-p130Cas-Crk complex recruits DOCK180 
and promotes Rac1 activation, membrane ruffling, actin cytoskeleton 
remodeling, FA turnover, and pseudopodia formation and extension at 
lamellipodia and filopodia adhesion sites (Kiyokawa et al., 1998; Sharma and 
Mayer, 2008). The involvement of the SD in cell motility appears to be 
conserved among the CAS family members. Cell migration is abolished in T 
cells expressing mutant Cas-L with SD deleted (Ohashi et al., 1999). High 
levels of p130Cas SD tyrosine phosphorylation detected in both estrogen 
receptor negative (ER-) and in tamoxifen-treated estrogen receptor positive 
(ER+) breast cancer cells have been implicated in progressed malignancy with 
increased migration, invasion, and survival of the breast cancer cells (Cowell 
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et al., 2006; Cunningham-Edmondson and Hanks, 2009). While the pathways 
conferring tamoxifen-resistance in ER+ breast cancer cells remains 
inconclusive, tyrosine phosphorylation of p130Cas SD appears to be critical 
for their tamoxifen-resistant survival (Kirsch et al., 2002; Soni et al., 2009). 
 
1.2.1.3 Serine-rich region of p130Cas 
At the C-terminal of the central substrate domain lies the SRR that has 
relatively little amino acid homology among the four CAS family members, 
except for the numerous serine residues. Structural analysis of the SRR using 
nuclear magnetic resonance (NMR) spectroscopy indicates a stable domain 
comprised of four-helix bundle that functions as a protein interaction site for a 
subset of p130Cas-interacting partners, such as 14-3-3 family members 
(Briknarova et al., 2005; Wisniewska et al., 2005). Two putative 14-3-3 








, have been reported and interaction 
between the p130Cas SRR and the interacting proteins is phospho-serine 
dependent (Briknarova et al., 2005). In affinity assays using mutant p130Cas 
with SRR deleted and protease-treated p130Cas, the association of p130Cas 
with 14-3-3 proteins significantly diminished (Garcia-Guzman et al., 1999). 
 
1.2.1.4 Carboxyl-terminus domain of p130Cas 
The C-terminal domain of p130Cas is highly conserved in the CAS 
family in terms of amino acid sequence and their predicted secondary structure. 
However, no structural data is currently available perhaps because 
overexpression of this isolated domain in cultured cells results in cell death 
(O'Neill and Golemis, 2001; Kim et al., 2004). Within the C-terminal domain 
of p130Cas, sequence analysis reveals a Src-binding domain (SBD) and a 
conserved C-terminal homology (CCH) domain, also known as FAT-like 
domain. The SBD is a bipartite binding site consist of a YDYVHL motif and a 
proline-rich region (RPLPSPP) that respectively functions as consensus 
binding sites for SH2 and SH3 domains of Src kinases (Nakamoto et al., 1996; 
Tikhmyanova et al., 2010a). The YDYVHL motif, found conserved in the C-
terminal domain of other CAS family members except CASS4/HEPL, is 
phosphorylated by FAK during early cell adhesion events, facilitating the 
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recruitment of Src family kinases (Tachibana et al., 1997). In addition to 
functioning as a binding site for the SH3 domain of Src family kinases, the C-
terminal proline-rich region serves to activate Src family kinases through the 
process of SH3 domain displacement which initially blocks the kinase domain 
(Pellicena and Miller, 2001). Therefore, while disruption of YDYVHL motif 
has little effect on the interaction between p130Cas and Src, the disruption of 
p130Cas C-terminal proline-rich region abolishes p130Cas-Src complex 
formation and diminishes tyrosine phosphorylation. Together, both YDYVHL 
motif and proline-rich region in the SBD contribute to processive 
phosphorylation of the multiple YxxP motifs in p130Cas SD by Src (Mayer et 
al., 1995). Several proteins containing SH3 domains, including PI3K and 
adaptor protein p140 Cas-associated protein (p140Cap), have also been 
reported to form complexes with p130Cas via its C-terminal proline-rich 
region (Di Stefano et al., 2011). Similar to disruption of its SH3 domain, 
deletion of p130Cas CCH domain alone impairs FA targeting of the protein 
(Donato et al., 2010). It is proposed that the p130Cas CCH domain can 
function as an FA targeting domain akin to the FAK FAT domain. The 
determination of the tertiary domain structure of p130Cas CCH domain will 
be beneficial in confirming this hypothesis particularly because structure 
prediction indicates only three helices (Arold et al., 2002; Donato et al., 2010).  
In the C-terminal of p130Cas, a HLH domain that promotes 
dimerization of proteins has also been reported (Kim et al., 2004). This HLH 
domain shares greater sequence homology with Id proteins than with bHLH 
proteins (Law et al., 1999) and has been implicated in caspase-mediated 
apoptosis (Kim et al., 2004) and cell cycle progression (Kim et al., 2008a). 
Though p130Cas homodimers have yet been reported, the conserved C-
terminal HLH domain has been shown to mediate homodimerization of 
NEDD9, a member of the CAS family, as well as NEDD9 heterodimerization 
with HLH-containing proteins, such as Id2, E12, E47, and p130Cas itself 
(Law et al., 1999). In addition, the HLH domain mediates the interaction 
between p130Cas and Smad3 and deletion of the HLH domain abolishes the 
interaction (Kim et al., 2008a). Thus, the potential existence of p130Cas dimer 
in vivo, which probably involves the HLH domain and other consensus 
binding sites based on their functionalities, remains.  
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1.2.1.5 Other p130Cas functional domains 
Aside from the key functional domains of p130Cas, sequence analysis 
reveals ten potential caspase-3 cleavage sites with the DxxD consensus 
sequence and majority of these sites are located in the SD region. In vitro 




 in rat 
p130Cas, are cleaved by caspase-3 to facilitate the processing and destruction 
of p130Cas during apoptosis and point mutations in these sites abolish 
caspase-3-mediated cleavage of p130Cas (Kook et al., 2000). DVPD
416
 
consensus sequence is located within p130Cas SD while DSPD
748
 consensus 
sequence lies within the SBD (Figure 1.3, red arrowheads). Generation of 
the p130Cas caspase-3-cleaved fragments has been shown to be dependent on 
the phosphorylation activities at the tyrosine and serine residues immediately 




 (Hoon Kim et al., 
2003). Dephosphorylation of p130Cas strongly facilitates caspase-3 activity 
while phosphorylation confers p130Cas protection against caspase-3-mediated 
degradation. This is further supported by the rapid p130Cas proteolysis 
observed during anoikis in which p130Cas is dephosphorylated when cell-
matrix interactions are disrupted (Wei et al., 2004).  
Caspase-3-mediated cleavage at DVPD
416
 generate a 74 kDa fragment 
of p130Cas, which in turn can be cleaved at DSPD
748
, giving rise to a 47 kDa 
and a 31 kDa fragments. Whereas the functions of other p130Cas fragments 
have yet been reported,  the C-terminal 31 kDa caspase-3 cleaved fragment 
has been shown to function as a dominant negative regulator which attenuates 
E2A-mediated p21
Waf1/Cip1
 expression and promotes apoptosis by forming a 
transcriptionally inactive dimer with E2A proteins via its HLH domain (Kim 
et al., 2004). This result illustrated the participation of p130Cas HLH domain 
in two distinct pathways, namely apoptosis and cell survival, depending 
whether it is the truncated C-terminal fragment or the full-length protein. 
Other p130Cas fragments generated by proteases’ activity may potentially 
serve some biological functions but this remains to be determined.  
In addition, following the SH3 domain is a short proline-rich region 
that has no known function to date but may act as a putative binding site for 
SH3 domain-containing proteins or other protein-interaction domains, e.g. 
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WW domain, that prefer ligand sequences rich in proline residues (Ball et al., 
2005). On the other hand, this N-terminal proline-rich region may simply be a 
structural element without any functionality. In Drosophila and C. elegans, 
proline-rich regions are the first and second most common motif found in their 
respective genomes and domains that bind to proline-rich regions are critical 
for the initiation of many intracellular signaling assembly (Zarrinpar et al., 
2003). Given the extensive involvement of proline-rich regions in signaling, 
designing drugs based on polyproline peptides or peptidomimetics to alter 
p130Cas signaling for therapeutic purposes may be a potential option. 
 
1.2.2 Multisite phosphorylation of p130Cas 
Phosphorylation is the major post-translational modification of 
p130Cas and multisite phosphorylation of its tyrosine, serine and threonine 
residues facilitates recruitment of downstream effector proteins and activates 
p130Cas-mediated signaling cascades. Serine/threonine phosphorylation of 
p130Cas has generally been less studied and majority of p130Cas tyrosine 
phosphorylation reported were found in the substrate domain (Shin et al., 
2004). The activities of p130Cas can be regulated by phosphorylation at more 
than one YxxP motif. For example, a mass spectrometry study showed that up 
to eleven YxxP motifs in p130Cas were phosphorylated by Src in vitro 
(Goldberg et al., 2003). Among these phosphorylated YxxP motifs, at least 
four have to be phosphorylated so as to promote p130Cas-dependent cell 
migration (Shin et al., 2004). On the other hand, phosphorylation of tyrosine 
12 alone is sufficient to recruit FAK to p130Cas SH3 domain and subcellular 
localization of p130Cas to focal adhesions (Janostiak et al., 2011). 
 
1.2.2.1 Tyrosine phosphorylation 
Tyrosine phosphorylation in p130Cas can be induced by a variety of 
stimuli. Among the many stimuli reported, growth factors and hormones, such 
as fibroblast growth factor 2 (FGF-2), vascular endothelial growth factor 
(VEGF), and angiotensin-II, increase p130Cas tyrosine phosphorylation and 
have been associated with cell motility and invasion (Avraham et al., 2003; 
Korah et al., 2004; Kyaw et al., 2004). As such, it is not surprising that cell 
surface receptors, such as integrins, receptor protein tyrosine kinases (RPTKs) 
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and estrogen receptor (ER), are major upstream regulators of p130Cas and Src 
family kinases has been identified as the main kinase inducing 
hyperphosphorylation of p130Cas in many of these receptor signaling 
pathways. In vascular smooth muscle cells (VSMCs), tyrosine 
phosphorylation of p130Cas is stimulated by angiotensin-II via angiotensin II 
type 1 (AT1) receptors and is inhibited in the presence of an AT1-receptor 
antagonist (Takahashi et al., 1998). In addition, both angiotensin-II-simulated 
migration of VSMC and p130Cas tyrosine phosphorylation are inhibited in the 
presence of Src family kinase inhibitors, suggesting that Src activity is 
required for VSMC growth and cell migration (Kyaw et al., 2004). This is 
further supported by the overexpression of kinase-inactive Src which does not 
co-localize with p130Cas in VSMC. Tyrosine phosphorylation of p130Cas is 
also induced by forced re-expression of fibroblast growth factor-2 (FGF-2), 
leading to stabilization of focal adhesion complexes and inhibition of motility 
in breast cancer cells (Korah et al., 2004). 
Physical stimuli, such as extracellular matrix cell attachment, physical 
stretching and shear stress, have also been reported to trigger conformational 
changes in p130Cas which promotes tyrosine phosphorylation of p130Cas, 
thereby facilitating functions such as actin cytoskeleton organization, cell 
spreading and focal adhesion formation (Defilippi et al., 2006). Integrin-
mediated cell attachment to extracellular matrix increases the binding affinity 
between FAK and p130Cas, promoting the recruitment of Src family kinases 
which will rapidly phosphorylated multiple tyrosine phosphorylation (YxxP) 
motifs in p130Cas (Tachibana et al., 1997). This, in turn, creates binding sites 
for p130Cas-interacting proteins to form functional multi-protein complexes 
and promotes actin cytoskeleton reorganization. In detaching/detached cells, 
p130Cas is rapidly dephosphorylated and exhibit impaired actin stress fiber 
formation (Yamakita et al., 1999). In addition to cell attachment-induced 
phosphorylation, it is determined that physical stretching of the protein is able 
to induce tyrosine phosphorylation of p130Cas through exposing tyrosine 
phosphorylation motifs in the SD, making it available for Fyn kinase (Kostic 
and Sheetz, 2006; Sawada et al., 2006). In a time- and force-dependent 
manner, fluid shear stress is reported to stimulate tyrosine phosphorylation of 
p130Cas by activating c-Src in endothelial cells and subsequent recruitment of 
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Crk (Okuda et al., 1999). However, an alternate report shows that shear force 
does not induce but instead inhibits local p130Cas tyrosine phosphorylation at 
the upstream lamellae of cell, suppressing Rac1 activation, delaying focal 
adhesion turnover and cell migration against the flow subsequently (Zaidel-
Bar et al., 2005). This spatial regulation of p130Cas has been suggested to 
promote extravasation of metastatic tumor cells from the blood vessels into 
surrounding tissues (Guerrero et al., 2012). Rac1 mediates lamellipodial 
protrusion, which is essential for cell migration, and the recruitment of Crk 
and DOCK180 by phosphorylated p130Cas promotes activation of Rac1 
(Sharma and Mayer, 2008). 
 
1.2.2.2 Serine/threonine phosphorylation 
Though not so commonly studied, earlier reports have demonstrated 
that p130Cas is serine phosphorylated in cells freshly adherent to fibronectin 
and that serine phorphorylation within p130Cas SRR mediates its association 
with phosphoserine-binding 14-3-3 proteins in an integrin-dependent manner 
(Schlaepfer et al., 1997; Garcia-Guzman et al., 1999). On the other hand, 
p130Cas has also been reported to be phosphorylated on its serine and 
threonine residues during mitosis whereby the adherent cells momentarily 
detach, coincident with its tyrosine residues being dephosphorylated 
(Yamakita et al., 1999). The serine/threonine phosphorylation of p130Cas is 
thought to disrupt the interaction with FAK and results in the dissociation of 
focal adhesions during mitosis. This mitosis-specific phosphorylation is 
reversed at re-entry into G1 phase or post-mitotic cell spreading. While 
specific serine or threonine residue(s) phosphorylated has not been identified 
in this instance, it appears that a balance between serine/threonine and tyrosine 
phosphorylation of p130Cas plays a role in regulating cell cycle progression.  
In breast cancer cells, adhesion-dependent phosphorylation of rat 
p130Cas at the serine residues 139, 437 and 639 and Src-mediated p130Cas 
tyrosine phosphorylation have been shown to be facilitated by binding to 
BCAR3 (Makkinje et al., 2009; Makkinje et al., 2012). Despite the fact that 
the report did not conclusively reveal the functional role of BCAR3 in 
p130Cas serine phosphorylation, it showed that p130Cas serine 
phosphorylation is involved in focal adhesion assembly, actin stress fiber 
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formation and potentially promoted epithelial-to-mesenchymal transition or 
mesenchymal-to-epithelial transition. Common signaling pathways involving 
focal adhesions dissociation and reorganization of actin stress fibers mediated 
by p130Cas serine/threonine phosphorylation may exist during cell re-
adhering and detaching processes. 
 
1.2.3 Biological functions of p130Cas 
Members of CAS family have been recognized as important 
multifunctional adaptor/scaffold/docking proteins modulating cellular 
signaling networks and influencing biological processes, such as cell cycle, 
cell migration, cell adhesion, wound healing, differentiation and survival, in 
both normal and pathological conditions (Defilippi et al., 2006; Singh et al., 
2007; Tikhmyanova et al., 2010a). Among the four members, the adaptor 
protein p130Cas has been the most extensively studied. It is involved in many 
biological functions, ranging from its involvement in cell attachment to cancer 
development, and the activation of p130Cas-mediated signaling pathways can 
be regulated through post-translational modifications of the protein as 
mentioned in earlier sections. To date, the majority of studies on p130Cas are 
focused in the context of control of cell migration and invasion relating to 
cancer with a growing number of studies supporting the mechanistic and 
biological roles of p130Cas protein contributing to tumor progression through 
dynamic regulation of the cytoskeleton (Tikhmyanova et al., 2010a; Guerrero 
et al., 2012). 
While the role of p130Cas in regulating cytoskeleton and cell 
migration is intensively investigated, functional studies of p130Cas during 
postnatal development and adulthood have been largely hindered due to 
embryonic lethality of a global p130Cas knockout (CasKO) (Honda et al., 
1998). However, several studies have been able to define the critical roles 
played by p130Cas in certain aspects of postnatal development or adulthood 
by adopting various research strategies such as gene mutation, gene 
knockdown, overexpression of the protein, expression of dominant-negative, 
and manipulation of upstream genes that regulate p130Cas activity or 
expression. Additionally, the recent availability of full-length p130Cas 
conditional knockout mice (Nagai et al., 2013) will be able to provide a more 
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defined conclusion on p130Cas research. The following sections will discuss 
the role(s) of p130Cas pertain to developmental biology. 
 
1.2.3.1 p130Cas knockout mice 
The full-length p130Cas knockout mice, generated by Hirai and his 
group in 1998, gave a better understanding to the biological function of 
p130Cas in embryonic development (Honda et al., 1998). The p130Cas gene 
was disrupted by inserting a neomycin-resistance cassette into an exon 
encoding part of the SH3 domain. Mice heterozygous for p130Cas, showing 
no phenotypic changes, were used to intercross to generate homozygous 
mutants which died in utero at 11.5 – 12.5 dpc (Honda et al., 1998). On the 
other hand, deletion of the single CAS family member, DCas/CG1212, in D. 
melanogaster does not appear to have any significant effect on embryonic 
development but only on axon guidance during development of the central 
nervous system (Huang et al., 2007; Liu et al., 2007; Tikhmyanova et al., 
2010b). Mice embryos lacking full-length p130Cas exhibit severe anomalies 
which include a poorly developed heart, dilated blood vessels, marked 
systemic congestion and growth retardation. Disorganized myofibrils and 
disrupted Z-discs in p130Cas-deficient cardiomyocytes were also observed. 
Immunofluorescence analysis showed that p130Cas co-localized with actinin, 
a Z-disc marker protein, in normal cardiomyocytes. Subsequent study showed 
that p130Cas-mediated signaling facilitates cardiac myocyte hypertrophy by 
modulating basal and endothelin-stimulated atrial natriuretic peptide (ANP) 
gene expression (Kovacic-Milivojevic et al., 2001). Therefore, while CasKO 
mice are embryonic lethal and its role(s) in postnatal development and 
adulthood remains undefined, it is clear that p130Cas plays an important role 
in mouse embryogenesis. Particularly in cardiovascular development, p130Cas 
is required to maintain organized myofibrils and integrity of the Z-discs which 
cannot be compensated by the other members of CAS family, namely 
NEDD9/HEF1/Cas-L, EFS/Sin and CASS4/HEPL. 
In addition, adaptor protein p130Cas mediates the organization of the 
actin cytoskeleton in a cell by functioning as an assembling molecule of 
filamentous actin (F-actin) formation. Actin is an important component of the 
cytoskeleton, which facilitates the shape, function and survival of a cell. Cells 
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treated with cytochalasin-D, which inhibits F-actin formation, display cell 
rounding, disrupted focal adhesions and inhibition of p130Cas adhesion-
mediated phosphorylation (Nojima et al., 1995; Kwong et al., 2003). In 
comparison to the wild-type cells, CasKO fibroblasts exhibit a flat, thin and 
round-shaped morphology due to a severe impaired formation of actin stress 
fibers and not focal adhesion formation, as indicated by the analysis of focal 
adhesion protein immunostaining (Honda et al., 1998). In addition, cellular 
events, such as cell movement, cell migration and cell spreading, are 
significantly hindered in CasKO fibroblast (Honda et al., 1999). Re-expression 
of p130Cas in the CasKO fibroblasts restores morphological abnormalities and 
actin stress fiber formation, facilitating cell motility and cell spreading. While 
p130Cas lacks an actin-binding domain (ABD), p130Cas protein has been 
reported to colocalize with actin stress fiber ends and is recruited to focal 
adhesions to facilitate the interaction between integrins and actin stress fibers 
in podocytes (Welsch et al., 2001). Activated Src (a-Src)-transformed cells 
displayed rounded and refractile morphology with highly concentrated actin 
filaments in podosomes and forms colonies in soft agar assay (Honda et al., 
1998). In contrast, a-Src-transformed CasKO cells exhibit incomplete actin 
aggregation in the podosomes with residual actin filaments detected in the 
cytoplasm and colony formation in soft agar assay is disrupted (Honda et al., 
1998). Taken together, these results suggest that p130Cas mediates the 
maintenance of actin dynamics which is pivotal in embryonic development 
and oncogene-driven transformation. 
 
1.2.3.2 p130Cas in bone remodeling 
Bone is a dynamic living tissue that is constantly undergoing 
remodeling and p130Cas plays a critical role in the function of osteoclast, a 
highly differentiated giant multinucleated bone cell responsible for bone 
resorption during the bone remodeling process. During bone resorption, 
activation of osteoclasts by integrin-mediated adhesion to the bone tissues is 
characterized by the formation of actin ring-like structures called the sealing 
zone with tyrosine phosphorylated p130Cas localized to the sealing zone 
facilitating actin reorganization (Nakamura et al., 1998). Previous studies of 
p130Cas function in bone remodeling have been hindered since CasKO 
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osteoclasts are unavailable due to embryonic lethality of CasKO mice. The 
functional interplay between the kinase activity of Src and p130Cas 
phosphorylation has been studied with reference to the role of p130Cas in 
bone remodeling. In Src knockout (SrcKO) osteoclasts, the tyrosine 
phosphorylation of p130Cas is greatly reduced and shows a complete absence 
of the sealing zone in these cells with p130Cas diffusely distributed in the 
cytoplasm, resulting in defective bone resorption and osteopetrosis in SrcKO 
mice observed (Lowe et al., 1993; Nakamura et al., 1998). In addition, while 
the downstream signaling of p130Cas has been shown significantly associated 
with proline-rich tyrosine kinase 2 and thyroid hormone receptor-interacting 
protein 6 in promoting osteoclast sealing zone formation, an absence of 
p130Cas expression or a defect in tyrosine phosphorylation of p130Cas 
significantly affects sealing zone formation in osteoclasts (Lakkakorpi et al., 
1999; Duong et al., 2001; McMichael et al., 2010). Furthermore, a recent 
study has shown that osteoclast-specific p130Cas conditional knockout 
(p130Cas
ΔOCL-
) mice exhibited defective bone resorption due to defects in 
formation of actin rings and resorb pits (Nagai et al., 2013). Finally, consistent 
with the action of p130Cas as a force-sensing protein, osteoclast attachment 
and rigidity of extracellular matrix enhances p130Cas phosphorylation and its 
downstream signaling (Lakkakorpi et al., 1999; Tamada et al., 2004; Sawada 
et al., 2006), supporting enhanced osteoclast function in resorbing the bone 
tissue. Hence, p130Cas plays a critical role in osteoclast function in 
facilitating osteoclast adhesion signaling and formation of the sealing zone. 
 
1.2.3.3 p130Cas in vascular smooth muscle 
CasKO mouse embryos exhibiting poorly developed hearts with 
disruption in the contractile structures, resulting cardiac pump failure and 
venous dilation, strongly suggest a fundamental role of p130Cas in smooth 
muscle function (Honda et al., 1998). Smooth muscle cells are found within 
the walls of blood vessels, termed vascular smooth muscle cells (VSMCs), as 
well as other parts of the body such as gastrointestinal tract, respiratory tract, 
and iris of the eye. Many recent evidences have supported the importance of 
p130Cas in regulating various biophysical activities such as contractility, cell 
migration, hypertrophy and growth, in vascular smooth muscle. In response to 
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contractile activation, p130Cas translocation and actin polymerization occur at 
focal adhesions, facilitating local actin assembly and force development (Tang 
and Tan, 2003; Wang et al., 2007b). Down-regulation of p130Cas expression 
in smooth muscle tissues using antisense oligodeoxynucleotides against 
p130Cas attenuates actin polymerization and force development during 
contractile stimulation. Furthermore, disruption of p130Cas phosphorylation 
by inhibiting Src kinase activity hinders p130Cas spatial translocation and 
focal adhesion formation, thereby attenuating smooth muscle contraction and 
cell motility (Tang, 2009). The increased motility and hypertrophic growth of 
VSMCs in the presence of angiotensin-II or insulin-like growth factor-1 (IGF-
1) reportedly associates with an increase in p130Cas phosphorylation which 
mediates focal adhesion formation (Kyaw et al., 2004; Ceacareanu et al., 
2006). These results indicate that phosphorylation of p130Cas plays an 
important role in regulating vascular smooth muscle development and its 
function. 
 
1.2.3.4 p130Cas in neural development 
To date there are only limited volume of studies on p130Cas in 
neurons.  However, biochemical analysis has revealed that p130Cas is highly 
tyrosine-phosphorylated in neuronal cells, particularly in developing brain 
(Fagerstrom et al., 1998; Huang et al., 2006). In differentiating SH-SY5Y 
human neuroblastoma cells, p130Cas tyrosine phosphorylation exhibits a 
biphasic pattern (Fagerstrom et al., 1998). Although the physiological 
relevance of this biphasic pattern remains unclear, the initial rapid 
phosphorylation of p130Cas is independent of Src activity that is only 
enhanced at a much later stage after induction of differentiation. Instead, 
tyrosine phosphorylation of p130Cas is regulated by PKC during neuronal 
differentiation as inhibition of PKC activity results in a rapid retraction of 
growth cone filopodia and blocks p130Cas phosphorylation, which is known 
to facilitate focal adhesion formation. On the other hand, in the presence of 
FRNK, a dominant-negative FAK mutant, or PP2, a pharmacological inhibitor 
of the Src family kinases, localization of tyrosine-phosphorylated p130Cas in 
the neurites and growth cones of neurons is attenuated. This suggests that 
FAK and Src family kinases potentiate tyrosine phosphorylation of p130Cas, 
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thereby promoting neuronal differentiation and development (Huang et al., 
2006; Liu et al., 2007). Inhibition of p130Cas phosphorylation or 
overexpression of a phosphorylation-defective p130Cas mutant, Cas15YP, 
attenuates p130Cas signaling, leading to defective neuronal axon guidance and 
growth cone formation. In Drosophila flies, the single homologue of Cas, 
DCas, is found highly expressed in the neurons and mediates axon guidance 
and axonal defasciculation in vivo during neuronal development (Huang et al., 
2007). Similar defective fasciculation phenotypes can be observed in 
Drosophila flies when DCas is disrupted or overexpressed, suggesting that a 
stringent regulation of p130Cas signaling is essential for neuronal network 
development. These results imply a functional role of p130Cas in directing 






















The adaptor protein p130Cas is involved in mediating multiple 
intracellular signaling events. Full-length p130Cas facilitates biological events 
such as cell survival and migration, while its C-terminal fragment promotes 
apoptosis under certain circumstances. Early studies showed that p130Cas 
played a critical role in early embryonic development of mice. Disruption of 
p130Cas gene in mice led to prenatal death with the phenotypes showing 
systemic congestion, growth retardation and disorganized myofibrils with 
disrupted Z-discs observed in cardiac muscle (Honda et al., 1998). Further 
evidences has also supported the role of p130Cas in cardiac muscle (Kovacic-
Milivojevic et al., 2001) and vascular smooth muscle development (Tang and 
Tan, 2003) by promoting various biophysical activities such as hypertrophy 
and contractility. These observations signified an essential role of p130Cas in 
normal cardiovascular development and the role of p130Cas in embryogenesis 
was exclusive since the presence of other CAS members did not compensate 
for the lack of p130Cas in CasKO mouse embryos.  
However, due to the embryonic lethality of CasKO mice embryos, 
subsequent studies of development beyond prenatal stage have been hindered 
and restricted to cell culture. While the involvement of p130Cas in muscle 
development has been supported, these experiments were conducted with 
respect to cardiac muscle and vascular smooth muscle development. The role 
of p130Cas in skeletal myogenesis, an important biological process pertaining 
to many physiological functions in most, if not all, living organism, has not yet 
been defined. In addition, cells lacking p130Cas exhibit impaired formation of 
actin stress fiber and myofibrils (Honda et al., 1998) but the mechanism in 
which p130Cas regulates these processes remains to be explored. Similarly, 
factors interfering with actin polymerization, such as latrunculin B and 
cytochalasin D, or actin de-polymerization have also been shown to impede 
myoblast fusion (Nowak et al., 2009). In Drosophila flies, a dynamic F-actin-
enriched finger-like protrusions localized at the fusion site facilitates myoblast 
fusion and disruption of these F-actin foci accumulation or dissociation 
blocked myogenic fusion (Richardson et al., 2007; Sens et al., 2010). Together, 
40 
Tan Wee Wee (HT080929L) 
these results suggested a potential relationship between p130Cas-mediated 
actin re-modeling and myoblast fusion with the regulatory mechanism to be 
addressed. 
This study focuses on addressing the role of p130Cas in skeletal 
myogenesis and investigating the relationship between p130Cas and actin 
during induction of myogenic differentiation. The objectives in this study are: 
 To address whether p130Cas is critical for skeletal myogenic 
differentiation 
 To examine the physiological relevance of p130Cas in skeletal 
myogenic differentiation 
o Evaluate the relationship between p130Cas and expression of 
myogenic genes 
o Examine whether p130Cas modulates actin dynamics during 
skeletal myogenic differentiation 
o To identify the interacting partners involved in p130Cas-
mediated actin reorganization during skeletal myogenic 
differentiation 
 To characterize the molecular mechanism of p130Cas in mediating 
skeletal myogenic differentiation 
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3 MATERIALS AND METHODS 
 
3.1 Cell culture 
 
3.1.1 Maintenance of cell lines 
 Murine myoblastic C2C12 cells, human embryonic kidney (HEK) 
293T cells and Platinum E (Plat-E) cells were cultured in growing medium 
(GM; Dulbecco’s modified Eagles medium [DMEM; Nissui Pharmaceutical 
Co., Tokyo, Japan], containing 2.0 mM L-glutamine, 10 % heat-inactivated 
fetal bovine serum [FBS], 0.2 % sodium bicarbonate [NaHCO3] solution, 100 
units/mL penicillin and 100 g/mL streptomycin). All reagents were 
purchased from Gibco® (Life Technologies™, Carlsbad, CA) unless 
otherwise stated. All cell lines were maintained under standard cell culture 
environment (5 % CO2-containing humidified atmosphere) in a CO2 incubator 
(Thermo Fisher Scientific, Waltham, MA) at 37 
o
C. C2C12 cells were kindly 
provided by Dr. Keiko Kawauchi (Mechanobiology Institute, Singapore). 
All stably expressing C2C12 cell lines were also maintained under the 
same cell culture condition as mentioned above and these C2C12 cell lines 
includes CasKD cells, ITG3KD cells, TESK1KD cells, TESK2KD cells, 
resCasWT-expressing-CasKD cells, resCas15YF-expressing-CasKD cells, 
CflS3E-expressing-CasKD cells,  and hILKS343D-expressing-CasKD cells. 
 
3.1.2 Differentiation of C2C12 myoblasts to myotubes 
 C2C12 cells were seeded in a cell culture dish (Nunc, Rochester, NY) 
and cultured in growing medium (GM; DMEM with 10% FBS) until 90 % 
confluency was reached. Induction of differentiation was then carried out by 
substituting the growing medium with differentiation medium (DM; DMEM 
with 2% horse serum [HS]). During the differentiation period, the medium is 
replaced every 2 days. 
 
3.2 Antibodies and chemical reagents 
 Anti-phospho p130Cas (Y165) polyclonal (Cell Signaling Technology, 
Beverly, MA), anti-p130Cas polyclonal (Cas3) (Sawada et al., 2006), anti-
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myogenin monoclonal (F5D; BD Biosciences Pharmingen, San Jose, CA), 
anti--actin monoclonal (5C5; Sigma-Aldrich®, St. Louis, MO), anti-integrin 
3 polyclonal (Cell Signaling Technology), anti-phospho cofilin (S3) 
polyclonal (Cell Signaling Technology), anti-cofilin polyclonal (Cell 
Signaling Technology), anti-MHC monoclonal (MY32; Sigma-Aldrich®), 
anti-MAL polyclonal (H-140; Santa Cruz Biotechnology, Santa Cruz, CA), 
anti-ILK rabbit monoclonal (EP1593Y; Millipore, Billerica, MA), anti-ILK 
mouse monoclonal (65.1.9; Upstate, Lake Placid, NY), anti-phospho paxillin 
(Y118) polyclonal (Cell Signaling Technology), anti-phospho-ERK1/2 
(T202/Y204) polyclonal (Cell Signaling Technology), anti-ERK1/2 polyclonal 
(Cell Signaling Technology), anti-phospho-p38 MAPK (T180/Y182) 
polyclonal (3D7; Cell Signaling Technology), anti-p38 MAPK polyclonal 
(Cell Signaling Technology), anti-phospho LIMK (T508/T505) polyclonal 
(Cell Signaling Technology), anti-LIMK1 polyclonal (Cell Signaling 
Technology), anti-hemagglutinin (HA) monoclonal (16B12; Abcam®, 
Cambridge, MA) and anti-tubulin monoclonal (DM1A; Sigma-Aldrich®) 
antibodies were used for immunoblot, immunoprecipitation and 
immunofluorescence analyses.  
For immunoblot analyses, horse radish peroxidase (HRP)-conjugated 
antibodies against mouse or rabbit IgG were purchased from Amersham (GE 
Healthcare Life Sciences, Piscataway, NJ). Alexa Fluor® 488- or 546-
conjugated goat anti-mouse and anti-rabbit IgG (Molecular Probes, Carlsbad, 
CA) were used as secondary antibodies in immunofluorescence analyses.  
LIMK inhibitor (LIMKi; BMS-5) was purchased from Synkinase (San 
Diego, CA) and prepared as a 10 mM stock concentration in DMSO. 
 
3.3 Transfection 
 Transfection of plasmids or siRNAs was performed using GeneJuice® 
transfection reagent (Merck KGaA, Darmstadt, Germany) or Lipofectamine™ 
RNAiMAX transfection reagent (Invitrogen®) respectively. Both were 
conducted according to the user’s manual. One day before transfection, cells 
were plated in a cell culture dish with culture medium without antibiotics. For 
each transfection, transfection reagent and plasmids/siRNAs were diluted in 
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Opti-MEM® I reduced serum medium (Gibco®) and incubated at room 
temperature for 15 min to allow formation of transfection complexes before 
adding dropwise onto the cells. After incubating at 37 
o
C for 4 hr, the culture 
medium was replaced with fresh medium. 
 
3.4 Retroviral generation of stable C2C12 cell lines 
 Stably-expressing C2C12 cell lines were generated using a retrovirus 
vector system. Retrovirus was produced by co-transfecting retroviral 
expression plasmid (pBabe-hygromycin or pSuper-puromycin constructs) and 
an ecotropic helper plasmid that encodes viral envelope protein into HEK 
293T cells. For retrovirus production using pMX-neomycin retroviral 
expression vector, the plasmid was transfected into retrovirus packaging cells, 
Plat-E (Morita et al, Gene Therapy, 2000). After 20 hr post transfection, the 
culture medium was changed to fresh culture medium and then further 
incubated for 24 hr at 37 
o
C. The virus-containing medium was collected 
within 48 hr post transfection, filtered through a 0.45 mm filter (Millipore) and 
used immediately for infection. 
Retroviral infection was performed as previously described with slight 
modifications (Kawauchi et al., 2008; Kim et al., 2009b). 8 g/mL polybrene 
was added to the filtered virus-containing medium, mixed thoroughly by 
gentle vortexing, and then added to target cell line that was plated at low 
density in a 6-well plate (Nunc) a day before for retroviral infection. After 24 
hr post infection, the virus-containing medium was replaced with fresh 
medium and allowed to grow till near confluency before transferring to a 10 
cm cell culture dish for antibiotic selection of successful infected cells. 
Depending on the retroviral plasmid used, infected cell populations 
were selected in either hygromycin (300 g/ml) or puromycin (4 g/ml) for 3 
days, or neomycin (G418; 400 g/ml) for 14 days. After antibiotic selection, 
cells were screened by either western blotting or reverse transcription 
polymerase chain reaction (RT-PCR) or quantitative real-time polymerase 
chain reaction (qPCR) to examine the expression efficiency of shRNA or 
target gene. Generated cell lines were evaluated either by immunoblot assays 
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or polymerase chain reaction (PCR) to determine the knockdown efficiency or 
expression of the target genes. Primers used are listed in table 3.1. 
 
 
Table 3.1: Primers used for checking the presence of exogenously expressed human 
ILKS343D in cDNA generated from C2C12 cells. 
 
Primer Name Primer Sequence (5’  3’) 
hILK RT-PCR 37F GCAGTCGCCGTTCGCCT 
hILK RT-PCR 798R AGTAGGATGAGGAGCAGGT 
 
 
3.5 Preparation of cell lysate and protein estimation assay 
  
3.5.1 Cell harvesting/solubilization 
Cells were washed twice with ice-cold 1X phosphate-buffered saline 
(PBS; 3.2 mM Na2HPO4, 0.5 mM KH2PO4, 2.7 mM KCl, 135 mM NaCl, pH 
7.4) briefly and then solubilized with modified radioimmunoprecipitation 
assay (RIPA) buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1% Triton™ X100, 
0.5% SDS, 10 mM EDTA, 1 mM Na3VO4, 10 mM NaF, protease inhibitor 
cocktail [Roche Molecular Biochemicals, Indianapolis, IN] and 1 mM 
dithiothreitol [DTT]). 
All chemicals were purchased from Sigma-Aldrich® unless otherwise 
stated. The cell lysates were then transferred into individual 1.5 mL microfuge 
tubes (Axygen, Union City, California), sonicated briefly and incubated on ice 
for 15 min. The lysed samples were then centrifuged at 20,000 x g for 20 min 
and clarified supernatants were collected in fresh 1.5 mL microfuge tubes for 
further experiments or stored at -30 
o
C. All steps were performed at 4 
o
C or on 
ice unless otherwise stated. 
 
3.5.2 Protein quantification 
Protein concentrations of each sample collected were determined using 
a bicinchoninic acid (BCA) protein assay kit (Thermo Fisher Scientific) by 
following the instructions provided. A standard curve with 6 dilutions (0.2 to 
1.5 g/L) of a protein standard (bovine serum albumin [BSA], provided by 
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the kit) was generated for every assay conducted. The samples were also 
diluted appropriately (between 2X to 10X dilutions) and prepared in duplicates 
each time. Absorbance values were read at wavelength 562 nm using Tecan 
Infinite® 200 PRO multiplate reader (Männedorf, Switerland) and protein 
concentrations of each sample were calculated according to the protein 
concentration standard curve generated in each assay each time. 
 
3.6 Western blotting 
 
3.6.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
SDS-PAGE was performed using either Invitrogen® NuPAGE® SDS-
PAGE gel system or Bio-Rad Mini-PROTEAN® Tetra cell (Hercules, CA). 
The gel electrophoresis tanks of each system were assembled according to 
manufacturer’s instruction. Extracted protein lysates were mixed by vortexing 
with 6X SDS sample loading buffer (12 % [w/v] SDS, 30 % [v/v] glycerol, 
600 mM -mercaptoethanol [ME], and 0.1 % [w/v] bromophenol blue in 150 
mM Tris-HCl pH 6.8). Samples were then denatured at 95 
o
C for 5 min, 
following centrifugation at maximum speed at room temperature for 1 min to 
pellet down any residues prior to loading into the gels. The protein samples 
were resolved by SDS-PAGE alongside with Precision Plus Protein™ All 
Blue standards (Bio-rad).  
For NuPAGE® SDS-PAGE gel system, precast polyacrylamide gels 
were used and gel electrophoresis was conducted in MOPS-SDS buffer (50 
mM MOPS, 50 mM Tris-Base, 0.1 % SDS, 1 mM EDTA, pH 7.7) at a 
constant current of 50 mA per gel at room temperature. For Mini-
PROTEAN® Tetra cell, SDS-PAGE gels of different acrylamide/bis 
percentages, ranging from 8% to 15%, were prepared as shown in table 3.2 
and gel electrophoresis was conducted in Tris-Glycine-SDS buffer (25 mM 
Tris-base, 192 mM Glycine, 0.1 % [w/v] SDS) at a constant current of 12 mA 
per gel. After electrophoresis, the gels were either stained with Commassie 
Brilliant Blue (CBB) staining solution or electroblotted onto nitrocellulose 
membranes. Acrylamide/bis solution (30 % stock; 29:1 ratio [3.3 % C]), 
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ammonium persulfate (APS), N, N, N', N'-tetramethylethylenediamine 
(TEMED) and SDS powder were purchased from Bio-Rad. Tris-base and 
glycine were purchased from 1
st
 Base (Singapore).  
 
 
Table 3.2: Preparation for different percentages of SDS-PAGE gels. Measurement 
units are all in milliliter (mL) unless otherwise stated. 
 
Reagents 
Resolving gel per 10mL 
Stacking gel 
per 4mL 
8% 10% 12% 15% 4% 
30 % 
Acrylamide/Bis 
2.7 3.3 4.0 5.0 0.53 
1.5 M Tris-HCl, 
pH8.8 
2.5 2.5 2.5 2.5 -- 
1.0 M Tris-HCl, 
pH6.8 
-- -- -- -- 0.5 
MilliQ 
Water 
4.6 4.0 3.3 2.3 2.9 
10 % (v/v) 
SDS 
0.1 0.1 0.1 0.1 0.04 
10 % (v/v) 
APS 
0.1 0.1 0.1 0.1 0.04 
TEMED 6 L 4 L 4 L 4 L 4 L 
 
 
3.6.2 Immunoblot assay 
Extracted protein lysates were mixed thoroughly with 6x SDS sample 
buffer and resolved on SDS-PAGE gels as described in the previous section 
XX. The proteins in the gels were then electroblotted onto Protran™ 
nitrocellulose (NC) membranes (0.2 m; Whatman™, Kent, UK). After 
electroblotting, the membranes were incubated in a blocking buffer (1X TBST 
containing 5 % skimmed milk [Bio-Rad]) for 1 hr. They were then rinsed 
briefly with copious 1X tris-buffered saline with Tween (TBST; 50 mM Tris-
HCl pH7.4, 150 mM NaCl, 0.1% Tween® 20) twice, followed by 1 hr or 
overnight incubation with primary antibodies diluted 1X TBST, containing 5 % 
BSA. The membranes were then incubated with secondary HRP-conjugated 
antibodies, pre-diluted with 1X TBST containing 1% skimmed milk, for 1 hr 
after removal of primary antibodies. Membranes were washed 3 x 5 min with 
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copious 1X TBST after each antibody incubation step. Target proteins were 
visualized with SuperSignal West Pico Chemiluminiscent Substrate (Thermo 
Fisher Scientific) and Fuji SuperRX X-ray films (FUJIFILM Medical Systems, 
Fuji, Japan), which were developed using a Kodak X-ray film processor. 
Unless otherwise stated, all steps were performed at room temperature and all 
incubation was done on a Labotron bench-top shaker (Infors AG, Bottmingen, 
Switzerland). Overnight primary antibody incubation was performed with on a 
bench-top shaker in a 4 
o
C cold room. 
 
3.7 Coomassie Brilliant Blue staining of SDS-PAGE gels 
After SDS-PAGE run (refer to section 3.6.1), the polyacrylamide gels 
were stained in Coomassie Brilliant Blue (CBB) staining solution (0.25 % 
[w/v] Coomassie Blue R-250 in 50 % [v/v] methanol and 10 % [w/v] glacial 
acetic acid), shaking at room temperature for 30 min on a bench-top shaker. 
The staining solution was then replaced with destaining buffer (30 % [v/v] 
methanol, 10 % [w/v] glacial acetic acid) to remove excess background. 
 
3.8 Plasmids construction 
 
3.8.1 Primers and oligos 
All primers and oligos were designed with the required restriction sites 
incorporated and checked for their specificity against the gene of interest using 
BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) before purchasing from AIT 
biotech (Singapore) or Sigma-Aldrich ®. 
 
3.8.2 Generation of pSuper-p130Cas-shRNA, pSuper-Integrin-3-shRNA, 
pSuper-TESK1-shRNA and pSuper-TESK2-shRNA constructs 
 To generate pSuper-p130Cas-shRNA, pSuper-Integrin-3-shRNA, 
pSuper-TESK1-shRNA and pSuper-TESK2-shRNA constructs, target 
sequences for the genes of interest were designed using RNAi Design Tool 
provided by Oligoengine (Seattle, WA). After selection, the oligonucleotides 
were generated with 5’ overhangs and a central hairpin loop sequence 
according to the pSuper RNAi System™ (Oligoengine) manual. The 
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complementary pairs of shRNA oligonucleotides containing mouse p130Cas-
shRNA (5′-GCATGACATCTACCAAGTT-3′), mouse integrin 3-shRNA 
(5′-CAGCTCATTGTTGATGCTT-3′ (White et al., 2007)), mouse TESK1-
shRNA (5′-GTGCCTGCTTTCCGAACTTTG-3′) or mouse TESK2-shRNA 
(5′-CCTGAGTTCTTGCATCA-3′) were then annealed and ligated into 
pSuper-retro-puromycin vector (Oligoengine) linearized with BglII and 
HindIII restriction enzymes. Subsequently, the ligated construct was 
transformed into competent bacterial cells and screened for successful 
transformants. Plasmid amplification and collection was performed for 
successful transformants and sent for DNA sequencing to confirm the desired 
sequences. 
 
3.8.3 Generation of shRNA-resistant wild-type and mutants of mouse 
p130Cas retroviral expression vectors 
 To generate pBabe-hygromycin retroviral constructs, expressing wild-
type and phosphorylation-defective (15YF) mutant of mouse p130Cas 
resistant to p130Cas-shRNA (i.e., pBabe-resCasWT and pBabe-resCas15YF, 
respectively), full length BamHI/EcoRI wild-type or phosphorylation-
defective mutant 15YF of mouse p130Cas (Sawada et al., 2006) was first 
amplified by polymerase chain reaction (PCR) with PrimeSTAR HS DNA 
Polymerase (Takara). PCR reaction was conducted using Veriti® 96-Well 
Thermal Cycler (Life Technologies™) and the PCR products were sub-cloned 
into pBabe-hygromycin retroviral vector (Cell Biolabs Inc., San Diego, CA). 
The sequences of forward (Cas_F) and reverse (Cas_R) primers used are listed 
in table 3.3 and PCR condition was set at 98 
o
C for 5 min, followed by 30 
cycles of 98 
o
C 10 sec, 55 
o
C 5 sec, and 72 
o
C for 3 min. PCR reaction mixture 
consisted of 10 L 5X PrimeSTAR buffer containing Mg2+, 4 L 2.5 mM 
dNTP mixture, 1 L 10 mM forward primer, 1 L 10 mM reverse primer, 100 
ng DNA template, 0.5 L PrimeSTAR HS DNA polymerase, and then topped 
up to 50 L with sterile nuclease-free MQ water. 
The PCR products were purified by DNA gel extraction and double 
digested with restriction enzymes, Bam HI and Eco RI. After digestion, the 
PCR products were purified again by DNA gel extraction and then ligated into 
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pBabe-hygromycin vector to generate pBabe retrovirus expression constructs, 
pBabe-CasWT and pBabeCas15YF. After ligation, the ligation products were 
transformed into competent bacterial cells and screened for successful 
transformants. Plasmids were then purified and sent for DNA sequencing to 
check for mutations.  
Whole plasmid site-directed mutagenesis (SDM) was performed to 
obtain pBabe-resCasWT and pBabe-resCas15YF using pBabe-CasWT and 
pBabe-Cas15YF respectively as the template in a PCR reaction. SDM primers 
(resCas_F and resCas_R) used contain the desired silent mutations with no 
changes to the originally coded amino acid as stated in table 3.3. PCR 
condition was set at 98 
o
C for 5 min, followed by 40 cycles of 98 
o
C 10 sec, 
and 68 
o
C for 9.5 min. PCR reaction mixture consisted of 10 L 5X 
PrimeSTAR buffer containing Mg
2+
, 4 L 2.5 mM dNTP mixture, 1 L 10 
mM forward primer, 1 L 10 mM reverse primer, 100 ng DNA template, 0.5 
L PrimeSTAR HS DNA polymerase, and then topped up to 50 L with 
sterile nuclease-free MQ water. The PCR products were then subjected to 
restriction enzyme DpnI digestion at 37 
o
C for 2 hr to remove the template 
before transformation into competent bacterial cells using heat-shock method. 
Subsequently, the purified plasmids were sent for DNA sequencing to confirm 
the desired silent mutations. 
 
 
Table 3.3: Primers used for the cloning of p130Cas wildtype and phosphorylation-
defective mutant (15YF). The primers (resCas_F and resCas_R) used for site-directed 
mutagenesis contains 3 silent mutations (underlined and bold). 
 
Primer Name Primer Sequence (5’  3’) 
Cas_F CGGGATCCATGAAGTACCTGAACGT 
Cas_R GCGAATTCTCAGGCAGCAGCTAGCT 




3.8.4 Generation of pBabe-HA-cofilinS3E and pGEX-cofilinWT 
To generate pBabe-HA-cofilinS3E mutant, full length EcoRI/EcoRI 
wildtype mouse cofilin (cfl) was first obtained from NIH 3T3 cDNA pool 
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(template) by PCR and cloned into linearized pBabe-HA vector. PCR 
condition was set at 98 
o
C for 5 min, followed by 30 cycles of 98 
o
C 10 sec, 55 
o
C 5 sec, and 72 
o
C for 40 sec. PCR reaction mixture consisted of 10 L 5X 
PrimeSTAR buffer containing Mg
2+
, 4 L 2.5 mM dNTP mixture, 1 L 10 
mM forward primer (Cfl_F), 1 L 10 mM reverse primer (Cfl_R), 250 ng 
cDNA template, 0.5 L PrimeSTAR HS DNA polymerase, and then topped 
up to 50 L with sterile nuclease-free MQ water. After PCR, restriction 
enzyme digestion with EcoRI, and DNA gel extraction, the PCR product was 
then ligated into EcoRI-linearized pBabe-HA vector, transformed into 
competent bacterial cells and screened for successful transformants on LB 
agar plate containing ampicillin. The transformants were then inoculated 
overnight in LB with antibiotics, followed by plasmids purification and DNA 
sequencing to check for mutations. 
After confirmation of the sequence, full length EcoRI/EcoRI mouse 
wildtype cofilin was excised by restriction enzyme digestion from pBabe-HA-
cofilinWT and ligated into EcoRI-linearized GST fusion vector, pGEX-4T-1, 
to construct pGEX-cofilinWT. Similarly, mouse cofilinS3E mutant was 
obtained by PCR using pBabe-HA-cofilinWT as a template and substituting 
the forward primer with one (CflS3E_F) containing a mutation in which the 
coding sequence at amino acid position 3 was from serine (Ser) to glutamic 
acid (Glu). The resulting PCR product was then ligated into pBabe-HA vector 
to obtain pBabe-HA-cofilinS3E construct. Sequences of the primers used are 
stated in table 3.4. 
 
 
Table 3.4: Primers used for the cloning of wildtype and S3E mutant of mouse cofilin. 
The primers used for site-directed mutagenesis contains a mutation (underlined and 
bold) that changes the amino acid at position 3 from serine to glutamic acid. 
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3.8.5 pMX-ILKS343D constructs 
 pMX-ILK343D was a gift from Dr. Kim Minsoo (University of Tokyo, 
Tokyo, Japan). Full length ILK343D was obtained from NIH 3T3 cells stably 
expressing constitutively active kinase domain ILK mutant, ILKS343D 
(Lynch et al., 1999) cDNA pool and sub-cloned into pMX-neo retroviral 
expression vector. Sequence of the plasmid pMX-ILKS343D was also 
checked by DNA sequencing to confirm the ILK mutant sequence. 
 
3.8.6 Annealing oligonucleotides 
Each oligonucleotide was dissolved in TE buffer (10 mM Tris-HCl 
[pH8.0], 1 mM EDTA) to a stock concentration of 100 M. Annealing 
reaction mixture (1 L forward oligonucleotide, 1 L reverse oligonucleotide 
and 8 L sterile milliQ [MQ] water) was then incubated at 95 oC for 2 min and 
cooled gradually to room temperature over a period of 2 hr to allow the 
complementary pair of oligonucleotides to anneal. 
 
3.8.7 Restriction enzyme digestion 
To perform restriction enzyme digestion, intact plasmids or PCR 
products was incubated with the appropriate restriction enzymes (Takara Bio 
Inc., Shiga, Japan) in a 50 L reaction volume (1X Buffer K; 20 mM Tris-HCl 
[pH8.5], 10 mM MgCl2, 1 mM DTT and 100 mM KCl) at 37 
o
C for 1 hr. 
Enzyme activity was terminated by mixing the reaction mixture with 10X 
loading buffer (0.9 % SDS, 50 % glycerol, 0.05 % bromophenol blue), 
following agarose gel electrophoresis and gel extraction to obtain the digested 
product. 
 
3.8.8 Agarose gel electrophoresis  
Agarose gel electrophoresis was performed using Mupid®-2plus 
electrophoresis system (Advance co. ltd, Chuo-ku, Tokyo). DNA samples 
were mixed with 10X loading buffer before resolving in 1% agarose gel (1 g 
agarose powder [Sigma-Aldrich] in 100 mL 1X TAE buffer [40 mM Tris-
acetate pH 8.0, 1 mM EDTA) containing SYBR® Safe DNA gel stain 
(50,000X dilution; Invitrogen®). Electrophoresis was run at 100 V for 30 min 
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at room temperature and visualization of the DNA was done using the 
Molecular Imager Gel Doc XR system (Bio-Rad). GeneRuler 1kb DNA ladder 
(Fermentas, Burlington, ON) was run alongside as a reference to aid in size 
determination. 
 
3.8.9 DNA gel extraction 
 A sterile blade was used to excise the desired band from the gel after 
electrophoresis. DNA plasmids or PCR products was then purified from the 
excised gel plug using GenElute™ Agarose Spin Columns (Sigma-Aldrich®) 
according to the manufacturer’s instructions. Excised gel plugs were placed in 
the spin column and centrifuged at 16,000 x g for 10 min. The eluted product 





Ligation of target insert sequence (PCR products or annealed products) 
into linearized target vector was performed using Mighty Mix DNA ligation 
kit (Takara) to generate intact target gene expression constructs. Ligation was 
conducted by mixing equal volume of 2X Ligation mix (Takara) to that of 
annealed product-vector mixture (4:1 [v/v]) in a 1.5 mL microfuge tube and 
then incubating in a 16 
o
C water bath for 1 hr. Subsequently, the ligation 
mixture was used for transformation into competent bacterial cells using the 
heat shock method (see section 3.5.2). 
 
3.8.11 Plasmid purification from transformed bacterial colonies 
 Single colonies were inoculated into individual round bottom tube 
(Nunc) with 5 mL of LB broth containing the appropriate antibiotics and shake 
overnight at 37
o
C. Bacteria were lysed to extract the plasmids using QIAprep 
Spin Miniprep Kit (Qiagen, Valencia, CA) according to the manufacturer’s 
instructions. The quantity and quality of the eluted plasmids were determined 
using NanoDrop 1000 Spectrophotometer (Thermo Fisher Scientific). Colony 
PCR using the picked bacterial colony as template or restriction enzyme test 
cut was performed to omit false positive results prior sending for DNA 
sequencing to check for mutations. 
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3.8.12 DNA sequencing for plasmids 
 The purified plasmids were sent for DNA sequencing (performed by 
AIT biotech [Singapore]) and the sequencing primers used for each vector is 
listed in table 3.5. The sequencing results obtained back were then aligned 
against the designed target sequences using Genetyx® (ver. 9.0; Genetyx 
Corporation, Tokyo, Japan) and checked for any mutations. 
 
 
Table 3.5: Sequencing primers used for DNA sequencing.  
 







3.8.13 RNA isolation 
 Extraction of total RNA from cells or mouse testis was performed 
using Takara’s FastPure™ RNA kit. Cells were cultured on a 60 mm cell 
culture dish overnight and harvested according to the user manual. For mouse 
testis, the tissue was excised, snapped freeze by liquid nitrogen and then grind 
finely with a mortar and pestle prior to solubilization. In both cases, the lysate 
was then homogenized using needle-and-syringe method and total RNA was 
eluted with sterile diethylpyrocarbonate (depc)-treated MQ water. The purity 
and quantity of the extracted total RNA was measured using NanoDrop 1000 
Spectrophotometer. Extracted RNA was used immediately for reverse 




3.8.14 Reverse transcription polymerase chain reaction (RT-PCR) 
To obtain first strand complementary DNA (cDNA), RT-PCR was 
performed by mixing 5 g of the extracted RNA (template), 100 pmol 
oligo(dT)18, 0.5 mM dNTP mix in 14.5 L depc-treated water, incubated at 65 
o
C for 5 min and then chilled on ice immediately. 4 L 5X RT buffer, 0.5 L 
RiboLock™ Rnase inhibitor, and 1 L RevertAid™ reverse transcriptase 
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(Fermentas) was then added and incubated for 30 min at 50 
o
C. The reaction 
was terminated by incubation at 85 
o
C for 5 min. The resulting cDNA was 
then stored at -30 
o
C or used as a template for subsequent amplification of 
target genes by conventional PCR. 
 
3.9 Competent cells and transformation 
 
3.9.1 Preparation of competent bacterial cells 
Escherichia coli (E. coli), strain DH5 and BL21, was used to prepare 
chemically competent bacterial cells. The bacterial cells were first streaked 
onto an antibiotic-free Luria-Bertani (LB) agar plate and incubated overnight 
at 37 
o
C. A starter culture was then prepared by inoculating a single colony 
into 5 mL of antibiotics-free LB broth and allowed to grow overnight at 37 
o
C, 
shaking at 250 rpm. On the next day, 0.5 mL of the starter culture was 
inoculated into a flask containing 50 mL of antibiotic-free LB broth and 
incubated at 37 
o
C with shaking at 250 rpm until absorbance value at OD600nm 
reached 0.6. The culture was then chilled on ice for 10 minutes before 
pelleting the bacterial cells at 4,000 x g, 4 
o
C, for 15 min. The pelleted cells 
were then resuspended completely by gentle vortexing in 1/3 volume of the 
original culture (17 mL) of ice-cold calcium/manganese based buffer (CCMB; 
80 mM CaCl2∙2H20, 20 mM MnCl2∙4H20, 10 mM MgCl2∙6H20, 10 mM 
KOAc [pH 7.0], 10 % [v/v] glycerol, adjusted to a final pH of 6.4) and 
incubated on ice for 20 minutes. After centrifugation (5,000 x g, 4 
o
C, 10 min), 
the bacteria cells were again gently resuspended in 1/12 volume of the original 
culture (4 mL) of ice-cold CCMB. The competent cells were then snap-frozen 
in 100 l aliquots and stored at -80 oC until use. Strain DH5 was used for 
plasmid amplification while strain BL21 was used for expression of protein. 
 
3.9.2 Heat-shock transformation of plasmids into competent bacterial cells 
Intact plasmids were mixed gently with 100 L of competent bacterial 
cells in a 1.5 mL microfuge tube and incubated on ice for 15 min. The mixture 
was then subjected to heat-shock treatment at 42 
o
C for 1 min and replaced 
immediately back on ice for another 5 min. Thereafter, 700 L of LB broth 
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was added to the mixture prior incubation at 37 
o
C with shaking at 250 rpm for 
1 hr to allow recovery of the cells. The bacteria was concentrated to 100 L 
volume of LB broth and then spread onto a LB agar plate containing the 
appropriate antibiotics for selection of successful transformants. The plates 
were placed in a 37 
o
C incubator overnight and colonies were picked for 
inoculation the next day. Working concentrations for both ampicillin and 
kanamycin used were 100 g/mL. 
 
3.10 ILK In-gel kinase assay 
 To examine the kinase activity of ILK, in-gel kinase assay was 
performed as previously described with slight modifications (Wooten, 2002) 
and fusion protein GST-cofilin as the substrate. 
 
3.10.1 Preparation of glutathione S-transferase-cofilin(GST-cofilin) fusion 
protein 
 The bacterial expression vector, pGEX-cofilinWT, was transformed 
into Escherichia coli strain BL21 competent cells and streaked onto a LB agar 
plate containing 100 g/mL ampicillin, which was then incubated at 37 oC 
overnight. A single bacterial colony was then inoculated into a starter culture 
(5 mL LB broth with 100 g/mL ampicillin) and shake at 37 oC overnight. The 
starter culture was subsequently transferred to a culture flask containing 100 
mL of LB broth with 100 g/mL ampicillin and continued to incubate at 37 oC, 
shaking at 250 rpm. Induction of GST-cofilin fusion protein in the presence of 
1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) was performed when the 
absorbance value at OD600nm reached 0.6. The flask of bacteria was further 
incubated for another 3 hr before pelleting and lysing the bacterial cells for 
subsequent protein purification.  
Collection of the bacterial pellet was performed by centrifuging the 
bacterial culture at 6,000 x g for 5 min. The bacterial  pellet was washed once 
with ice-cold 1X PBS and then lysed in ice-cold bacteria lysis buffer (1X PBS 
containing 1 % Triton™ X100, 5 mM EDTA, 1 mM DTT and a protease 
inhibitor cocktail) and then subjected to 3 x 1 min sonication at 30 % power 
on ice, with a 5 min-interval between each sonication step. The bacterial lysate 
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was further incubated with rocking, in a cold room for 30 min and then 
centrifuged at 20,000 x g for 30 min. Supernatant was collected and 
transferred to a falcon tube with 200 L pre-equilibrated glutathione (GSH) 
sepharose 4B beads (50 % slurry; GE Healthcare), and incubated with rocking, 
in a cold room for 1 hr. Thereafter, the beads were recovered by centrifuging 
(500 x g, 4 
o
C, 1 min), followed by 3 x washes with ice-cold wash buffer (1X 
PBS containing 0.1 % NP40s). The GST-cofilin was then eluted from the GSH 
beads by incubating the beads with elution buffer (50 mM Tris-HCl pH 8.0, 20 
mM reduced GSH [Sigma-Aldrich]) for 15 min, rocking gently in a coldroom. 
Purity of eluted GST-cofilin was accessed by SDS-PAGE and coomassie 
brilliant blue staining. The eluted GST-cofilin was then stored at -80 
o
C prior 
use. All steps were carried out at 4 
o
C unless otherwise stated. 
  
3.10.2  Sample preparation and immunoprecipitation 
C2C12 cells were washed twice with ice-cold 1X PBS and solubilized 
with an ice-cold cell lysis buffer (50 mM Tris-HCl pH 7.4, 50 mM NaCl, 1 % 
NP-40s, 0.5 % SDS, 5 mM EDTA, 0.1 mM Na3VO4, 5 mM -
glycerophosphate, 2.5 mM sodium fluoride and a protease inhibitor cocktail 
[Roche]) on indicated days. For each sample, 1 mg protein lysate (in less than 
1 mL volume) was then incubated with 2 g anti-ILK monoclonal antibody 
(Upstate) and 10 L 50 % pre-equilibrated protein-G conjugated agarose 
beads slurry on a rocker at 4 
o
C overnight. Thereafter, the immunoprecipitated 
complexes were collected by pulse centrifugation (5 sec, 18,000 x g), followed 
by 3 times washing with ice-cold 0.8X lysis buffer. The beads were then re-
suspended in 15 L 1X SDS sample loading buffer, mixed and subjected to 
SDS-PAGE using a polyacrylamide gel containing 1.0 mg GST-cofilin. 
 
3.10.3 Preparation of GST-cofilin gel and gel electrophoresis 
 SDS-PAGE gels (8 % resolving gel and 4 % stacking gel) were 
prepared as described in section 3.6.1 with 1.0 mg of GST-cofilin was mixed 
thoroughly with the resolving gel before solidification. Gel electrophoresis 
was carried out at 12 mA/gel. 
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3.10.4 Denaturation, renaturation, and in-gel kinase reaction 
After electrophoresis, denaturation and renaturation of proteins in the 
gels was performed. SDS was first removed from the gel by washing it in SDS 
removal solution I (50 mM Tris-HCl pH8.0, 20 % 2-propanol), agitating 
gently on a bench-top shaker for 30 min. The gel was further washed in SDS 
removal solution II (50 mM Tris-HCL pH8.0, 5 mM ME) for 2 x 30 min. 
Denaturation of the proteins was performed by incubating the gel in 
Denaturation buffer (50 mM Tris-HCl pH8.0, 5 mM ME, 6 M Guanidine 
hydrochloride [GndCl; Sigma-Aldrich]) with agitation for 2 x 30 min. 
Renaturation was then carried out by incubating the gel in Renaturation buffer 
(50 mM Tris-HCl pH8.0, 5 mM ME, 0.04% Tween® 20), agitating gently for 
1 hr, replacing the Renaturation buffer at 15 min intervals. The gel was then 
incubated overnight in Renaturation buffer in a cold room. 
After renaturation of proteins, the gel was washed with Kinase Assay 
buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM NaCl, 100 mM 
Na3VO4, 20 mM -glycerophosphate, 1 mM DTT) with agitation for 2 x 15 
min. The gel was then incubated in a Hot Kinase Assay buffer (100 M ATP 
in Kinase Assay buffer) with agitation for 1 hr at 30 
o
C. Subsequently, the 
proteins in the gel was electroblotted onto a polyvinylidene difluoride (PVDF) 
membrane (Millipore) and the level of GST-cofilin phosphorylation was 
assessed by immunoblotting using an anti-phospho-cofilin (S3) antibody. All 
steps were performed at room temperature unless otherwise stated. 
 
3.11 Immunofluorescence analysis 
 
3.11.1 Immunofluorescence staining 
 Immunofluorescence staining was performed as described previously 
(Hirata et al., 2008). Cells were seeded on glass bottom dishes (35 mm dish; 
Iwaki®) or 24-well glass bottom plate (Iwaki®) and cultured accordingly. The 
cells were then fixed with 4% paraformaldehyde (PFA) for 30 min and 
permeabilized with 0.1% Triton™ X100 for 5 min, followed by blocking with 
2% BSA in cytoskeletal stabilizing buffer (CS buffer; 137 mM NaCl, 5 mM 
KCl, 1.1 mM Na2HPO4, 0.4 mM KH2PO4, 4 mM NaHCO3, 2 mM MgCl2, 5.5 
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mM glucose, 2 mM EGTA, and 5 mM PIPES, pH 6.1) for 1 hr. Subsequently, 
the cells were incubated in pre-diluted primary antibodies at either room 
temperature for 1 hr or 4 
o
C overnight. After primary antibody incubation, the 
cells were washed 3 times with 1X PBS, following incubation in pre-diluted 
fluorophore-conjugated secondary antibody in the dark for 1 hr and then 
washed 3 times with 1X PBS. The cells were then kept in 1X PBS containing 
4',6-diamidino-2-phenylindole (DAPI). All antbodies were prediluted with 2% 
BSA in CS buffer prior use. 
The cells were observed with an inverted microscope (Nikon ECLIPSE 
TE2000-S) or a confocal microscope comprised of either an inverted 
microscope (IX81, Olympus, Tokyo) equipped with a spinning disk confocal 
unit (Perkin-Elmer, Boston, MA), a water-immersion objective (NA 1.20, 60X; 
PLFL Olympus) and an EMCCD camera (C9100-50, Hamamatsu Photonics, 
Hamamatsu, Japan) or a confocal microscope (A1Rsi, Nikon, Tokyo, Japan) 
equipped with oil-immersion (NA 1.40, 100X; Plan Apochromat VC, Nikon) 
and air (NA 0.95, 40X; Plan Apochromat, Nikon) objectives. Acquired images 
were analyzed offline with the public domain Image J program (version 1.45f). 
Alexa Fluor 488- or 546-conjugated goat anti-mouse and anti-rabbit IgG 
(Molecular Probes, Carlsbad, CA) were used as secondary antibodies. DAPI 
(Vector Laboratories, Burlingame, USA), Alexa Fluor 488 phalloidin 
(Molecular Probes, Carlsbad, CA), and Alexa-594 DNase I (Molecular Probes, 
Carlsbad, CA) were used to stain the nucleus, F-actin, and G-actin, 
respectively.  
 
3.11.2 Ratio of F-actin to G-actin 
F-actin and G-actin were visualized with Alexa Fluor 488-phalloidin 
and Alexa Fluor 594-DNase I, respectively. After image acquisition, the 
intensity ratio of F-actin to G-actin was calculated for each pixel using Image 
J program and the calculated values were averaged within individual cell 
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3.11.3 Stress fiber thickness analysis 
Stress fiber thickness was quantitatively analyzed as described 
previously (Hoffman et al., 2006), with slight modifications. In brief, F-actin 
images were subjected to erosion spatial filtering with a 3  3 pixel matrix, 
which replaced the center pixel in the matrix with the darkest value found in 
the matrix. Fluorescence intensities on stress fibers were gradually decreased 
by repeating the erosion filtering. The decay curve of stress fiber intensity 
against the cycle number of erosion filtering was fitted by the following 
equation; 
                        I = A + B exp (-N/), 
where I is fluorescence intensity on a stress fiber, N is the cycle number of the 
erosion filtering,  is the decay constant, and A and B are constants. Since 
fluorescence intensity on a thinner stress fiber decayed more rapidly in 
response to the filtering, the decay constant  was used as a stress fiber 
thickness index (SFTI) - thicker stress fibers have larger SFTI values. Data 
represents the mean  SD of more than thirty stress fibers from more than ten 
independent cells. 
 
3.12 Luciferase assay 
 Cells were cultured on 24-well plate (Nunc) and co-transfected with 
target reporter construct and a control plasmid (Renilla luciferase reporter) 
using GeneJuice® transfection reagent. Luciferase assay was then performed 
using Promega Dual-Luciferase® reporter (DLR™) assay system (Madison, 
WI) and luminescence was measured with GloMax®-Multi Jr detection 
system equiped with a luminescence module (Promega). pSRE-Luc reporter 
construct was obtained from Clontech Laboratories Inc (Palo Alto, CA) while 
-actin-Luc reporter construct was generated by subcloning a 1.2 kbp 
fragment encompassing the promoter region (-1200 to +10) of the mouse 
skeletal muscle -actin gene into the pGL3-basic vector (Promega). Control 
plasmid pRL-TK was obtained from Toyobo (Osaka, Japan). The luciferase 
activity was scaled to the average value of the cells cultured in GM and set at 
1. Data represents the mean  SD of three independent assays. A p value of 
<0.02 was considered statistically significant.  
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3.13 Quantitative real-time PCR 





 Supermix (Bio-Rad Laboratories, Hercules, CA) under 
the following conditions: 30 sec at 95 
o
C, followed by 40 cycles of 95 
o
C for 
10 sec and 60 
o
C for 10 sec using Bio-Rad CFX96
TM
 Real-Time PCR 
Detection System. The primer sets used were: mouse TESK1 forward, 5’- 
CCTCAGCATGGTCTCAAT -3’, reverse 5’- TGTCTAGTTCGGTGATCC -
3’, mouse TESK2 forward, 5’- TACAACTCTGGCTGACTG -3’, reverse 5’- 
TCCGTACTTGAGACTACTG -3’, mouse -actin forward, 5’- 
CATCCGTAAAGACCTCTATG -3’, reverse 5’- 
TGATCTTGATCTTCATGGTG -3’. After normalization against -actin, data 
show mRNA expression levels relative to control expression levels for each 
experiment. 
 
3.14 Trypan blue dye exclusion cell viability assay 
 Cells were trypsinized and suspended in DMEM, followed by mixing 
at a 1:1 (v/v) proportion with 0.4 % trypan blue solution which was filtered to 
get rid of any particles that would interfere with the counting process. The 
resulting cell/trypan blue mixture was then injected into the hemocytometer 
chamber and left to incubate for 1 minute at room temperature. The cells were 
then counted using an automated cell counter (LUNA
TM
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4 RESULTS 
 
4.1 Adaptor protein p130Cas is involved in myogenic differentiation 
The effects of p130Cas on myogenic differentiation in murine C2C12 
myoblasts were investigated using a retroviral shRNA system to silence the 
expression of p130Cas. The infected myoblasts were then subjected to 
antibiotic selection to obtain stable p130Cas knockdown (CasKD) C2C12 
myoblasts. Introduction of the p130Cas shRNA efficiently attenuated the 
expression of p130Cas in C2C12 myoblasts (Figure 4.1A) and this attenuated 
p130Cas expression was maintained for at least up to day 4 after induction of 
myogenic differentiation, i.e. replacement of growth medium (GM) with 
differentiation medium (DM) (Figure 4.1B, first panel). Under myogenic 
differentiation condition (i.e. culture medium switched from GM to DM), 
control cells exhibited an elongated morphology and cells aligned by day 2, 
with multinucleated myotubes observed on day 4 (Figure 4.1C, top). In 
contrast, no myoblast was observed in CasKD myoblasts, although cell 
elongation and alignment occurred by day 2 (Figure 4.1C, bottom). To 
further support the absence of myotube formation in CasKD cells, both control 
and CasKD cells were then subjected to immunostaining for the detection of 
MHC, a typical marker of terminally differentiated muscle cells, and MHC-
positive multinucleated myotubes were observed in the control cells but not 
CasKD cells (Figure 4.1C). In addition, the expression of skeletal muscle-
specific proteins, including myogenin, MHC and -actin, in control cells 
increased during the myogenic differentiation period, but was undetected in 
CasKD cells (Figures 4.1, B and C). These results suggest that p130Cas plays 
a vital role in promoting myogenic differentiation in C2C12 myoblasts. 
 
4.2 p130Cas phosphorylation is necessary for C2C12 myotube formation 
Signaling cascades mediated by p130Cas often involve the 
phosphorylation of p130Cas and as reported previously (Goel and Dey, 2002), 
a gradual increase of p130Cas phosphorylation was observed during myogenic 
differentiation of C2C12 myoblasts (Figure 4.2A). To address whether  
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Figure 4.1 - p130Cas is required for myotube formation in C2C12 myoblasts. 
C2C12 myoblasts were infected with shRNA vector- or p130Cas-shRNA-expressing 
retroviruses and selected with antibiotics to obtain stable p130Cas knockdown 
(CasKD) and control cell lines. (A) The cells cultured in GM were solubilized and 
expression level of p130Cas was evaluated by immunoblot analysis to confirm the 
knockdown efficiency. (B) Cells were cultured in GM and then switched to DM when 
near confluency to induce myogenic differentiation. The cells were then solubilized 
on the indicated days and immunoblot analysis was performed to evaluate the 
expression levels of p130Cas and skeletal muscle-specific proteins. (C) Cells were 
induced to differentiate in DM and fixed with 4% paraformaldehyde on the indicated 
days, followed by immunostaining with anti-MHC antibody (red), a marker for 
terminally differentiated muscle cells, and DAPI staining (blue), for the nuclei. 
Images were acquired with an inverted microscope (Nikon ECLIPSE TE2000-S). 








Figure 4.2 – Phosphorylation of p130Cas is crucial for myotube formation in 
C2C12 myoblasts. (A) Naïve C2C12 myoblasts were differentiated in DM and 
solubilized on the indicated days, followed by immunoblot analysis of the 
phosphorylation levels of p130Cas (p-p130Cas). (B–D) C2C12 myoblasts were co-
infected with shRNA vector- or p130Cas-shRNA-expressing retroviruses, together 
with the shRNA-resistant form of wild-type p130Cas- or mutant p130Cas15YF-
expressing retroviruses. (B) Cells cultured in GM were solubilized and the expression 
and phosphorylation level of p130Cas were evaluated by immunoblot analysis. (C) 
Cells cultured in GM were switched to DM at near confluency to induce myogenic 
differentiation. The cells were then solubilized on the indicated days and subjected to 
immunoblot analysis to evaluate the expression levels of skeletal muscle-specific 
proteins. (D) Cells were induced to differentiate for 4 days in DM and fixed with 4% 
paraformaldehyde, followed by immunostaining with anti-MHC antibody (red), a 
marker for terminally differentiated muscle cells, and DAPI staining (blue) for the 
cell nuclei. Scale bar: 50 m. Images were acquired with a confocal microscope (A1R) 
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phosphorylation of p130Cas is critical for myogenic differentiation in C2C12 
myoblasts, a shRNA-resistant form of wildtype p130Cas (CasWT) or its 
phosphorylation-defective mutant (Cas15YF) (Sawada et al., 2006), was 
introduced into CasKD myoblasts. The phosphorylation-defective Cas15YF 
was generated by substituting the tyrosine (Y) residues in the fifteen YxxP 
motifs located in p130Cas SD to phenylalanine (F) residues. The expression 
level of exogenous p130Cas (CasWT or Cas15YF) was detected at a 
comparable level to that of endogenous p130Cas (Figure 4.2B). The cells 
were then cultured and differentiated in DM. The expression of muscle-
specific proteins (i.e. myogenin, MHC and -actin) and formation of myotube 
(MHC-positive cells) were restored in wild-type p130Cas-expressing cells 
(CasWT cells), but not in p130Cas15YF-expressing cells (Cas15YF cells) 
(Figures 4.2C and 4.2D). These results suggest that p130Cas phosphorylation 
is crucial for the progression of myogenic differentiation in murine C2C12 
myoblasts.   
 
4.3 SRF transcriptional activity is affected in differentiating CasKD cells 
The formation of myotubes is associated to the expression of muscle-
specific proteins which many are regulated by SRF transcriptional activity 
(Wei et al., 1998; L'Honore et al., 2003; Pipes et al., 2006; Kim et al., 2009a). 
As shown earlier, the expression of muscle-specific proteins was affected 
when p130Cas was silenced in C2C12 myoblasts (Figures 4.1B). Hence, 
p130Cas-dependent modulation of SRF transcriptional activity was 
investigated using a dual-luciferase reporter assay. No significant difference in 
the SRF transcriptional activity was detected between control cells and CasKD 
cells However, a significantly greater decrease was observed in CasKD cells 
when compared to control cells after the replacement of GM with DM (Figure 
4.3, left). In addition, the activity of the skeletal muscle -actin promoter, 
containing SRE(s), was significantly increased after switching to culturing the 
cells in DM while there was no apparent increase observed in CasKD cells 
(Figure 4.3, right). This current data indicate that p130Cas is involved in 
modulating transcriptional activity of SRF target genes, which includes 
muscle-specific genes.  
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Figure 4.3 – SRF transcriptional activity is mediated by p130Cas. C2C12 
myoblasts were infected with shRNA vector- or p130Cas-shRNA-expressing 
retroviruses. The cells were co-transfected with SRE-Luc (left) or -actin promoter-
Luc (right) reporter plasmid, together with phRL-TK (internal control). One day after 
transfection, the cells continued to culture in GM or switched to DM for one day and 
subjected to luciferase assay. Values were normalized with the mean values of the 
cells cultured in GM set at 1. Data represent the mean ± SD of three independent 
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4.4 Erk1/2 and p38 MAPK activities are unaltered in CasKD cells during 
myogenic differentiation  
Erk1/2 and p38 MAPK signaling pathways are important components 
of myogenic differentiation. During myogenic differentiation, down-regulation 
of Erk1/2 activity inhibits mitogenic signals, leading to cell cycle arrest while 
up-regulation of p38 MAPK activity promotes myogenic action, leading to 
myotube formation (Wu et al., 2000). To determine whether p130Cas 
regulates myogenic differentiation by altering Erk1/2 and p38 MAPK 
signaling, the expression profiles of the phosphorylated (active) forms of 
Erk1/2 and p38 MAPK during myogenic differentiation were examined by 
immunoblotting assays. The phosphorylation level of Erk1/2 and p38 MAPK 
was respectively down-regulated and up-regulated in both control and CasKD 
cells (Figure 4.4), indicating that p130Cas potentially modulates myogenic 
differentiation through an alternate pathway and not through Erk1/2 and p38 
MAPK signaling. 
 
4.5 p130Cas is involved in the regulation of MAL translocalization 
during myogenic differentiation  
SRF transciptional activity has been reported to be regulated by two 
distinct SRF co-factors, namely members of the ternary complex factor (TCF) 
family that is activated by Erk1/2 activity and megakaryocytic acute leukemia 
(MAL/MKL1/MRTF-A) which is regulated by actin dynamics. Since TCF is 
regulated by mitogenic ERK signaling which is down-regulated  during 
myogenic differentiation (Figure 4.4) (Wu et al., 2000; Vickers et al., 2004), 
it is an unlikely candidate involved in promoting SRF-driven-expression of 
muscle-specific proteins. On the other hand, MAL/SRF activity is required for 
the transcriptional activation of SRF myogenic target genes at the onset of 
myogenic differentiation whereby MAL translocates into the nucleus (Cen et 
al., 2004). Therefore, to investigate whether p130Cas plays any role in 
regulating MAL/SRF activity, the subcellular localization of MAL in C2C12 
myoblasts was examined after the expression of p130Cas was silenced. In the 
presence of GM, MAL protein was diffusely distributed throughout in both 
control cells and CasKD cells, and with a seemingly higher cytoplasmic 
distribution in both cells (Figure 4.5A, top). After medium replacement with   
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Figure 4.4 – p130Cas knockdown does not interfere with Erk1/2 and p38 MAPK 
activities in C2C12 myoblasts. Control and CasKD cells were cultured in DM to 
induce myogenic differentiation and solubilized on the indicated days. Immunoblot 
analysis was performed to evaluate the phosphorylation levels of Erk1/2 and p38 
MAPK. White arrowheads indicate Erk1; black arrowheads indicate Erk2. Tubulin 
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Figure 4.5 – p130Cas phosphorylation regulates MAL translocation into the 
nucleus during myogenic differentiation. (A, B) Control and CasKD cells were 
cultured in fresh GM or DM for one day prior to analysis. Cells were then fixed with 
4% paraformaldehyde, followed by immunostaining with anti-MAL antibody (green, 
A and C; red, B) and DAPI (blue) for the cell nucleus. (B) Z-projections and intensity 
plots of MAL (red line) and DAPI (blue line) along the dotted lines of the XZ-section 
(yellow line) of the z-projected images (representatives) are shown. Intensities were 
normalized with the maximum values in each individual plot. The Z-stack images 
(0.2 m interval) were acquired using a spinning disk confocal microscope equipped 
with a water-immersion objective (60X). (C) Control cells and CasKD cells 
expressing CasWT or Cas15YF were cultured in fresh GM or DM for one day prior 
to analysis. Cells were then fixed with 4% paraformaldehyde, followed by 
immunostaining with anti-MAL antibody (green) and DAPI (blue) for the cell 
nucleus. The images (A, C) were acquired with a confocal microscope (A1R) 
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DM, MAL was equally distributed in both the cytoplasm and nuclei of control 
cells but not in the case of CasKD cells whereby the presence of MAL 
diminished greatly from their nuclei (Figure 4.5A, bottom, and B). 
Subsequently, to determine whether localization of MAL to nucleus during 
medium replacement with DM was modulated by the phosphorylation of 
p130Cas, CasWT or Cas15YF was expressed in CasKD cells. Nuclear 
localization of MAL, which was diminished in CasKD cells, was restored by 
the exogenous expression of CasWT, but not Cas15YF (Figure 4.5C). 
Together, these results indicated that phosphorylated p130Cas was involved in 
the regulation of MAL localization. 
 
4.6 p130Cas participates in the regulation of actin remodeling in 
myoblasts 
It is reported that MAL translocation is regulated by actin dynamics, 
specifically monomeric/globular actin (G-actin) (Wu and Crabtree, 2007; 
Olson and Nordheim, 2010). The actin cytoskeleton appears disorganized in 
p130Cas-deficient mouse embryonic fibroblasts (MEFs) (Honda et al., 1998; 
Huang et al., 2002) and therefore, raises the question whether p130Cas 
regulates MAL localization in differentiating C2C12 myoblasts through its 
action on the actin cytoskeleton. To address this issue, immunohistostaining 
was performed to examine the actin stress fibers in both control myoblasts and 
CasKD myoblasts when cultured in either GM or DM. In GM, stress fibers 
appeared less defined in CasKD cells when compared with control cells 
whereby the stress fibers were thicker (Figure 4.6A, top). However, the ratio 
of F- to G-actin (F-/G-actin) was comparably similar between these cells 
(Figures 4.6B, top, and 7C). In comparison to when cultured in GM, actin 
stress fiber formation and the F-/G-actin ratio were significantly decreased in 
both control and CasKD cells when the culture medium is switched to DM, 
(Figures 4.6, A–C). Notably, the decrease in actin stress fiber formation and 
the F-/G-actin ratio were both significantly enhanced in CasKD cells 
compared to control cells (Figures 4.6A, bottom, 4.6B, bottom, 4.6C, and 
Figures 4.7, A–C). In addition, re-introduction of CasWT, but not Cas15YF, 
restored actin stress fiber formation in CasKD cells under both culture   
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Figure 4.6 – p130Cas regulates actin remodeling in C2C12 myoblasts. (A–C) 
CasKD cells and (D–F) CasKD cells expressing CasWT or Cas15YF, with 
corresponding control cells, were cultured in fresh GM or DM for one day and fixed 
with 4% paraformaldehyde prior to analysis. (A, D) Cells were subjected to 
phalloidin staining to visualize F-actin. Scale bar: 20 m. (B, E) Images of cells 
depicting the ratio between F- and G- actin. Cells were stained for F-actin and G-actin 
with Alexa 488-phalloidin and Alexa 594-DNase I, respectively, and their intensity 
ratio was calculated. Scale bar: 20 m. (C, F) F-actin to G-actin (F-/G-actin) ratio. 
Values were normalized with the mean value of the control cells cultured in GM. 
Data represent the mean  SD of more than ten independent cells. Asterisks, p < 0.01 
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Figure 4.7 – Knockdown of p130Cas results in thinner actin stress fiber 
formation in C2C12 myoblasts 
(A, B) Images illustrating the principle of erosion filtering-based method for stress 
fiber thickness analysis. In response to the erosion/filtering cycles, fluorescence 
intensities on thick stress fibers (cells infected with shRNA vector-expressing 
retrovirus, control cells) decayed slower compared with those on thin stress fibers 
(cells infected with p130Cas-shRNA-expressing retrovirus, CasKD cells). The decay 
constant () of stress fiber intensity against the cycle number of erosion filtering was 
used as a stress fiber thickness index (SFTI). Refer to section 3.11.3 for greater 
details. Scale bar: 10 m. (C) SFTI of control cells and CasKD cells after switching 
to DM for one day. Stress fibers formed in CasKD cells are thinner in comparison to 
the control cells. (D) SFTI of CasKD cells and CasKD cells expressing CasWT or 
Cas15YF. Expression of CasWT, not Cas15YF, in CasKD cells recovers the 
formation of thicker stress fibers. Each bar represents the mean  SD for more than 
30 stress fibers of >10 cells. Asterisks, p < 0.01 (unpaired Student’s t-test.). 
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conditions i.e. GM and DM (Figure 4.6D and Figure 4.7D). The decrease in 
the F-/G-actin ratio after medium replacement with DM was moderated by the 
expression of CasWT but not Cas15YF (Figures 4.6, E and F). Taken 
together, the data show that phosphorylated p130Cas modulates actin 
remodeling which consequently, contributes to the regulation of MAL nuclear 
localization in differentiating C2C12 myoblasts. 
 
4.7 Integrin-3 drives p130Cas phosphorylation in differentiating C2C12 
myoblasts  
It is reported that integrin-3 plays a role in promoting myogenic 
differentiation (Liu et al., 2011) and that activation of integrin-3 signaling 
supports p130Cas phosphorylation (Smith et al., 2008). To investigate whether 
integrin-3 is involved in the increase in p130Cas phosphorylation during 
myogenic differentiation, the expression of integrin-3 was silenced in C2C12 
myoblasts. Consistent with the previous report (Liu et al., 2011), the 
expression of integrin-3 increased during differentiation of C2C12 myoblasts 
(Figure 4.8A, first panel). In contrast, after switching to culturing in DM, the 
increase in p130Cas phosphorylation was greatly attenuated by the silencing 
of integrin-3 (Figure 4.8A). This suggests that integrin-3 acts upstream of 
p130Cas, regulating its phosphorylation, in differentiating C2C12 myoblasts. 
Furthermore, knockdown of integrin-3 significantly decreased the number of 
myotube formed in C2C12 myoblasts (Figure 4.8B). In addition, the 
expression of muscle-specific proteins (Figure 4.8C) and nuclear localization 
of MAL were also significantly impaired by integrin-3 knockdown in C2C12 
myoblasts cultured in DM (Figure 4.8D). These results suggest that integrin-
3 regulates myogenic differentiation by facilitating p130Cas phosphorylation, 
contributing to subsequent MAL nuclear translocation and SRF activation of 
muscle specific genes. 
 
4.8 Cofilin inactivation is important for myogenic differentiation via 
p130Cas mediation 
Active (unphosphorylated) cofilin disassembles actin filaments (F-
actin), leading to an increase in the intracellular G-actin pool and subsequent  
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Figure 4.8 – Integrin-3 facilitates phosphorylation of p130Cas during myogenic 
differentiation of C2C12 myoblasts. C2C12 myoblasts were infected with shRNA 
vector- or integrin 3-shRNA-expressing retroviruses and selected with antibiotics to 
obtain a stably integrin-3 knockdown (ITG3KD) cells and its corresponding 
control cells. Cells were cultured in GM before differentiating in DM, followed by 
solubilization or fixed with 4% paraformaldehyde on indicated days (A) Immunoblot 
analysis was performed to evaluate the expression of integrin-3 (ITG3) and 
phosphorylated p130Cas (p-p130Cas). (B) Cells were subjected to immunostaining 
with anti-MHC antibody (red) and DAPI staining (blue) for nuclei after 4 days in DM. 
Images were obtained with a confocal microscope (A1R) equipped with an objective 
(40X). Scale bar: Scale bar: 50 m. (C) Expression of muscle-specific proteins were 
evaluated by immunoblot analysis. (D) Cells were subjected to immunostaining with 
anti-MAL antibody (green) and DAPI staining (blue) for nuclei after 1 day in DM. 
The images were obtained with a confocal microscope (A1R) equipped with an oil-
immersion objective (100X). Scale bar: 20 m. (A, C) Tubulin was used as a loading 
control in immunoblot analyses. 
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inhibition of MAL nuclear translocation and down-regulation of SRF activity 
(Olson and Nordheim, 2010). An increased phosphorylation of cofilin at the 
Ser3 residue, which leads to its inactivation, was observed in control cells but 
not in CasKD cells when the cells were cultured in DM (Figure 4.9A). To 
investigate whether cofilin plays a role in p130Cas-mediated regulation of 
C2C12 differentiation, the phospho-mimetic (inactive) mutant form of cofilin 
(CfnS3E) was introduced and expressed in CasKD cells (Figure 4.9B). Actin 
stress fiber formation and MAL nuclear localization were restored in CasKD 
cells when CfnS3E was exogenously expressed (Figures 4.9, C-E). 
Accordingly, the expression of skeletal muscle-specific proteins and myotube 
formation were also restored in CasKD cells expressing CfnS3E (Figures 4.9, 
F and G). These results suggest that inactivation of cofilin is involved in 
p130Cas-mediated differentiation of C2C12 myoblasts.  
 
4.9 LIMKs are not involved in cofilin inactivation via p130Cas-mediated 
pathway during myogenic differentiation 
The activity of cofilin is regulated through phosphorylation by several 
kinases, including LIM-kinase (LIMK), testicular protein kinases (TESKs) and 
integrin-linked kinase (ILK), and dephosphorylation by phosphatases, such as 
Slingshot and Chronophin (Kim et al., 2008b; Bernstein and Bamburg, 2010). 
To address how p130Cas is linked to cofilin inactivation during C2C12 
myogenic differentiation, the activity of kinases that phosphorylate cofilin was 
investigated. First, immunostaining was conducted to examine LIMK activity 
in CasKD cells. Similar decrease in the phosphorylation level of LIMK was 
observed between control and CasKD cells after switching the culture medium 
to DM (Figure 4.10A). Upon treatment with a LIMK inhibitor (LIMKi; BMS-
5) in GM, phosphorylation of cofilin, but not p130Cas, was decreased (Figure 
4.10B). However, inhibition of LIMK activity did not affect p130Cas 
phosphorylation and cofilin phosphorylation induced after switching culture 
medium to DM (Figure 4.10C). Therefore, the involvement of LIMK in 
p130Cas-mediated phosphorylation of cofilin in differentiating myoblasts is 
unlikely.  
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Figure 4.9 – Cofilin inactivation restores myogenicity in p130Cas knockdown 
cells. (A) C2C12 myoblasts were infected with shRNA vector- or p130Cas-shRNA-
expressing retroviruses to generate a stably p130Cas knockdown (CasKD) cells and 
its corresponding control cells. Cells were then cultured in GM before differentiating 
in DM, followed by solubilization on indicated days. Cofilin and its phosphorylated 
form (p-cofilin) were evaluated by immunoblot analysis. (B–G) C2C12 myoblasts 
were co-infected with shRNA vector- or p130Cas-shRNA-expressing retroviruses, 
together with either vector- or HA-tagged mutant cofilin (CfnS3E) -expressing 
retroviruses. (B) Cells were cultured in GM and solubilized and expression of HA-
tagged CfnS3E was confirmed by immunoblot analysis. (C–E) Cells were cultured in 
GM or DM for one day and fixed with 4% paraformaldehyde prior to analysis. 
Images were obtained with a confocal microscope (A1R) equipped with an oil-
immersion objective (100X). Scale bars: 20 m. (C) Cells were stained for F-actin 
with phalloidin. (D) SFTI of CasKD cells and CasKD cells expressing CfnS3E. Each 
bar represents the mean  SD for more than 30 stress fibers of >10 cells. Asterisks, p 
< 0.01 (unpaired Student’s t-test). (E) Cells were subjected to immunostaining with 
anti-MAL antibody (green) and DAPI staining (blue). (F) Cells cultured in GM were 
solubilized and immunoblot analysis was performed to evaluate the expression of 
muscle-specific proteins. (G) Cells were subjected to immunostaining with anti-MHC 










Figure 4.10 – p130Cas knockdown does not significantly alter LIMK activity in 
C2C12 myoblasts. (A) CasKD and control cells were differentiated in DM and 
solubilized on indicated days. Immunoblotting was performed and the activity of 
LIMK was evaluated with anti-LIMK and anti-phospho-LIMK antibodies. (B) C2C12 
myoblasts were cultured in GM in the presence or absence of LIMK inhibitor (LIMKi; 
3 M) for 24 hours and then solubilized. Phosphorylation level of p130Cas (p-
p130Cas) and cofilin (p-cofilin) were evaluated by immunoblot analysis. (C) C2C12 
myoblasts were cultured in DM in the presence or absence of LIMKi for 24 hours and 
then solubilized. Immunoblot analysis was then performed to evaluate the 
phosphorylation level of p130Cas (p-p130Cas) and cofilin (p-cofilin). Tubulin was 
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4.10 TESKs are not involved in cofilin inactivation via p130Cas-mediated 
pathway during myogenic differentiation 
TESK1 and TESK2 are found highly expressed in testis and at low 
levels in other tissues (Toshima et al., 2001b; Toshima et al., 2001c), whereas 
their expression levels in skeletal muscle or myogenic cells remain undefined. 
The results from quantitative real-time PCR (qPCR) showed that both TESK1 
and TESK2 were expressed in C2C12 myoblasts but at a much significantly 
lower levels than in murine testicular tissues (Figure 4.11A). To examine the 
roles of TESKs in the process of myogenic differentiation, silencing of TESK1 
or TESK2 expression was performed in C2C12 myoblasts (Figure 4.11B). 
While myotube formation was impaired by the knockdown of TESK2, 
myotubes formed, comparable to control cells, in TESK1-knockdown 
(TESK1KD) C2C12 myoblasts (Figure 4.11, C and D). These results 
excluded the possibility of TESK1 involvement in p130Cas-mediated 
myogenic differentiation. In the case of TESK2-knockdown (TESK2KD) 
myoblasts, elongation and alignment of cells on day 2, which was observed in 
both control and CasKD cells (Figure 4.1C), was absent (Figure 4.11C). 
While both TESK1KD and TESK2KD cells were viable in GM, cell viability 
of TESK2KD cells appeared remarkably decreased when cultured in DM 
(Figure 4.11E). The results suggest that silencing of TESK2 expression 
impedes the progression of myogenic differentiation through a mechanism 
independent of p130Cas-mediated signaling. Taken together, TESK1 and 
TESK2 are unlikely to be involved in p130Cas-mediated phosphorylation of 
cofilin that occurs during the myogenic process. 
 
4.11 ILK is involved in p130Cas-mediated inactivation/phosphorylation of 
cofilin during myogenic differentiation 
ILK has been reported to directly bind the integrin  subunits 
(Hannigan et al., 2011) and also phosphorylates cofilin at serine-3 (Kim et al., 
2008b). As both LIMKs and TESKs are determined unlikely to participate in 
p130Cas-mediated inactivation of cofilin during myogenic differentiation, 
analysis of ILK distribution in C2C12 myoblasts was performed to investigate 
if ILK was involved in p130Cas-mediated cofilin inactivation. Although ILK  
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Figure 4.11 - Knockdown of TESK2, but not TESK1, impairs alignment of 
myoblasts and subsequent myotube formation. (A) Relative mRNA expressions of 
TESK1 and TESK2 in C57/B6 mouse testis and C2C12 myoblasts were examined by 
quantitative real-time PCR (qPCR). The mRNA expression levels of TESK1 and 
TESK2 were normalized against -actin expression and scaled with the expressions in 
mouse testis set as 1. (B–E) C2C12 myoblasts were infected with shRNA vector-, 
TESK1-, TESK2-, or p130Cas-shRNA (E) -expressing retroviruses. (B) Quantitative 
real-time PCR was performed to evaluate the knockdown efficiency of TESK1 
shRNA or TESK2 shRNA in the myoblasts. (C) The cells were initially cultured in 
GM and then switched to DM. Phase-contrast images of the cells cultured in DM 
were captured on indicated days using OLYMPUS CKX41 microscope. Scale bar: 50 
m. (D) Cells were differentiated in DM for 4 days, followed by fixation with 4% 
paraformaldehyde and then subjected to anti-MHC immunostaining (red) and DAPI 
staining (blue). Images were obtained with an inverted microscope (OLYMPUS IX-
71). Scale bar: 50 m. (E) CasKD, TESK1KD, TESK2KD and control cells were 
cultured in GM and then switched to DM for 2 days before subjecting to trypan blue 
dye exclusion cell viability assay. Data are expressed as the percentage of dead cells 
over total cell number on the indicated days and presented as the mean  SD of three 
independent assays. Asterisks, p < 0.02 (unpaired Student’s t-test.). TESK1KD and 













Figure 4.12 – ILK is involved in p130Cas-mediated phosphorylation of cofilin. 
(A) CasKD cells and control cells were cultured in GM or DM for one day prior to 
immunostaining with anti-phospho-paxillin (p-Paxillin; green) and anti-ILK (red) 
antibodies. The images were obtained with a confocal microscope (A1R) equipped 
with an oil-immersion objective (100X). Scale bar: 20 m. (B–D) C2C12 myoblasts 
were co-infected with p130Cas-shRNA-expressing retroviruses, with or without 
phospho-mimetic mutant human (h-) ILK (hILKS343D)-expressing retroviruses. (B) 
The cells cultured in GM were solubilized and immunoblot analysis and RT-PCR 
were performed to evaluate the expression levels of p130Cas and mutant ILK, 
respectively. (C) The cells were differentiated in DM for indicated days before 
solubilization. Immunoblot analysis was then performed to evaluate the expression 
levels of skeletal muscle-specific proteins. (D) Cells were fixed with 4 % 
paraformaldehyde and subjected to immunostaining with anti-MHC antibody (red) 
and DAPI staining (blue). Scale bar: 50 m. Tubulin and mouse (m-) -actin serve as 
loading control for immunoblot and RT-PCR analyses, respectively.   
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co-localized moderately with phosphorylated paxillin, it was not able to 
clearly define ILK distribution to adhesion sites in control and CasKD cells 
cultured with GM (Figure 4.12A, top). On the contrary, the distribution of 
ILK appeared markedly different between control and CasKD cells after the 
induction of myogenic differentiation. A more distinct accumulation and co-
localization of ILK with phosphorylated paxillin was observed in control cells, 
while in CasKD cells, ILK was more diffusely distributed in the cytoplasm 
(Figure 4.12A, bottom). The data suggest that ILK plays a role in adhesion-
associated p130Cas-mediated signaling events related to the induction of 
myogenic differentiation.  
To further examine whether ILK is involved in p130Cas-dependent 
C2C12 differentiation, human ILK mutant (hILKS343D), which has been 
reported as constitutively active (Hannigan et al., 2011), was expressed in 
CasKD cells (Figure 4.12B). Similar to CasKD cells expressing the phospho-
mimetic form of cofilin (Figures 4.9, F and G), the expression of muscle-
specific proteins and myotube formation were restored in CasKD cells 
expressing hILKS343D (Figures 4.12, C and D). Together, these results 
indicate that ILK participates in the regulation of myogenic differentiation in a 
p130Cas-dependent manner. 
 
4.12 ILK-associated protein(s) phosphorylates cofilin during myogenic 
differentiation 
To determine whether ILK phosphorylated cofilin directly in 
differentiating C2C12 myoblasts, an in-gel kinase assay of anti-ILK immune-
precipitates was performed using GST-cofilin as a substrate (Figure 4.13A). 
Phosphorylation of GST-cofilin by protein(s) of 51 kDa, the molecular weight 
of ILK, was not apparent (Figure 4.13B, top panel, arrowhead). Instead, at 
higher molecular weights, several bands of phosphorylated cofilin that were 
larger than 51 kDa were detected by immunoblot analysis. These higher 
molecular bands of phosphorylated cofilin are likely to be due to kinase 
activity of ILK-associated proteins, suggesting that ILK itself may not have 
phosphorylated cofilin directly. The activity of cofilin phosphorylation was 
significantly increased in control cells after medium replacement with DM 
(Figure 4.13B, top panel, lanes 2 and 3) and was attenuated by silencing of 
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p130Cas (Figure 4.13B, top panel, lanes 5 and 6). While an increase in ILK 
expression was observed after the induction of myogenic differentiation 
(Figure 4.13B, bottom, lane 1 vs. lanes 2 and 3), it did not appear to fully 
account for the remarkable increase in cofilin phosphorylation in the in-gel 
kinase assay (Figure 4.13B, top, lane 1 vs. lanes 2 and 3). Furthermore, ILK 
expression levels were comparable between CasKD and control cells (Figure 
4.13B, bottom). It is therefore likely that p130Cas modulated the activity of 
ILK complexes, but not ILK expression. These results indicate that p130Cas 
regulates myogenic differentiation through cofilin inactivation by ILK 
complexes that consequently contributes to MAL nuclear translocation and 
SRF-mediated transcriptional activation of muscle-specific genes. Collectively, 
with the current findings in this study, a model for p130Cas-dependent actin 
remodeling in the regulation of skeletal myogenic differentiation is proposed 









Figure 4.13 – p130Cas regulates cofilin phosphorylation through ILK associated 
protein(s). (A) The recombinant GST-cofilin fusion protein expressed in BL21 E. 
coli was purified using glutathione-sepharose beads and eluted from the beads with 
20 mM reduced glutathione. A Coomassie Brilliant Blue (CBB)-stained gel showed 
the eluted GST-cofilin fusion protein which was used as a substrate in in-gel kinase 
assay. (B) CasKD and control cells were differentiated in DM and solubilized on the 
indicated days. Cell lysates were subjected to immunoprecipitation with anti-ILK 
monoclonal antibody. The activity of ILK-associated proteins was assessed by an in-
gel kinase (IGK) assay (top panel) using purified GST-cofilin as a substrate. 
Phosphorylated cofilin (p-cofilin) was evaluated by immunoblot analysis using an 
anti-phospho-cofilin antibody. Arrowheads indicate the position of ILK (~51 kDa). 










Figure 4.14 – Proposed model for p130Cas-mediated signaling facilitating 
skeletal muscle-specific gene expression during myogenic differentiation. 
Phosphorylation of p130Cas promotes inactivation/phosphorylation of cofilin which 
mediates intracellular remodeling of actin molecules through ILK complexes and 
subsequently, releasing MAL and stimulating SRF/MAL transcriptional expression of 























 Myogenesis is an essential biological process for the development, as 
well as the maintenance and repair of muscle tissues, throughout an 
organism’s life. During myogenic differentiation, the actin cytoskeleton 
undergoes remarkable re-organization during the transition from 
mononucleated myoblasts to multinucleated myotubes that subsequently 
organize into muscle fibers. The entire process is controlled by a tightly 
orchestrated expression of muscle-specific genes. Re-modeling of the actin 
cytoskeleton mediates the morphological changes that occur during cell 
elongation, alignment and fusion of myoblasts. The inhibition of actin 
dynamics has been known to disrupt myotube formation (Nowak et al., 2009). 
The adaptor protein p130Cas, in addition to its role as a signal convergence 
center, functions as a cytoskeletal mechano-sensor through stretch-dependent 
tyrosine phosphorylation (Sawada et al., 2006) and regulates the actin 
cytoskeleton (Honda et al., 1998), contributing to the generation of specific 
cellular responses. From the findings of this study, p130Cas displays a pivotal 
role in the regulation of myogenic differentiation. Integrin-3 dependent 
phosphorylation of p130Cas promotes actin-remodeling by inactivation of 
cofilin and subsequently, promotes MAL/SRF transcriptional activation of 
muscle-specific genes.  
 
5.1.1 p130Cas mediates SRF transcriptional activity during myogenic 
differentiation 
Serum response factor (SRF) is a MADS-box transcription factor that 
binds to a conserved DNA sequence, CC(A/T)6GG, known as CArG box or 
serum response element (SRE) and is implicated in several biological 
processes, including proliferation and myogenesis (Miano, 2003). In contrast 
to an early study which demonstrated that SRF expression was required to 
promote myogenic differentiation (Soulez et al., 1996), the results in this 
thesis clearly show that the SRF activity is decreased at the onset of myogenic 
differentiation. Transcriptional activity of TCF is regulated by two distinct 
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cofactors, namely ERK-regulated TCFs and actin-regulated MAL (Cen et al., 
2004). As previously reported (Bennett and Tonks, 1997), mitogenic ERK 
activity decreased in control cells after the induction of differentiation by 
medium replacement with DM and was similarly decreased in CasKD cells. 
The decreased ERK activity led to an attenuation of TCF activity, accounting 
for the decrease in SRE-luciferase activity detected in differentiating cells, i.e. 
after medium replacement with DM. Concomitantly, actin dynamics was 
affected with a decrease in the formation of actin stress fiber observed, and 
attenuated MAL-mediated SRF activity due to the increased pool of 
intracellular actin monomers. This is consistent with experiments using actin-
binding drugs or actin overexpression showing that MAL activity is affected 
in a G-actin concentration-dependent-manner (Sotiropoulos et al., 1999; 
Vartiainen et al., 2007). Together, these results suggested that both TCF- and 
MAL-mediated SRF activities are mitigated at the onset of myogenic 
differentiation. The decrease in SRE-luciferase activity and actin stress fiber 
formation were enhanced after medium replacement with DM when p130Cas 
was silenced, i.e. in differentiating CasKD cells. Correspondingly, MAL 
translocation to the nucleus was diminished in CasKD cells cultured in DM 
and subsequently interrupted MAL-mediated SRF transcriptional activity. 
These results are consistent with the enhanced decrease in the SRE-luciferase 
activity observed in differentiating CasKD cells.  
In contrast, the expression of skeletal muscle-specific genes and the 
activity of the skeletal muscle -actin promoter were remarkably increased 
after medium replacement with DM in control cells. Previous studies have 
demonstrated that the myogenic transcriptional repressor YinYang1 (YY1), 
together with polycomb protein Ezh2 and histone deacetylase HDAC1, form a 
repressive complex that binds to the -actin promoter and suppresses -actin 
expression in proliferating C2C12 myoblasts (Lee et al., 1992; Wang et al., 
2007a). The promoter region of skeletal -actin gene contains not only SREs 
but also E-boxes, the consensus sequence for the binding of basic helix-loop-
helix (bHLH) transcription factors such as MyoD (Marsh et al., 1998). It is 
proposed that at the onset of myogenic differentiation, the YY1/Ezh2/HDAC1 
transcriptional repressive complex is replaced by transcriptional activators, 
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SRF and MyoD, and co-transcriptional activators, histone acetyltransferase 
CBP or p300/CBP-associated factor (PCAF), which together promote 
transcriptional activation of muscle-specific genes, such as skeletal -actin 
gene (Lee et al., 1992; Wang et al., 2007a). The increase in -actin promoter 
activity after medium replacement with DM may be due to the loss of the 
YY1/Ezh2/HDAC1 repressive complex and a subsequent recruitment of SRF, 
MyoD and histone acetyltransferase(s). In this study, silencing of p130Cas 
abrogates the increase in -actin promoter activity after medium replacement 
with DM. Since SRF activity was regulated by p130Cas at the onset of 
differentiation and MyoD expression could be induced by SRF (L'Honore et 
al., 2003), the suppression of -actin promoter activity by silencing of 
p130Cas may be a synergistic inhibitory effect on SRF and MyoD 
transcriptional activities. 
 
5.1.2 Integrin-3-dependent phosphorylation of p130Cas promotes actin 
remodeling during myogenic differentiation 
 Several reports have demonstrated that integrin-3 is involved in 
myogenic differentiation through the activation of p38 MAPK, mediated by 
Rac1 (Bryan et al., 2005; Liu et al., 2011) and activity of p38 MAPK 
increases during myogenic differentiation (Wu et al., 2000). Silencing of 
integrin-3 attenuates the activity of p38-dependent myogenesis regulators 
such as p21
CIP1
 and myogenin (Liu et al., 2011), whereas in this study, 
knockdown of p130Cas did not interfere with p38 MAPK activity. In contrast, 
while integrin-3 signaling mediates actin cytoskeleton reorganization during 
myogenic differentiation (Liu et al., 2011), it is observed that actin 
cytoskeleton reorganization is dependent on the phosphorylation of p130Cas 
in this study. This is supported by the re-expression of CasWT, but not 
phosphorylation-defective mutant Cas15YF, in CasKD cells which recovered 
actin stress fiber formation. Together with the decrease in p130Cas 
phosphorylation by silencing of integrin-3, it is likely that integrin-3 
regulates myogenic differentiation by facilitating phosphorylation of p130Cas, 
which potentiated actin remodeling. Furthermore, MAL nuclear localization 
was attenuated in differentiating myoblasts by silencing of either p130Cas or 
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integrin-3. These results support the notion that the integrin-3/p130Cas 
pathway regulates MAL nuclear localization through the modulation of actin 
cytoskeletal dynamics. 
 
5.1.3 Knockdown of p130Cas disrupts mechanotransduction of physical 
signals into chemical signals during myogenic differentiation 
Cellular movement, such as cell alignment, and cellular morphological 
changes, such as cell elongation, involve remodeling of actin cytoskeleton 
which generates intracellular mechanical forces (Kumar et al., 2006; 
Ananthakrishnan and Ehrlicher, 2007). The forces, produced intracellularly, 
are transduced to the surrounding extracellular matrix (ECM), and facilitated 
ECM remodeling in response to the mechanical stress within the cell 
(Lemmon et al., 2009; Kraning-Rush et al., 2011). During myogenic 
differentiation, CasKD cells aligned and extended similarly as observed in 
control cells, suggesting that silencing of p130Cas does not impede 
differentiation-induced cell movement or morphological changes. In addition, 
actin stress fiber formation is decreased in both CasKD and control cells upon 
medium replacement with DM, which potentially led to a dynamic change in 
the existing actin cytoskeleton, generating mechanical stress on the 
differentiating cells and altering the surrounding ECM integrity or rigidity. 
Both proliferating cells and cells undergoing differentiation secrete different 
compositions of ECM proteins and polysaccharides (Henningsen et al., 2010). 
Transmembrane receptors, integrins, form the physical connection 
between the actin cytoskeleton and the surrounding ECM. Through integrins, 
cells sense and respond to changes in the ECM and propagate the physical 
signals into the cells which are then converted into chemical signals to activate 
genes or responses through mechanotransduction pathways involving 
mechano-sensing proteins such as p130Cas and talin (Sawada et al., 2006; Lee 
et al., 2007). Silencing of mechanosensor p130Cas in C2C12 myoblasts 
disrupt the mechanochemical signal conversion process which likely rendered 
the cells inability to respond to the ECM changes for subsequent stages in 
myogenic differentiation. In consistent with this notion, the results show that 
while myotubes were observed in control cells at day 4, no myotube was 
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present in CasKD cells when subjected to same differentiation condition. It is 
likely that the silencing of p130Cas impairs mechanochemical signal 
transduction which translates physical signals into chemical signals in vivo and 
subsequently, the activation of pro-myogenic responses and genes. Moreover, 
as shown in this study, the silencing of integrin-3 by shRNA also attenuated 
p130Cas phosphorylation and abolished myotube formation after medium 
replacement with DM. In addition, while silencing of integrin-3 did not 
completely abolish myotube formation as observed in CasKD cells, p130Cas 
may be involved in the downstream signal transduction pathways of other 
transmembrane receptors such as integrin-1 subunit which binds to laminins 
(Gullberg et al., 1999) and also promotes phosphorylation of p130Cas 
(Armulik et al., 2004). Taken together, the mechanosensing property of 
p130Cas likely plays a key role in facilitating myotube formation through 
mechanochemical signal conversion and transduction processes mediated by 
integrins. 
 
5.1.4 p130Cas-mediated inactivation of cofilin promotes MAL/SRF 
myogenic activity during myogenic differentiation 
Actin remodeling is a dynamic cycle whereby monomeric actin, i.e. G-
actin, is arranged into polymers, i.e. filamentous actin (F-actin) by actin-
binding proteins (ABPs) and is then disassembled back into monomers with 
the process repeating over and over (Rottner and Stradal, 2011). Cofilin 
promotes actin filament disassembly and thus, enhancing cofilin activity will 
contributes toward supplying an abundant pool of G-actin (Kiuchi et al., 2007). 
G-actin regulates MAL activity by binding to MAL and concomitantly, 
interrupts MAL/SRF interaction and the corresponding transcriptional activity 
(Olson and Nordheim, 2010). In epidermal stem cells, cofilin inactivation and 
concomitant MAL/SRF activation are required for their differentiation into 
keratinocytes (Connelly et al., 2010). The results in this study suggested that 
p130Cas was involved in the inactivation of cofilin during skeletal muscle 
differentiation. Cofilin inactivation decreases the concentration of G-actin and 
enhances MAL/SRF activity, which is critical for muscle-specific gene 
expression (Miralles et al., 2003; Posern and Treisman, 2006). p130Cas-
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dependent inactivation of cofilin and restoration of myogenicity in CasKD 
cells expressing a dominant-negative form of cofilin, CfnS3E, suggest that 
cofilin acts as a downstream mediator of p130Cas in the context of C2C12 
myogenic differentiation. Thus, supporting the hypothesis that p130Cas 
tampers the decrease in F-actin formation through inactivation of cofilin and 
thereby contributing to the maintenance of SRF activity required for muscle-
specific gene expression. 
 
5.1.5 Myogenic differentiation-induced inactivation of cofilin is 
independent of LIMKs and TESKs 
Modulation of actin cytoskeleton remodeling is mediated by cofilin 
activity which is reversibly regulated by phosphorylation or dephosphorylation 
at its serine residue at the 3
rd
 amino acid position (Ser3), with the 
phosphorylated form being inactive (Moriyama et al., 1996). Silencing of 
p130Cas in C2C12 myoblasts resulted in an increased pool of active 
(unphosphorylated) cofilin and hindered inactivation (phosphorylation) of 
cofilin in DM, indicating that p130Cas mediated cofilin inactivation during 
myogenic differentiation. Inactivation of cofilin has been proposed to halt 
actin threadmilling to provide ATP for other immediate cellular activities in 
response to stress (Bernstein et al., 2006). Cofilin phosphorylation is mainly 
regulated by LIMKs and TESKs that inactivate cofilin activity by specifically 
phosphorylating cofilin Ser3 residue and therefore mediating actin 
cytoskeleton reorganization (Arber et al., 1998; Toshima et al., 2001a; 
Toshima et al., 2001c). In this study, both LIMKs and TESKs are unlikely 
candidates in p130Cas-mediated reorganization of actin cytoskeleton. In both 
control and CasKD cells, activity of LIMK was similarly decreased during 
myogenic differentiation and inhibition of LIMKs with specific LIMK 
inhibitor (LIMKi), BMS-5, failed to suppress differentiation-induced 
inactivation/phosphorylation of cofilin. Likewise, silencing of TESK1 did not 
interfere with formation of myotubes in C2C12 myoblasts. Although myotube 
formation was inhibited when TESK2 was silenced, cell mortality was 
significantly higher in these cells when subjected to myogenic differentiation. 
In GM, viability and proliferation of TESK2KD cells was comparable to 
control, TESK1KD and CasKD cells. This indicates that TESK2 mediated 
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myogenic differentiation in a different mechanism unrelated to p130Cas-
mediated signaling. 
Unlike TESK1, TESK2 is predominantly localized in the nucleus of 
sertoli cells, with translocation to the cytoplasm being dependent on its kinase 
catalytic activity (Toshima et al., 2001c), suggesting that TESK2 
phosphorylates nuclear cofilin and potentially mediates the nucleoskeleton 
remodeling. Remodeling of the nuclear lamina and nucleoskeleton mediates 
the activation of muscle-specific genes during skeletal muscle differentiation 
(Markiewicz et al., 2005; Brosig et al., 2010). The components of 
nucleoskeleton include mainly actin- and lamin-binding proteins which play 
important roles in regulating nuclear functions (Shumaker et al., 2003; Boban 
et al., 2010). An increased expression of lamin A preceding the expression of 
muscle-specific proteins during myogenic differentiation (Lourim and Lin, 
1989), indicated that nucleoskeleton remodeling occurred at the onset of 
myogenic differentiation. Therefore, the high cell mortality observed in 
TESK2KD cells in DM may be due to an impaired nucleoskeleton remodeling 
affecting nucleus integrity during onset of myogenic differentiation, 
subsequently leading to cell death. Further experiments are required to 
conclude TESK2 molecular role(s) in myogenic differentiation. While LIMKs 
and TESKs are the main regulators of cofilin phosphorylation, they remain as 
unlikely downstream effectors in the context of p130Cas-mediated myogenic 
differentiation. 
 
5.1.6 p130Cas regulates myotube formation through ILK-mediated 
inactivation of cofilin 
ILK is a focal adhesion serine/threonine protein kinase and is involved 
in integrins-mediated signaling pathways (Hannigan et al., 1996). ILK is 
reported to play a critical role in the development and maintenance as well as 
contractibility of all muscle types, namely skeletal, smooth and cardiac 
muscles (Hannigan et al., 2011). ILK-mediated phosphorylation of cofilin 
Ser3 residue has been reported to be independent of LIMKs or TESKs, which 
are known upstream regulators of cofilin (Kim et al., 2008b). A recent study 
demonstrated that Kindlin-2, an integrin-associated adaptor protein, regulated 
the recruitment of ILK to focal adhesions (Wickstrom et al., 2009) and was 
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required in cell elongation, a morphological change that preceded myogenic 
fusion of mononucleated muscle precursor cells (Dowling et al., 2008). The 
recruitment of Kindlin-2 to the cytoplasmic tails of integrin  subunits 
activated integrins, leading to assembly of ILK/PINCH/parvin (IPP) complex 
into focal adhesions and facilitated intracellular signaling (Legate et al., 2006; 
Legate et al., 2009). However, while these studies demonstrated ILK was 
involved in focal adhesion assembly and integrin-mediated signal transduction, 
detailed molecular mechanisms behind ILK-dependent regulation of myogenic 
differentiation remained undefined. Consistent with previous report that ILK 
translocated to focal adhesions under differentiation condition (Dowling et al., 
2008), ILK co-localized with phosphorylated focal adhesion-associated 
protein, paxillin, in control C2C12 cells. However, in CasKD cells, ILK 
exhibited diffused distribution in the cytoplasm with no obvious colocalization 
with phospho-paxillin when cultured in DM. Hence, suggesting that 
translocation of ILK to the focal adhesions is mediated by p130Cas during 
myogenic differentiation. 
Over-expression of wildtype ILK, but not its kinase-deficient mutant 
ILKE359K, inhibits C2C12 myotube formation via a defect in ERK 
inactivation at the onset of differentiation, suggests that the expression level 
and kinase activity of ILK are functionally important in determining the 
progression of myogenesis in C2C12 myoblasts (Huang et al., 2000). In 
contrast, the expression of phospho-mimetic ILK mutant (ILKS343D), which 
has been reported as a constitutively active form of ILK (Persad et al., 2001), 
restored myogenicity in CasKD cells when subjected to myogenic 
differentiation. The kinase activity in ILKE359K is not completely abolished 
but retains a minimal 20% of its activity (Persad et al., 2001) and functions as 
a potent dominant negative instead (Novak et al., 1998). As such, the reduced 
kinase activity of ILKE359K potentially promoted myogenic differentiation 
instead. In addition, the overexpression of wildtype ILK may resulted in an 
excessive kinase catalytic activity that potentially disrupts actin dynamics as 
seen in cells expressing C-terminal deleted TESK2 mutants (Toshima et al., 
2001c). 
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ILK has been initially described as a kinase due to a significant 
sequence homology of its C-terminal to serine/threonine protein kinases and 
several studies have also demonstrated ILK kinase activity in directly 
phosphorylating various substrates such as MLC-20 (Deng et al., 2001), Akt 
(Persad et al., 2001) and myosin phosphatase inhibitors (Deng et al., 2002). 
However, several conserved catalytic residues, which are crucial for protein 
kinase activity, are lacking in ILK kinase domain (Hanks et al., 1988). The 
kinase activity of ILK remains controversial and instead, has been classified as 
a pseudokinase by some researchers. Although the results showed that the 
expression of mutant ILK (S343D) restored the expression of muscle-specific 
proteins and myotube formation in CasKD cells, cofilin phosphorylation by 
ILK itself was not apparent. Instead, the results from the in-gel kinase assay 
indicated that cofilin was phosphorylated by proteins with higher molecular 
weights, with the corresponding detected cofilin phosphoryation significantly 
decreased in CasKD cells cultured in DM when compared to control cells. 
Interactions between ILK and several focal adhesion proteins, such as paxillin 
and vinculin, as well as forming a complex with parvin and PINCH has 
indicated that ILK functions as a scaffolding protein and mediates integrin-
mediated signaling (Legate et al., 2006). Taken together, ILK may be a crucial 
scaffold/adaptor molecule that determines ERK-mediated proliferation and 
p130Cas-mediated myogenic differentiation of myoblasts. 
Myoblasts elongate and align prior to their fusion, with a decrease in 
RhoA activity involved in these cell morphological changes (Fortier et al., 
2008). Reduced F-actin formation after medium replacement with DM may 
have therefore resulted from the down-regulation of RhoA activity. The 
concomitant increase in G-actin was tempered by p130Cas-dependent 
inactivation of cofilin via ILK complexes. Taken collectively, a novel model 
for the molecular mechanism underlying myogenic differentiation mediated by 
integrin-3/p130Cas signaling, in which skeletal muscle-specific gene 
expression is induced by MAL/SRF transcriptional activity through ILK-
dependent cofilin inactivation is proposed (Figure 4.14). As differentiation is 
strictly programmed by integrin-mediated mechanosensing machinery (Engler 
et al., 2006), p130Cas-dependent actin remodeling during myogenic 
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differentiation may facilitates adhesion-cytoskeleton organization and serves 
as a mediator for the mechanical regulation of cell and tissue differentiation. 
 
5.2 Conclusion and perspectives 
 This study demonstrated the functional role of p130Cas in regulating 
skeletal myogenic differentiation and its mechanism through the integrin-
3/p130Cas axis. p130Cas mediated the expression of muscle-specific genes 
through actin cytoskeleton remodeling, facilitated by inactivation of cofilin. 
The results proposed that ILK is a potential downstream target of p130Cas-
mediated signaling and during myogenic differentiation, the inactivation of 
cofilin is mediated by ILK-associated proteins. In addition, p130Cas-mediated 
myogenic differentiation seems to be independent of LIMKs and TESKs 
activities. However, the identity of the ILK-associated proteins that 
phosphorylated GST-cofilin has yet to be defined (Figure 4.13B). The 
identification of these ILK-associated proteins may reveal novel kinases of 
cofilin and further biochemical analysis of these proteins would potentially 
contribute to further understanding of actin cytoskeleton remodeling. 
While it is shown in this thesis that the ILK complex lies downstream 
of the p130Cas-mediated signaling pathway, the activation of ILK complex by 
p130Cas remains elusive.  ILK and p130Cas are localized mainly in the 
cytosol of the cell whilst they are focal adhesion-associated proteins 
(Nakamoto et al., 1997; Li et al., 1999). Consistently, it is observed that ILK 
translocated to the focal adhesions during myogenic differentiation and 
silencing of p130Cas abolished the translocation. This strongly suggested that 
p130Cas potentially recruits ILK and its associated proteins. The inactivation 
of cofilin may subsequently occur at the focal adhesions or in their close 
proximity but this notion remains to be determined. Elucidating this will 
provide potential insights into the regulation of actin dynamics and address 
whether actin assembly occurs at specific subcellular locations. 
Actin cytoskeleton remodeling is a biochemical process that can be 
activated by intracellular or extracellular signals. The actin cytoskeleton and 
the external environment, i.e ECM, are connected physically and any changes 
in either will invoke a response from the other. Here, it is proposed that 
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silencing of p130Cas interrupts the ‘outside-in’ integrin-mediated 
mechanochemical transduction. Cell alignment and elongation is not hindered 
in CasKD cells during myogenic differentiation. In addition, myogenicity is 
not recovered with the introduction of phospho-defective mutant, Cas15YF), 
further supporting that the function of p130Cas as a mechano-sensor in 
mechanochemical signal transduction during myogenic differentiation. 
Lastly, this study focused mainly on the role of p130Cas in the 
formation of myotubes and not the maintenance of myotubes, which is another 
critical process in the organization of muscle integrity. In addition, it has been 
reported that the C-terminal p130Cas fragment plays a role in apoptosis (Kim 
et al., 2004). During myogenic differentiation, the activities of proteases, such 
as caspases, are upregulated (Fernando et al., 2002; Honda et al., 2008) and 
caspase-3 proteolytic activity can generate three p130Cas fragments (Hoon 
Kim et al., 2003), including the apoptosis-associated C-terminal fragment. 
Thus it will be intriguing to determine whether these p130Cas fragments play 
any functional roles in the regulation of muscle homeostasis that comprises 
myogenic differentiation and maintenance of myotubes and myofibrils. 
In summary, this present study demonstrated p130Cas, mediated by 
integrin-3, plays an essential role in skeletal myogenic progression and 
involves modulation of actin cytoskeleton remodeling and enhancing 
MAL/SRF transcriptional activity through cofilin inactivation. 
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 Actin dynamics are implicated in various cellular processes, not only through 
the regulation of cytoskeletal organization, but also via the control of gene expression.  
Here we show that the Src family kinase substrate p130Cas influences actin 
remodeling and concomitant muscle-specific gene expression, thereby regulating 
myogenic differentiation. In C2C12 myoblasts, silencing of p130Cas expression by 
RNA interference impaired F-actin formation and nuclear localization of the SRF co-
activator MAL following the induction of myogenic differentiation. Consequently, 
formation of multinucleated myotubes was abolished. Re-introduction of wild-type 
p130Cas, but not its phosphorylation-defective mutant, into p130Cas-knockdown 
myoblasts restored F-actin assembly, MAL nuclear localization and myotube 
formation. Depletion of the adhesion molecule integrin 3, a key regulator of 
myogenic differentiation as well as actin cytoskeletal organization, attenuated 
p130Cas phosphorylation and MAL nuclear localization during C2C12 differentiation. 
Moreover, knockdown of p130Cas led to the activation of the F-actin severing protein 
cofilin. The introduction of a dominant-negative mutant of cofilin into p130Cas-
knockdown myoblasts restored muscle-specific gene expression and myotube 
formation. These results suggest that p130Cas phosphorylation, mediated by integrin 
3, facilitates cofilin inactivation and promotes myogenic differentiation through 
modulating actin cytoskeleton remodeling.  
 
Keywords: p130Cas (Crk-associated substrate), actin dynamics, MAL 
(megakaryoblastic leukemia-1), cofilin, integrin, myogenic differentiation. 
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 The differentiation of muscle precursor cells or myoblasts into myotubes, 
which plays a central role in skeletal myogenesis, is a complex multi-step process 
involving cell cycle withdrawal, muscle-specific gene expression and cell 
alignment and fusion [1, 2]. These steps are orchestrated by various signal 
transduction molecules, such as MAP kinases and Akt, cell cycle regulators and 
transcription factors [3-5]. The expression of muscle-specific genes, including -actin, 
MyoD, myosin heavy chain (MHC) and myogenin, is dependent upon serum response 
factor (SRF) binding to the CArG box motif of the serum response element (SRE) [6-
9]. Extracellular stimuli, such as serum and growth factors, induce SRF 
transcriptional activation via two distinct signaling cascades [8, 10]. One pathway is 
through complex formation of SRF with the ternary complex factor (TCF) family of 
SRF cofactors activated by extracellular signal-regulated kinase (ERK). The other 
involves modulation of actin cytoskeletal dynamics and concomitant nuclear 
translocation of another SRF cofactor megakaryocytic acute leukemia (MAL), also 
known as MKL1 and MRTF-A. Monomeric actin (G-actin) directly binds to MAL 
and mitigates SRF transcriptional activity by sequestering MAL from the nucleus 
[11]. At the onset of myogenic differentiation, both ERK down-regulation and 
MAL/SRF activity are required for expression of skeletal muscle-specific genes [12, 
13]. 
 The adaptor molecule p130Cas (Crk-associated substrate), which localizes to 
focal adhesions, is involved in various cellular processes including migration, 
survival, transformation and invasion [14]. It is composed of multiple functional 
domains, including an N-terminal SH3 domain (CasSH3), a central substrate domain 
(CasSD) and a C-terminal Src-binding domain (CasSBD). CasSH3 interacts with 
various proteins including focal adhesion kinase (FAK). CasSD comprises fifteen 
YxxP motifs that are the major sites of tyrosine phosphorylation by Src family 
kinases. We previously reported that mechanical extension of CasSD potentiates its 
susceptibility to phosphorylation, which provides docking sites for Crk, Nck and 
Ship2, and facilitates downstream signaling [15-17]. p130Cas-deficient (p130Cas
-/-
) 
mice are embryonic lethal at 11.5 to 12.5 days post-coitum (dpc), exhibiting systemic 
congestion and growth retardation [18]. The hearts of p130
-/-
 mice exhibited 
disorganized myofibrils with disrupted Z disks, indicating significant roles for 
p130Cas in cardiac myocyte development. However the mechanism of how p130Cas 
regulates skeletal muscle differentiation remains elusive. 
 The integrins, which form functional heterodimers of  and  subunits, 
constitute a family of transmembrane receptors for extracellular matrix (ECM) 
 
 
proteins. They play a major role in cell-matrix adhesion and adhesion-initiated signal 
transduction [19]. Integrin 3 has been reported to be involved in myogenic 
differentiation [20]. We find that phosphorylation of p130Cas, which is integrin 3-
dependent, plays an essential role in myotube formation via modulation of the actin 
cytoskeleton and muscle-specific gene expression. During the initial phase of 
myogenic differentiation, cells become elongated and aligned, involving a decrease in 
stress fiber formation [2]. On the other hand, integrin 3-p130Cas signaling, which 
positively regulates F-actin formation [18, 19, 21, 22], is up-regulated in 
differentiating myoblasts and required for muscle-specific gene expression. In this 
report, we demonstrate that the integrin 3-p130Cas axis restricts the amount of 
available G-actin and concomitantly facilitates the nuclear localization of MAL 
through suppression of cofilin activity. These findings provide novel insights into 




Cell culture and retroviral infection 
 C2C12 myoblasts were cultured in growth medium (GM; DMEM [Nissui 
Pharmaceutical Co., Tokyo, Japan] supplemented with 10% FBS). To induce 
differentiation of C2C12 myoblasts, the culture medium was replaced with 
differentiation medium (DM; DMEM containing 2% horse serum). Retroviral 
infection was performed as previously described [23, 24]. Depending on the retroviral 
vectors used, infected cell populations were selected in either hygromycin (300 g/ml) 
or puromycin (4 g/ml) for 3 days, or neomycin (G418; 400 g/ml) for 14 days. 
 
Antibodies 
 Anti-phospho p130Cas (pCas-165) polyclonal (Cell Signaling Technology, 
Beverly, MA), anti-p130Cas polyclonal (Cas3) [17], anti-myogenin monoclonal 
(BD Biosciences Pharmingen, San Jose, CA), anti--actin monoclonal (5C5, Sigma, 
St. Louis, MO), anti-integrin 3 polyclonal (Cell Signaling Technology), anti-
phospho cofilin (S3) polyclonal (Cell Signaling Technology), anti-cofilin polyclonal 
(Cell Signaling Technology), anti-MHC monoclonal (MY32; Sigma), anti-MAL 
polyclonal (H-140; Santa Cruz Biotechnology, Santa Cruz, CA), anti-ILK rabbit 
monoclonal (EP1593Y; Merck Millipore, Billerica, MA), anti-ILK mouse 
monoclonal (65.1.9; Upstate, Lake Placid, NY) and anti-phospho paxillin (Y118) 
polyclonal (Cell Signaling Technology) antibodies were used for immunoblot, 





 To generate retroviral vectors pSuper-p130Cas and pSuper-integrin 3, 
mouse p130Cas target sequence, 5′-GCATGACATCTACCAAGTT-3′,  mouse 
integrin 3 target sequence, 5′-CAGCTCATTGTTGATGCTT-3′ [25], mouse TESK1 
target sequence, 5′-GTGCCTGCTTTCCGAACTTTG-3′, or mouse TESK2 target 
sequence, 5′-CCTGAGTTCTTGCATCA-3′ were cloned into pSuper-puro vector 
(Oligoengine, Seattle, WA), respectively. The wild-type or phosphorylation-defective 
mutant 15YF [17] of mouse p130Cas was subcloned into pBabe-hygro vector. To 
protect from shRNA-mediated knockdown, these pBabe-p130Cas-hygro constructs 
contained several nucleotide mismatch mutations, 5′-GCATGATATATATCAAGTT-
3′, compared with the p130Cas shRNA sequence without amino acids substitution. A 
full-length mouse cofilin cDNA was obtained from NIH3T3 cDNA pools and cloned 
into a pBabe-HA vector. pBabe-HA-cofilinS3E encoded a mutant cofilin in which 
serine at amino acid position 3 was replaced with glutamic acid. The bacterial 
expression vector for GST-cofilin was constructed by subcloning wild-type cofilin 
into pGEX-4T-1. pMX-IlkS343D-neo was generated as previously described [24]. 
 
Immunoblot analysis 
 C2C12 cells were solubilized with an ice-cold cell lysis buffer (50 mM Tris 
pH 8.0, 150 mM NaCl, 1% Tritone-X100, 0.5% SDS, 10 mM EDTA, 1 mM Na3VO4, 
10 mMNaF, protease inhibitor cocktail [Roche Molecular Biochemicals, 
Indianapolis, IN, USA] and 1 mM DTT), sonicated and centrifuged at 20,000 ×g for 
20 min. The supernatants were then subjected to sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). 
 
Luciferase assay 
 pSRE Luc was obtained from Clontech Laboratories Inc (Palo Alto, CA). The 
control plasmid pRL-TK (renilla luciferase reporter) was obtained from Toyobo 
(Osaka, Japan). The reporter construct -actin-Luc was generated by subcloning the 
1.2 kbp fragment encompassing the promoter region (-1200 to +10) of the mouse 
skeletal muscle -actin gene into the pGL3-basic vector. The luciferase activity was 
scaled to the average value of the cells cultured in GM set at 1. Data represents the 
mean ± SD of three independent assays. A p value of <0.02 was considered 






 Immunofluorescence staining was performed as described previously [26]. 
Cells were fixed with 4% paraformaldehyde (PFA), permiabilized with 0.1% 
TritonX-100, and then blocked with 2% BSA in cytoskeletal stabilizing buffer (137 
mM NaCl, 5 mM KCl, 1.1 mM Na2HPO4, 0.4 mM KH2PO4, 4 mM NaHCO3, 2 mM 
MgCl2, 5.5 mM glucose, 2 mM EGTA, and 5 mM PIPES, pH 6.1). Alexa Fluor 488- 
or 546-conjugated goat anti-mouse and anti-rabbit IgG (Molecular Probes, Carlsbad, 
CA) were used as secondary antibodies. DAPI (Vector Laboratories, Burlingame, 
USA), Alexa Fluor 488 phalloidin (Molecular Probes, Carlsbad, CA), and Alexa-594 
DNase I (Molecular Probes, Carlsbad, CA) were used to stain the nucleus, F-actin 
and G-actin, respectively. The cells were observed with an inverted microscope 
(Nikon ECLIPSE TE2000-S) or a confocal microscope comprised of either an 
inverted microscope (IX81, Olympus, Tokyo) equipped with a spinning disk confocal 
unit (Perkin-Elmer Life Sciences, Boston, MA), a water-immersion objective (NA 
1.20, 60X; PLFL Olympus) and an EMCCD camera (C9100-50, Hamamatsu 
Photonics, Hamamatsu, Japan) or a confocal microscope (A1Rsi, Nikon, Tokyo, 
Japan) equipped with oil-immersion (NA 1.40, 100X; Plan Apochromat VC, Nikon) 
and air (NA 0.95, 40X; Plan Apochromat, Nikon) objectives. Acquired images were 
analyzed off line with the public domain Image J program (version 1.45f). 
 
Ratio of F-actin to G-actin 
F-actin and G-actin were visualized with Alexa Fluor 488-phalloidin and 
Alexa Fluor 594-DNase I, respectively. The intensity ratio of F-actin to G-actin was 
calculated for each pixel and the calculated values were averaged within individual 
cell regions. Data represents the mean  SD of more than ten independent cells. 
 
In-gel kinase assay 
In-gel kinase assay of ILK was performed as previously described with 
slight modifications [27]. Briefly, C2C12 cells were solubilized with an ice-cold cell 
lysis buffer (50 mM Tris pH 7.4, 1% NP-40, 0.5% SDS, 50 mM NaCl, 5 mM EDTA, 
0.1 mM Na3VO4, 5 mM -glycerophosphate, 2.5 mM NaF and a protease inhibitors 
cocktail), and immunoprecipitated with an anti-ILK antibody (Upstate). The 
precipitated complexes were subjected to SDS-PAGE using a gel containing 0.25 
mg/ml GST-cofilin. After electrophoresis, the gel was incubated in a kinase assay 
buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM NaCl, 100 mM Na3VO4, 20 
mM -glycerophosphate, 1 mM DTT, 100 M ATP) at 30oC for 30 min after 
denaturation and renaturation, and then transferred onto a PVDF membrane. The 
level of GST-cofilin phosphorylation was assessed by Western blotting using an anti-





 Total RNA extraction and cDNA preparation were performed as previously 
described [23]. RT-PCR analysis of hILK S343D and -actin was carried out using the 
following primer pairs (hILK 762 bp, 5’-GCAGTCGCCGTTCGCCT-3’ forward and 
5’- AGTAGGATGAGGAGCAGGT-3’ reverse, m-actin 313 bp, 5’- 
ATGGATGACGATATCGCTGCGC-3’ forward and 5’- 




p130Cas phosphorylation is required for C2C12 myotube formation 
 To examine whether p130Cas was involved in myogenic differentiation, we 
silenced p130Cas expression in C2C12 myoblasts using a retroviral system. 
Expression of p130Cas was efficiently attenuated by shRNA-mediated gene 
knockdown at least up to day 4 after replacement of growth medium (GM) with 
differentiation medium (DM) (Figure 1A, top). Control-shRNA-expressing cells 
became elongated and aligned by day 2 and formation of multinucleated myotubes 
was observed on day 4 after medium replacement with DM (Figure 1B, top). In 
contrast, p130Cas-knockdown myoblasts (CasKD cells) did not form MHC-positive 
multinucleated myotubes by day 4, although cell elongation and alignment was 
observed by day 2 (Figure 1B, bottom). Expression of skeletal muscle-specific 
proteins, including skeletal muscle -actin, MHC and myogenin, increased with the 
period of time in culture with DM, but was hardly induced in CasKD cells (Figures 
1A and 1B). These results indicate the pivotal role of p130Cas in myogenic 
differentiation. 
Phosphorylation of p130Cas was increased during differentiation of C2C12 
myoblasts (Figure 1C), as previously reported [28]. To address whether p130Cas 
phosphorylation was required for myogenic differentiation, the shRNA-resistant form 
of p130Cas, either wild-type (CasWT) or the phosphorylation-defective mutant 
(Cas15YF) [17], was introduced into CasKD cells. We confirmed that the expression 
level of exogenous p130Cas (CasWT or Cas15YF) was comparable to that of 
endogenous p130Cas (Figure 1D). As shown in figures 1E and 1F, myotube 
formation and the expression of muscle-specific proteins were restored in wild-type 
p130Cas-expressing cells (CasWT cells), but not in p130Cas15YF-expressing cells 
(Cas15YF cells). These results indicate that p130Cas phosphorylation is required for 




p130Cas is involved in the regulation of MAL localization  
 Since SRF regulates the expression of skeletal muscle-specific genes [6-9], 
we tested whether p130Cas modulated SRF transcriptional activity, through the use 
of a luciferase assay. We found that the decrease in SRF activity after the replacement 
of GM with DM was significantly greater in CasKD cells when compared to control 
cells (Figure 2A, left). The activity of the skeletal muscle -actin promoter, which 
contains SRE(s), was remarkably increased after medium replacement with DM 
(Figure 2A, right). However, activation of the skeletal muscle -actin promoter by 
medium replacement in CasKD cells was insignificant (Figure 2A, right).  
At the onset of differentiation, MAL/SRF activity is required for expression 
of skeletal muscle-specific genes [13]. We therefore examined whether knockdown of 
p130Cas altered the subcellular localization of MAL in C2C12 myoblasts. When cells 
were cultured in GM, the distribution of MAL was diffuse in the cytoplasm and 
nuclei of both control and CasKD cells (Figure 2B, top). MAL was similarly 
distributed in the cytoplasm and nuclei after medium replacement with DM in control 
cells, however it was eliminated from nuclei after medium change in CasKD cells 
(Figures 2B, bottom and 2C). We next tested if p130Cas phosphorylation modulated 
the localization of MAL. The nuclear localization of MAL, which was diminished in 
CasKD cells, was restored by expression of CasWT, but not Cas15YF (Figure 2D), 
indicating that p130Cas phosphorylation is involved in the regulation of MAL 
localization. 
 
p130Cas participates in the regulation of actin remodeling in myoblasts 
It has been reported that MAL translocation is regulated by G-actin [11, 29]. 
Since the actin cytoskeleton is disorganized in p130Cas-deficient mouse embryonic 
fibroblasts (MEFs) [18, 21], we examined whether p130Cas regulated MAL 
localization in differentiating C2C12 myoblasts through its action on the actin 
cytoskeleton. Stress fibers appeared to be less developed in CasKD cells compared 
with control cells when cultured in GM (Figure 3A, top). However, the ratio of F- to 
G-actin was comparable between these cells (Figures 3B, top and 3C). After 
medium replacement with DM, stress fiber formation and the F-/G- actin ratio were 
decreased in both control and CasKD cells when compared to those cultured in GM 
(Figures 3A-C). Notably, both stress fiber formation and the F-/G-actin ratio were 
significantly decreased in CasKD cells compared to control cells (Figures 3A, 
bottom, 3B, bottom and 3C, and Supplementary Figures S1A-C). Re-introduction 
of CasWT, but not Cas15YF, restored actin stress fiber formation in CasKD cells 
under both culture conditions i.e. DM and GM (Figure 3D and Supplementary 
Figure S1D). The decrease in the ratio of F-actin to G-actin after medium 
 
 
replacement with DM was moderated by the expression of CasWT but not Cas15YF 
(Figures 3E and 3F). These results suggest that p130Cas phosphorylation plays a 
role in the regulation of actin remodeling and thereby regulates MAL nuclear 
localization in differentiating C2C12 myoblasts.  
  
Integrin 3 drives p130Cas phosphorylation in differentiating C2C12 myoblasts  
 It has been reported that integrin 3 is involved in myogenic differentiation 
[20] and that activation of integrin 3 signaling supports p130Cas phosphorylation 
[22]. We therefore tested whether integrin 3 was involved in the increase in 
p130Cas phosphorylation during myogenic differentiation. Consistent with the 
previous report [20], the expression of integrin 3 was increased during 
differentiation of C2C12 myoblasts (Figure 4A, first panel). The increase in 
p130Cas phosphorylation after medium replacement with DM was attenuated by 
silencing of integrin 3 (Figure 4A), suggesting that integrin 3 acts upstream of 
p130Cas in differentiating myoblasts. Furthermore, integrin 3 knockdown 
diminished C2C12 myotube formation (Figure 4B), as well as the expression of 
muscle-specific proteins (Figure 4C). Nuclear localization of MAL was also 
impaired by integrin 3 knockdown in C2C12 myoblasts cultured in DM (Figure 4D). 
These results suggest that integrin 3 plays a role in myogenic differentiation by 
facilitating p130Cas phosphorylation and subsequent MAL nuclear translocation and 
SRF activation.  
 
Cofilin inactivation is important for myogenic differentiation via p130Cas 
 Active (unphosphorylated) cofilin stimulates actin depolymerization and 
increases the G-actin pool, thereby inhibiting MAL nuclear translocation and down-
regulating SRF activity [29]. We found that phosphorylation of cofilin at the Ser3 
residue, which leads to its inactivation, increased in control cells but not in CasKD 
cells when cultured in DM (Figure 5A). To examine the role of cofilin in p130Cas-
mediated regulation of C2C12 differentiation, we expressed the phospho-mimetic 
mutant form of cofilin (cofilinS3E) in CasKD cells (Figure 5B). The expression of 
cofilinS3E restored stress fiber formation and MAL nuclear localization in CasKD 
cells (Figures 5C and 5D, Supplementary Figure S1E). Accordingly, the 
expression of skeletal muscle-specific proteins and myotube formation, which were 
attenuated by p130Cas gene silencing, were also restored upon cofilin S3E expression 
(Figures 5E and 5F). These results suggest that cofilin is involved in p130Cas-
mediated differentiation of C2C12 myoblasts.  
 
ILK is involved in cofilin inactivation via p130Cas 
 
 
It has been reported that cofilin is phosphorylated by several kinases, 
including LIM-kinase (LIMK), testicular protein kinase (TESK) and integrin-linked 
kinase (ILK), while it is dephosphorylated by phosphatases such as Slingshot and 
Chronophin [30, 31]. To address how p130Cas was linked to cofilin inactivation 
during C2C12 differentiation, we first tested whether LIMK activity was altered by 
silencing of p130Cas. Phosphorylation of LIMK decreased after medium replacement 
with DM and no significant difference in LIMK phosphorylation was observed 
between control and CasKD cells (Supplementary Figure S2A). Phosphorylation 
of cofilin, but not of p130Cas, was decreased by treating the cells in GM with a 
LIMK inhibitor (Supplementary Figure S2B). However, LIMK inhibition affected 
neither p130Cas phosphorylation nor cofilin phosphorylation induced after 
medium replacement with DM (Supplementary Figure S2C). LIMK is therefore 
unlikely to be involved in p130Cas-mediated phosphorylation of cofilin in 
differentiating myoblasts.  
TESK1 and TESK2 are expressed at high levels in testis and at low levels in 
other tissues [32, 33], whereas their expression levels in skeletal muscle or myogenic 
cells remain undefined. The results of quantitative real-time PCR showed that both 
TESK1 and TESK2 were expressed in C2C12 myoblasts, although their expression 
levels were significantly lower compared with that in mouse testicular tissues 
(Supplementary Figure S3A). To examine the roles of TESKs in the process of 
myogenic differentiation, we then silenced TESK1 and TESK2 expression in C2C12 
myoblasts (Supplementary Figure S3B). Myotube formation which was observed in 
the control cells on day 4 was impaired by knockdown of TESK2, but not TESK1 
(Supplementary Figures S3C and S3D). These results suggest that TESK1 is not 
involved in p130Cas-mediated myogenic differentiation. In the case of TESK2-
knockdown myoblasts (TESK2KD cells), cell elongation/alignment on day 2, which 
was observed in both control and CasKD cells (Figure 1B, bottom), was prevented 
(Supplementary Figures S3C). Notably, unlike in CasKD cells, cell viability 
appeared remarkably decreased in TESK2KD cells when cultured in DM 
(Supplementary Figure S3E). Taken together, we suggest that silencing of TESK2 
expression hampers myogenic differentiation by a mechanism unrelated to p130Cas-
mediated signaling. 
ILK has been reported to directly bind the integrin  subunit [34]. We 
analyzed the distribution of ILK in C2C12 myoblasts by immunostaining. Although 
ILK moderately colocalized with phosphorylated paxillin, we were not able to clearly 
define ILK distribution to adhesions in control and CasKD cells cultured with GM 
(Figure 6A, top). However, there was a distinct difference in ILK distribution 
between control and CasKD cells after the induction of myogenic differentiation. ILK 
 
 
showed a more distinct accumulation and colocalization with phosphorylated paxillin 
in control cells (Figure 6A, bottom), but was diffusely distributed in the cytoplasm 
of CasKD cells. These results suggest that ILK plays a role in adhesion-associated 
p130Cas-mediated signaling events related to the induction of myogenic 
differentiation. To examine whether ILK was involved in p130Cas-dependent C2C12 
differentiation, we expressed a human ILK mutant (hILK S343D), which has been 
reported as constitutively active [34], in CasKD cells (Figure 6B). Similar to CasKD 
cells expressing the phospho-mimetic form of cofilin (cofilin S3E) (Figures 5E and 
5F), expression of hILK S343D in CasKD cells restored myogenic differentiation 
(Figures 6C and 6D). These findings suggest that ILK is involved in the regulation 
of myogenic differentiation by p130Cas.  
To test whether ILK phosphorylated cofilin in C2C12 myoblasts, we 
conducted an in-gel kinase assay of anti-ILK immunoprecipitates using GST-cofilin 
as a substrate (Supplementary Figure S4). Cofilin phosphorylation by protein(s) of 
51 kDa, the molecular weight of ILK, was not apparent (Figure 6E, top panel, 
arrowhead). However, we found that cofilin was phosphorylated by ILK-associated 
proteins of several different molecular weights larger than 51 kDa, suggesting that 
ILK itself may not directly phosphorylate cofilin. The activity of cofilin 
phosphorylation was significantly increased in control cells after medium 
replacement with DM (Figure 6E, top panel, lanes 2 and 3) and was attenuated by 
silencing of p130Cas (Figure 6E, top panel, lanes 5 and 6). While an increase in 
ILK expression was observed after the induction of differentiation (Figure 6E, 
bottom, lane 1 vs lanes 2 and 3), it did not appear to fully account for the 
remarkable increase in cofilin phosphorylation (Figure 6E, top, lane 1 vs lanes 2 
and 3). Furthermore, ILK expression levels were comparable between control and 
CasKD cells (Figure 6B, bottom). It is therefore likely that p130Cas modulated the 
activity of ILK complexes, but not ILK expression. Based on these findings, we 
conclude that p130Cas regulates myogenic differentiation through cofilin inactivation 




 Myogenesis is involved not only in development but also during maintenance 
and repair of adult skeletal muscle tissues. The actin cytoskeleton exhibits striking 
rearrangements during the differentiation of myoblasts to multinucleated muscle 
fibers. Remodeling of the actin cytoskeleton is required for elongation, alignment and 
fusion of myoblasts. p130Cas acts as a cytoskeletal mechano-sensor through stretch-
dependent tyrosine phosphorylation [17] and regulates actin dynamics [18]. In this 
 
 
study we looked into the molecular function of p130Cas in myogenic differentiation, 
focusing on myotube formation and actin remodeling. 
SRF activity is regulated by two distinct cofactors, namely TCF that is 
activated by the ERK pathway, and MAL that is regulated by the modulation of actin 
cytoskeletal dynamics [13]. MAL/SRF activity is required for the expression of 
skeletal muscle-specific genes. As previously reported [12], ERK activity decreased 
in control cells after the induction of differentiation i.e. medium replacement with 
DM, and was similarly decreased in CasKD cells (Supplementary Figure S5). 
Concomitantly, F-actin formation also decreased (Figures 3A-C).  These results 
suggest that both TCF- and MAL-mediated SRF activities are mitigated at the onset 
of myogenic differentiation. The decrease in F-actin formation after medium 
replacement with DM was enhanced by silencing of p130Cas (Figures 3A-C and 
Supplementary Figures S1A-C). Correspondingly, MAL was eliminated from the 
nuclei of CasKD cells cultured in DM (Figures 2B and 2C). This was consistent with 
the decrease in the SRE-luciferase activity observed in CasKD cells under the same 
culture conditions (Figure 2A, left). In contrast, the expression of skeletal muscle-
specific genes (Figure 1A) and the activity of the skeletal muscle -actin promoter 
(Figure 2A, right) were remarkably increased after medium replacement with DM. 
Previous studies have demonstrated that the myogenic transcriptional repressor 
YinYang1 (YY1) binds to the -actin promoter and suppresses -actin expression in 
proliferating C2C12 myoblasts [35, 36]. It has been proposed that, at the onset of 
myogenic differentiation, YY1 that recruits the polycomb protein Ezh2 and histone 
deacetylase HDAC1, is replaced by SRF, MyoD and histone acetyltransferase CBP or 
p300/CBP-associated factor (PCAF) [35, 36]. The -actin promoter contains not only 
SREs but also E-boxes, the consensus sequence for the binding of basic helix-loop-
helix transcription factors including MyoD [37]. Taken together, the increase in -
actin promoter activity after medium replacement with DM (Figure 2A, right) may 
be due to the replacement of the YY1/Ezh2/HDAC1 repressive complex with SRF, 
MyoD and histone acetyltransferase(s). We found that silencing of p130Cas 
abrogated the increase in -actin promoter activity after medium replacement with 
DM (Figure 2A, right). Since SRF activity is regulated by p130Cas at the onset of 
differentiation (Figure 2A, left) and MyoD expression can be induced by SRF [7], 
the suppression of -actin promoter activity by silencing of p130Cas may be a 
synergistic effect of inhibition of SRF and MyoD activities. 
 Previous reports demonstrate that integrin 3 is involved in myogenic 
differentiation through the activation of p38MAPK, mediated by Rac1 [20, 38]. 
Integrin 3 silencing attenuates the activity of p38-dependent myogenesis regulators 
such as p21
CIP1
 and myogenin [20], whereas p130Cas knockdown did not interfere 
 
 
with p38 MAPK activity (Supplementary Figure S2). In contrast, actin cytoskeleton 
reorganization during myogenic differentiation, which is reportedly mediated by 
integrin 3 [20], did involve p130Cas phosphorylation (Figures 3D-F and 
Supplementary Figure S1D). Together with the decrease in p130Cas 
phosphorylation by silencing of integrin 3 (Figure 4A), we suggest that integrin 3 
regulates myogenic differentiation by facilitating phosphorylation of p130Cas, which 
potentiates actin remodeling. In addition, MAL nuclear localization in differentiating 
myoblasts was attenuated by silencing of either p130Cas or integrin 3 (Figures 2B-
D and 4D). These results support the notion that the integrin 3/p130Cas pathway 
regulates MAL nuclear localization through the modulation of actin cytoskeletal 
dynamics. 
Cofilin promotes actin filament disassembly and contributes toward 
supplying an abundant pool of cytoplasmic actin monomers i.e. G-actin [39]. 
Subsequently, G-actin binds to MAL and inhibits its nuclear localization [29]. In the 
case of epidermal stem cells, cofilin inactivation and concomitant MAL/SRF 
activation are required for their differentiation into keratinocytes [40]. Our results 
suggest that p130Cas is involved in cofilin inactivation during skeletal muscle 
differentiation. Cofilin inactivation lowers the concentration of G-actin and enhances 
MAL/SRF activity, which is critical for muscle-specific gene expression [10, 41]. 
p130Cas-dependent inactivation of cofilin (Figure 5A) and restoration of myogenic 
differentiation of CasKD cells by the expression of a dominant-negative form of cofilin 
(cofilinS3E) (Figures 5E and 5F) indicate that cofilin acts as a downstream mediator of 
p130Cas in the context of C2C12 differentiation. We suggest that p130Cas tempers 
the decrease in F-actin formation through inactivation of cofilin and thereby 
contributes to the maintenance of SRF activity required for muscle-specific gene 
expression. 
ILK has been reported to play a critical role in skeletal and cardiac muscle 
development and maintenance [34]. A recent study shows that Kindlin-2, which is an 
integrin-associated adaptor protein and regulates the recruitment of ILK to focal 
adhesions [42], is required for C2C12 myotube formation [43]. However, detailed 
molecular mechanisms behind ILK-dependent regulation of myogenic differentiation 
remain unclear. The expression level of ILK appears important, as its over-expression 
impairs C2C12 myotube formation via a defect in ERK inactivation at the onset of 
differentiation [44]. Although the expression of mutant ILK (S343D) restored 
differentiation of CasKD cells (Figures 6C and 6D), cofilin phosphorylation by ILK 
itself was not apparent (Figure 6E). Taken together, ILK may be a crucial scaffold 
molecule that determines ERK-mediated proliferation and p130Cas-mediated 
differentiation of myoblasts. Moreover, it has been reported that ILK is required for 
 
 
skeletal muscle fiber stability [45] and we have found that p130Cas regulates 
sarcomeric organization in myotubes (manuscript in preparation). From the 
mechanical implications of p130Cas and ILK functions [17, 46, 47], the interplay 
between p130Cas and ILK may be a key element for the maintenance of muscles. 
Myoblasts elongate and align prior to their fusion, with a decrease in RhoA 
activity involved in these cell morphological changes [2]. Reduced F-actin formation 
after medium replacement with DM (Figures 3A-C) may therefore result from the 
down-regulation of RhoA activity. The concomitant increase in G-actin was tempered 
by p130Cas-dependent inactivation of cofilin via ILK complexes (Figures 5A and 
6E). Taken collectively, we therefore propose a novel model for the molecular 
mechanism underlying myogenic differentiation mediated by integrin 3/p130Cas 
signaling, in which skeletal muscle-specific gene expression is induced by MAL/SRF 
through ILK-dependent cofilin inactivation (Figure 6F). 
Differentiation is strictly programmed by integrin-mediated 
mechanosensing machinery [48]. p130Cas-dependent actin remodeling during 
myogenic differentiation may facilitate adhesion-cytoskeleton organization and serve 
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Figure 1 p130Cas is required for myotube formation of C2C12 cells 
(A–B) C2C12 myoblasts were infected with shRNA vector- or p130Cas-shRNA-
expressing retroviruses. (A) The cells were cultured in GM and then switched to DM. 
The cells were then solubilized on the indicated days and the expression levels of 
p130Cas and skeletal muscle-specific proteins were evaluated by immunoblot 
analysis. An anti-tubulin blot provided a loading control. (B) Cells cultured in DM 
were fixed with 4% paraformaldehyde on the indicated days and subjected to anti-
MHC immunostaining (red) and DAPI staining (blue). Images were obtained with an 
inverted microscope (Nikon ECLIPSE TE2000-S). Scale bar: 50 m. (C) C2C12 
myoblasts cultured in GM were solubilized and phosphorylation levels of p130Cas 
(p-p130Cas) were evaluated by immunoblot analysis. (D–F) C2C12 myoblasts were 
co-infected with shRNA vector- or p130Cas-shRNA-expressing retroviruses, together 
with the shRNA-resistant form of wild-type p130Cas- or mutant p130Cas15YF-
expressing retroviruses. (D) The cells cultured in GM were solubilized and the 
expression and phosphorylation levels of p130Cas were evaluated by immunoblot 
analysis. (E) The cells were cultured in GM and then switched to DM. The cells were 
then solubilized on the indicated days and the expression of skeletal muscle-specific 
proteins evaluated by immunoblot analysis. (F) Cells were fixed with 4% 
paraformaldehyde 4 days after medium replacement with DM and subjected to anti-
MHC immunostaining (red) and DAPI staining (blue). Scale bar: 50 m. Images were 
obtained with a confocal microscope (A1R) equipped with an objective (40X).  
 
Figure 2 p130Cas regulates nuclear localization of MAL during myogenic 
differentiation  
(A-C) C2C12 myoblasts were infected with shRNA vector- or p130Cas-shRNA-
expressing retroviruses. (D) C2C12 myoblasts were co-infected with shRNA vector- 
or p130Cas-shRNA-expressing retroviruses, together with the shRNA-resistant form 
of wild-type p130Cas- or mutant p130Cas15YF-expressing retroviruses. (A) The 
cells were transfected with SRE-Luc (left) or -actin promoter-Luc (right) reporter 
plasmid, together with phRL-TK (internal control). One day after transfection, the 
cells were kept in GM or switched to DM one day prior to analysis, then lysed and 
subjected to a luciferase assay. Values were normalized with the mean values of the 
cells cultured in GM set at 1. Data represents the mean ± SD of three independent 
assays. Asterisks, p < 0.02 (unpaired Student’s t-test.). (B–D) The cells were cultured 
in GM or switched to DM one day prior to analysis and then subjected to anti-MAL 
immunostaining (green; B and D, red; C) and DAPI staining (blue). (B and D) The 
 
 
images were obtained with a confocal microscope (A1R) equipped with an oil-
immersion objective (100X). Scale bar: 20 m. (C) The Z-stack images with 0.2 m-
interval were obtained using a confocal microscope (Spinning disk) equipped with a 
water-immersion objective (60X). Projected images along the z-axis and XZ-section 
images along the yellow lines are shown. Plots of MAL (red lines) and DAPI (blue 
lines) intensities along dotted lines in the XZ-section images are also shown. 
Intensities were normalized by the maximum values in the individual plots.  
 
Figure 3 p130Cas regulates actin remodeling in myoblasts  
C2C12 myoblasts were cultured in GM or switched to DM one day prior to analysis. 
(A–C) The cells were infected with shRNA vector- or p130Cas-shRNA-expressing 
retroviruses. (D–F) The cells were co-infected with shRNA vector- or p130Cas-
shRNA-expressing retroviruses, together with either vector- or shRNA-resistant form 
of wild-type p130Cas- or mutant p130Cas15YF-expressing retroviruses. (A and D) 
Cells stained for F-actin. Scale bar: 20 m. (B and E) Ratio images of F-actin to G-
actin. Cells were stained for F-actin and G-actin with Alexa 488-phalloidin and Alexa 
594-DNase I, respectively, and their intensity ratio was calculated. Scale bar: 20 m. 
(C and F) F-actin/G-actin ratio. Values were normalized with the mean value of the 
control cells cultured in GM. Data represents the mean  SD of more than ten 
independent cells. Asterisks, p < 0.01 (unpaired Student’s t-test.). 
 
Figure 4 Integrin 3 is involved in p130Cas phosphorylation during myogenic 
differentiation 
C2C12 myoblasts were infected with shRNA vector- or integrin 3-shRNA-
expressing retroviruses. (A–C) The cells were cultured in GM and then switched to 
DM. (A) Cells were solubilized on the indicated days. The expression levels of 
integrin 3 (ITG3) and phosphorylated p130Cas (p-p130Cas) were evaluated by 
immunoblot analysis. (B) Cells were fixed with 4% paraformaldehyde 4 days after 
medium replacement with DM, and subjected to anti-MHC immunostaining (red) and 
DAPI staining (blue). The images were obtained with a confocal microscope (A1R) 
equipped with an objective (40X). Scale bar: Scale bar: 50 m. (C) Cells were 
solubilized on the indicated days. The expression of skeletal muscle-specific proteins 
was evaluated by immunoblot analysis. (D) The cells were cultured in GM or 
switched to DM one day prior to analysis and then subjected to anti-MAL 
immunostaining (green) and DAPI staining (blue). The images were obtained with a 
confocal microscope (A1R) equipped with an oil-immersion objective (100X). Scale 




Figure 5 Cofilin inactivation restores impaired myotube formation by p130Cas 
knockdown 
(A) C2C12 myoblasts were infected with shRNA vector- or p130Cas-shRNA-
expressing retroviruses. The expression level of cofilin and phosphorylation of cofilin 
(p-cofilin) were evaluated by immunoblot analysis. An anti-tubulin blot provided a 
loading control. (B–F) C2C12 myoblasts were co-infected with shRNA vector- or 
p130Cas-shRNA-expressing retroviruses, together with either vector- or HA-tagged 
mutant cofilin (cofilinS3E)-expressing retroviruses. (B) The expression of HA-tagged 
cofilinS3E was confirmed by immunoblot analysis. (C and D) The cells were 
cultured in GM or switched to DM one day prior to analysis. (C) The cells were 
stained for F-actin with phalloidin. (D) Anti-MAL immunostaining (green) and DAPI 
staining (blue). Images were obtained with a confocal microscope (A1R) equipped 
with an oil-immersion objective (100X). Scale bars: 20 m. (E and F) The cells were 
cultured in GM and then switched to DM. (E) Cells were solubilized on the indicated 
days and the expression levels of skeletal muscle-specific proteins were evaluated by 
immunoblot analysis. (F) Cells were fixed with 4% paraformaldehyde 4 days after 
medium replacement with DM and subjected to anti-MHC immunostaining (red) and 
DAPI staining (blue). Scale bar: 50 m.  
 
Figure 6 p130Cas regulates cofilin phosphorylation through ILK 
(A) C2C12 myoblasts were infected with shRNA vector- or p130Cas-shRNA-
expressing retroviruses. The cells were cultured in GM or switched to DM one day 
prior to analysis. Anti-ILK (red) and phospho-paxillin (green) immunostaining were 
performed. The images were obtained with a confocal microscope (A1R) equipped 
with an oil-immersion objective (100X). Scale bar: 20 m. (B-D) C2C12 myoblasts 
were co-infected with p130Cas-shRNA-expressing retroviruses, with or without 
mutant ILK (ILK-S343D)-expressing retroviruses. (B) The cells cultured in GM were 
solubilized and the expression levels of p130Cas and mutant ILK evaluated by 
immunoblot analysis and RT-PCR, respectively. (C) The cells were cultured in GM 
and switched to DM. The cells were then solubilized on the indicated days and the 
expression levels of skeletal muscle-specific proteins evaluated by immunoblot 
analysis. (D) Cells were fixed with 4% paraformaldehyde 4 days after medium 
replacement with DM and subjected to anti-MHC immunostaining (red) and DAPI 
staining (blue). Scale bar: 50 m. (E) C2C12 myoblasts were infected with shRNA 
vector- or p130Cas-shRNA-expressing retroviruses. Cells were solubilized on the 
indicated days and cell lysates were subjected to immunoprecipitation with an 
antibody against ILK. The activity of ILK-associated proteins in phosphorylating 
cofilin was estimated by an in-gel kinase (IGK) assay (top panel). Phosphorylated 
 
 
cofilin (p-cofilin) was evaluated by immunoblot analysis using an anti-phospho-
cofilin antibody. Arrowheads indicate the position of ILK (~51 kDa). (F) A proposed 
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Stress fiber thickness analysis 
Stress fiber thickness was quantitatively analyzed as described 
previously [1], with slight modifications.  In brief, F-actin images were 
subjected to erosion spatial filtering with a 3  3 pixel matrix, which replaced 
the center pixel in the matrix with the darkest value found in the matrix.  
Fluorescence intensities on stress fibers were gradually decreased by repeating 
the erosion filtering. The decay curve of stress fiber intensity against the cycle 
number of erosion filtering was fitted by the following equation; 
                        I = A + B exp (-N/), 
where I is fluorescence intensity on a stress fiber, N is the cycle number of the 
erosion filtering,  is the decay constant, and A and B are constants.  Since 
fluorescence intensity on a thinner stress fiber decayed more rapidly in 
response to the filtering (Figure S1), the decay constant  was used as a stress 
fiber thickness index (SFTI) - thicker stress fibers have larger SFTI values. 
Data represents the mean + SD of more than thirty stress fibers from more 
than ten independent cells. 
 
Antibodies and chemical reagent 
 Anti-phospho-ERK1/2 (T202/Y204) polyclonal (Cell Signaling 
Technology), anti-ERK1/2 polyclonal (Cell Signaling Technology), anti-
phospho-p38MAPK (T180/Y182) polyclonal (3D7; Cell Signaling 
Technology), anti-p38MAPK polyclonal (Cell Signaling Technology), anti-
phospho LIMK (T508/T505) polyclonal (Cell Signaling Technology), and 
anti-LIMK1 polyclonal (Cell Signaling Technology), antibodies were used for 
immunoblot analyse. LIMK inhibitor (LIMKi; BMS-5) was purchased from 
Synkinase (San Diego, CA). 
 
Quantitative real-time PCR 





 Supermix (Bio-Rad Laboratories, Hercules, CA) under the 
following conditions: 30 sec at 95
o
C, followed by 40 cycles of 95
o
C for 10 sec 
and 60
o
C for 10 sec using Bio-Rad CFX96
TM
 Real-Time PCR Detection 
System. The primer sets used were: mouse TESK1 forward, 5’-
AGATCAAGCTGCTGGACAC-3’, reverse 5’-
GGTAGAGGTAAGTGGTGATGG-3’, mouse TESK2 forward, 5’- 
CTATTACCAGCCACGAGATG-3’, reverse 5’- 
GACAGTCAGCCAGAGTTG-3’, mouse -actin forward, 5’- 
CATCCGTAAAGACCTCTATG-3’, reverse 5’- 
TGATCTTGATCTTCATGGTG-3’. After normalization against -actin, data 






SUPPLEMENTARY FIGURE LEGENDS 
 
Figure S1 Quantitative analyses of stress fiber thickness 
(A and B) Principle of the method for erosion filtering-based analysis of stress 
fiber thickness. In response to the filtering cycles, fluorescence intensities on 
thick stress fibers (cells infected with shRNA vector-expressing retrovirus) 
decayed slower compared with those on thin stress fibers (cells infected with 
p130Cas-shRNA-expressing retrovirus). The decay constant () of stress fiber 
intensity against the cycle number of erosion filtering was used as a stress 
fiber thickness index (SFTI). See SUPPLEMENTARY EXPERIMENTAL for 
details. Scale bar: 10 m. (C-E) SFTI of C2C12 cells after switching to DM 
for one day.  (C) SFTI of cells infected with shRNA vector- or p130Cas-
shRNA-expressing retrovirus. (D) SFTI of cells co-infected with p130Cas-
shRNA-expressing retrovirus together with control vector-, shRNA-resistant 
wild-type p130Cas- or shRNA-resistant p130Cas15YF-expressing retrovirus.  
(E) SFTI of cells co-infected with p130Cas-shRNA-expressing retrovirus 
together with control vector- or HA-cofilin S3E-expressing retrovirus.  Each 
bar represents the mean  SD for more than 30 stress fibers of >10 cells. 
Asterisks, p < 0.01 (unpaired Student’s t-test.). 
 
Figure S2 Knockdown of p130Cas does not significantly alter LIMK 
activity in C2C12 myoblasts 
(A) C2C12 myoblasts were infected with shRNA vector- or p130Cas-shRNA-
expressing retroviruses. The cells were cultured in GM and then switched to 
DM. The cells were then solubilized on the indicated days and the activity of 
LIMK was evaluated by immunoblot analysis using anti-phospho-LIMK and 
anti-LIMK antibodies. The anti-tubulin blot provided a loading control. (B) 
C2C12 myoblasts were cultured in GM with or without LIMKi (3 M) for 24 
hours. (C) C2C12 myoblasts were cultured in GM and then switched to DM 
with or without LIMKi. The cells were solubilized 24 hours after treatment. 
The levels of phosphorylation of p130Cas (p-p130Cas) and cofilin (p-cofilin) 
were evaluated by immunoblot analysis. 
 
Figure S3 Knockdown of TESK2, but not TESK1, impairs myoblast 
elongation/alignment and subsequent myotube formation 
(A) TESK1 (left panel) and TESK2 (right panel) gene expressions in C2C12 
myoblasts and C57/B6 mouse testis were examined by quantitative real-time 
PCR. The mRNA expression levels of TESK1 and TESK2 were normalized 
against -actin expression and scaled with the expressions in mouse testis set 
as 1. (B-E) C2C12 myoblasts were infected with shRNA vector-, TESK1-, 
TESK2-, or p130Cas-shRNA (E) -expressing retroviruses. (B) Knockdown 
efficiency of TESK1 shRNA or TESK2 shRNA in the myoblasts was 
evaluated by quantitative real-time PCR. (C) The cells were cultured in GM 
and then switched to DM. Phase-contrast images of the cells cultured in DM 
for indicated days were taken using OLYMPUS CKX41 microscope. Scale 
bar: 50 m. (D) Cells were fixed with 4% paraformaldehyde 4 days after 
medium replacement with DM and subjected to anti-MHC immunostaining 
(red) and DAPI staining (blue). Images were obtained with an inverted 
microscope (OLYMPUS IX-71). Scale bar: 50 m. (E) The cells were 
cultured in GM and then switched to DM. Dead cells were identified by 0.4% 
 
 
trypan blue exclusion-based cell staining. Data are expressed as the 
percentage of dead cells over total cell number on the indicated days and 
presented as the mean ± SD of three independent assays. Asterisks, p < 0.02 
(unpaired Student’s t-test.).  
  
Figure S4 Purification of GST-cofilin fusion protein 
The recombinant GST-cofilin fusion protein expressed in BL21 E. coli was 
purified using glutathione-sepharose beads and eluted from the beads with 20 
mM reduced glutathione. A Coomassie Brilliant Blue (CBB)-stained gel 
showed the GST-cofilin fusion protein used as a substrate in the in-gel kinase 
assay. 
 
Figure S5 Knockdown of p130Cas does not interfere with activation of 
ERK and p38 MAPK in C2C12 myoblasts  
C2C12 myoblasts were infected with shRNA vector- or p130Cas-shRNA-
expressing retroviruses. The cells were cultured in GM and then switched to 
DM. The cells were then solubilized on the indicated days and 
phosphorylation of ERK1/2 and p38 MAPK evaluated by immunoblot 
analysis. White arrowheads indicate ERK1; black arrowheads indicate ERK2. 
The anti-tubulin blot provided a loading control.  
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